<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<title>META-SPRINT: 40 dias para evid√™ncias confi√°veis</title>
<link href="https://fonts.googleapis.com" rel="preconnect"/>
<link crossorigin="" href="https://fonts.gstatic.com" rel="preconnect"/>
<link href="https://fonts.googleapis.com/css2?family=Cormorant+Garamond:ital,wght@0,400;0,600;0,700;1,400;1,600&amp;family=Source+Sans+Pro:wght@300;400;600;700&amp;display=swap" rel="stylesheet"/>
<style>
    :root {
      --navy: #1E2761;
      --deep-navy: #141B3D;
      --gold: #D4AF37;
      --cream: #FAF8F5;
      --light-cream: #FFFFFF;
      --text: #2D3748;
      --light-text: #718096;
      --red: #C53030;
      --green: #22c55e;
      --teal: #0f766e;
      --purple: #7c3aed;
      --orange: #f59e0b;
      --transition: 0.5s cubic-bezier(0.4, 0, 0.2, 1);
    }

    * { margin: 0; padding: 0; box-sizing: border-box; }
    html, body {
      height: 100%;
      font-family: 'Source Sans Pro', sans-serif;
      background: var(--deep-navy);
      color: var(--cream);
    }

    .course-container { display: flex; height: 100vh; overflow: hidden; }

    /* ====== SIDEBAR ====== */
    .sidebar {
      width: 300px;
      background: linear-gradient(180deg, var(--deep-navy) 0%, #0a0f1a 100%);
      border-right: 1px solid rgba(212,175,55,0.2);
      display: flex;
      flex-direction: column;
      flex-shrink: 0;
    }

    .sidebar-header {
      padding: 1.25rem;
      border-bottom: 1px solid rgba(212,175,55,0.2);
      text-align: center;
    }
    .sidebar-header h1 {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: 1.3rem;
      font-weight: 700;
      color: var(--gold);
    }
    .sidebar-header p {
      font-size: 0.75rem;
      color: rgba(255,255,255,0.6);
    }

    /* Gamification Stats Panel */
    .stats-panel {
      padding: 1rem;
      background: rgba(212,175,55,0.1);
      border-bottom: 1px solid rgba(212,175,55,0.2);
    }
    .level-display {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      margin-bottom: 0.75rem;
    }
    .level-badge {
      width: 48px;
      height: 48px;
      background: linear-gradient(135deg, var(--gold), #f0c040);
      border-radius: 50%;
      display: flex;
      align-items: center;
      justify-content: center;
      font-size: 1.5rem;
      box-shadow: 0 2px 8px rgba(212,175,55,0.4);
    }
    .level-info { flex: 1; }
    .level-title { font-weight: 700; font-size: 0.9rem; color: var(--gold); }
    .level-subtitle { font-size: 0.7rem; color: rgba(255,255,255,0.6); }
    .xp-bar {
      height: 8px;
      background: rgba(255,255,255,0.1);
      border-radius: 4px;
      overflow: hidden;
      margin-top: 0.5rem;
    }
    .xp-fill {
      height: 100%;
      background: linear-gradient(90deg, var(--gold), var(--orange));
      border-radius: 4px;
      transition: width 0.5s ease;
    }
    .xp-text {
      font-size: 0.65rem;
      color: rgba(255,255,255,0.5);
      text-align: right;
      margin-top: 0.25rem;
    }
    .quick-stats {
      display: grid;
      grid-template-columns: repeat(3, 1fr);
      gap: 0.5rem;
      margin-top: 0.75rem;
    }
    .quick-stat {
      background: rgba(0,0,0,0.2);
      padding: 0.5rem;
      border-radius: 6px;
      text-align: center;
    }
    .quick-stat-value {
      font-size: 1.1rem;
      font-weight: 700;
      color: var(--gold);
    }
    .quick-stat-label {
      font-size: 0.6rem;
      color: rgba(255,255,255,0.5);
    }

    .module-list { flex: 1; overflow-y: auto; padding: 0.5rem 0; }
    .module-item {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      padding: 0.6rem 1rem;
      cursor: pointer;
      transition: all 0.2s;
      border-left: 3px solid transparent;
    }
    .module-item:hover { background: rgba(212,175,55,0.1); }
    .module-item.active { background: rgba(212,175,55,0.15); border-left-color: var(--gold); }
    .module-item.completed .module-number { background: var(--green); color: white; }
    .module-item.locked { opacity: 0.5; cursor: not-allowed; }
    .module-number {
      width: 26px;
      height: 26px;
      border-radius: 50%;
      background: rgba(255,255,255,0.1);
      display: flex;
      align-items: center;
      justify-content: center;
      font-size: 0.7rem;
      font-weight: 700;
      flex-shrink: 0;
    }
    .module-item.active .module-number { background: var(--gold); color: var(--navy); }
    .module-info { flex: 1; min-width: 0; }
    .module-title { font-size: 0.8rem; font-weight: 600; white-space: nowrap; overflow: hidden; text-overflow: ellipsis; }
    .module-subtitle { font-size: 0.65rem; color: rgba(255,255,255,0.5); }
    .module-xp { font-size: 0.6rem; color: var(--gold); }

    /* Badges Panel */
    .badges-panel {
      padding: 1rem;
      border-top: 1px solid rgba(212,175,55,0.2);
    }
    .badges-title { font-size: 0.75rem; font-weight: 600; color: var(--gold); margin-bottom: 0.5rem; }
    .badges-grid { display: flex; flex-wrap: wrap; gap: 0.35rem; }
    .badge-item {
      width: 32px;
      height: 32px;
      min-width: 44px;
      min-height: 44px;
      background: rgba(255,255,255,0.05);
      border: 2px solid rgba(255,255,255,0.1);
      border-radius: 6px;
      display: flex;
      align-items: center;
      justify-content: center;
      font-size: 0.9rem;
      font-family: inherit;
      color: inherit;
      padding: 0;
      opacity: 0.3;
      transition: all 0.3s;
      cursor: help;
      position: relative;
    }
    .badge-item.earned { opacity: 1; background: rgba(212,175,55,0.2); border-color: var(--gold); }
    .badge-item:hover::after {
      content: attr(data-tooltip);
      position: absolute;
      bottom: 100%;
      left: 50%;
      transform: translateX(-50%);
      background: var(--navy);
      color: white;
      padding: 0.25rem 0.5rem;
      border-radius: 4px;
      font-size: 0.6rem;
      white-space: nowrap;
      z-index: 100;
    }

    /* ====== MAIN CONTENT ====== */
    .main-content { flex: 1; display: flex; flex-direction: column; overflow: hidden; }
    .content-header {
      padding: 0.75rem 1.5rem;
      background: rgba(0,0,0,0.3);
      border-bottom: 1px solid rgba(212,175,55,0.2);
      display: flex;
      align-items: center;
      justify-content: space-between;
    }
    .breadcrumb { font-size: 0.85rem; color: rgba(255,255,255,0.6); }
    .breadcrumb span { color: var(--gold); }
    .header-actions { display: flex; gap: 0.5rem; align-items: center; }
    .streak-display {
      display: flex;
      align-items: center;
      gap: 0.35rem;
      background: rgba(239,68,68,0.2);
      border: 1px solid rgba(239,68,68,0.4);
      padding: 0.35rem 0.75rem;
      border-radius: 20px;
      font-size: 0.8rem;
    }
    .streak-display.active { background: rgba(249,115,22,0.2); border-color: var(--orange); }
    .streak-flame { font-size: 1rem; }
    .streak-count { font-weight: 700; color: var(--orange); }

    .btn {
      padding: 0.5rem 1rem;
      border: 1px solid rgba(212,175,55,0.3);
      border-radius: 6px;
      background: rgba(255,255,255,0.05);
      color: var(--cream);
      font-size: 0.8rem;
      cursor: pointer;
      transition: all 0.2s;
    }
    .btn:hover { background: rgba(212,175,55,0.2); border-color: var(--gold); }
    .btn.primary { background: var(--gold); color: var(--navy); border-color: var(--gold); font-weight: 600; }

    .content-body { flex: 1; overflow: hidden; display: flex; }

    /* ====== SLIDES ====== */
    .slides-container { flex: 1; position: relative; overflow: hidden; touch-action: pan-y pinch-zoom; }
    .module-slides { display: none; width: 100%; height: 100%; }
    .module-slides.active { display: block; }

    .slide {
      position: absolute;
      top: 0; left: 0;
      width: 100%; height: 100%;
      display: flex;
      flex-direction: column;
      justify-content: flex-start;
      align-items: center;
      padding: 2rem 2rem 4rem;
      opacity: 0;
      visibility: hidden;
      transition: opacity var(--transition), visibility var(--transition);
      overflow-y: auto;
    }
    .slide.active { opacity: 1; visibility: visible; }
    .slide.dark { background: var(--deep-navy); }
    .slide.light { background: var(--cream); color: var(--text); }
    .slide.black { background: #000; }
    .slide.red-bg { background: linear-gradient(135deg, #7f1d1d, #450a0a); }
    .slide.green-bg { background: linear-gradient(135deg, #14532d, #052e16); }
    .slide.purple-bg { background: linear-gradient(135deg, #4c1d95, #2e1065); }

    .serif { font-family: 'Cormorant Garamond', Georgia, serif; }
    .title {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: clamp(1.8rem, 4vw, 3rem);
      font-weight: 700;
      margin-bottom: 1rem;
      line-height: 1.2;
      text-align: center;
    }
    .title.gold { color: var(--gold); }
    .title.navy { color: var(--navy); }
    .subtitle {
      font-size: clamp(0.9rem, 2vw, 1.3rem);
      color: rgba(255,255,255,0.7);
      margin-bottom: 1.5rem;
      text-align: center;
    }
    .slide.light .subtitle { color: var(--light-text); }

    .big-number {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: clamp(4rem, 12vw, 8rem);
      font-weight: 700;
      line-height: 1;
    }
    .big-number.gold { color: var(--gold); }
    .big-number.red { color: var(--red); }

    .refrain {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: clamp(1.3rem, 3vw, 2rem);
      font-style: italic;
      color: var(--gold);
      text-align: center;
      max-width: 700px;
    }

    .content { display: flex; flex-direction: column; align-items: center; width: 100%; max-width: 850px; }

    /* Cards */
    .card {
      background: var(--light-cream);
      border: 1px solid var(--gold);
      padding: 1.25rem 1.5rem;
      margin: 0.5rem 0;
      max-width: 750px;
      width: 100%;
      border-radius: 8px;
    }
    .card.navy-bg { background: var(--navy); color: var(--cream); }
    .card.red-border { border: 2px solid var(--red); }
    .card.green-border { border: 2px solid var(--green); }
    .card-label {
      font-size: 0.7rem;
      font-weight: 700;
      color: var(--gold);
      letter-spacing: 0.05em;
      margin-bottom: 0.4rem;
      text-transform: uppercase;
    }
    .card-text { font-size: 0.95rem; line-height: 1.6; }
    .card.navy-bg .card-text { color: var(--cream); }

    /* Story box */
    .story-box {
      background: linear-gradient(135deg, rgba(197,48,48,0.15), rgba(30,39,97,0.2));
      border-left: 4px solid var(--red);
      padding: 1.25rem;
      margin: 0.75rem 0;
      max-width: 750px;
      width: 100%;
      border-radius: 0 8px 8px 0;
    }
    .story-box.success { background: linear-gradient(135deg, rgba(34,197,94,0.15), rgba(30,39,97,0.2)); border-left-color: var(--green); }
    .story-box.warning { background: linear-gradient(135deg, rgba(245,158,11,0.15), rgba(30,39,97,0.2)); border-left-color: var(--orange); }
    .story-label {
      font-size: 0.7rem;
      font-weight: 700;
      letter-spacing: 0.1em;
      color: var(--red);
      margin-bottom: 0.4rem;
      text-transform: uppercase;
    }
    .story-box.success .story-label { color: var(--green); }
    .story-box.warning .story-label { color: var(--orange); }
    .story-text { font-size: 0.95rem; line-height: 1.6; }

    /* Epic Story Box */
    .story-box.epic {
      background: linear-gradient(135deg, rgba(20,27,61,0.95), rgba(0,0,0,0.9));
      border-left: 4px solid var(--gold);
      border-top: 1px solid rgba(212,175,55,0.3);
      border-right: 1px solid rgba(212,175,55,0.2);
      border-bottom: 1px solid rgba(212,175,55,0.2);
      padding: 1.5rem;
      position: relative;
    }
    .story-box.epic::before {
      content: '';
      position: absolute;
      top: 0;
      left: 0;
      right: 0;
      height: 2px;
      background: linear-gradient(90deg, var(--gold), transparent);
    }
    .story-box.epic .story-label { color: var(--gold); font-size: 0.65rem; letter-spacing: 0.15em; }
    .story-box.epic .story-text { font-family: 'Cormorant Garamond', Georgia, serif; font-size: 1.05rem; line-height: 1.7; }
    .story-box.epic .story-moral {
      margin-top: 1rem;
      padding-top: 1rem;
      border-top: 1px solid rgba(212,175,55,0.2);
      font-style: italic;
      color: var(--gold);
      font-size: 0.95rem;
    }

    /* Stats */
    .stats-grid {
      display: flex;
      gap: 0.75rem;
      margin: 1rem 0;
      flex-wrap: wrap;
      justify-content: center;
    }
    .stat-box {
      background: var(--navy);
      color: var(--cream);
      padding: 1rem 1.25rem;
      text-align: center;
      min-width: 120px;
      border-radius: 8px;
    }
    .stat-box.light { background: var(--light-cream); color: var(--navy); border: 1px solid var(--gold); }
    .stat-value {
      font-family: 'Cormorant Garamond', serif;
      font-size: clamp(1.3rem, 2.5vw, 2rem);
      font-weight: 700;
    }
    .stat-value.gold { color: var(--gold); }
    .stat-value.red { color: var(--red); }
    .stat-label { font-size: 0.75rem; opacity: 0.8; margin-top: 0.2rem; }

    /* Timeline */
    .timeline { display: flex; flex-direction: column; gap: 0.4rem; width: 100%; max-width: 650px; }
    .timeline-item {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      padding: 0.6rem 0.75rem;
      background: rgba(255,255,255,0.05);
      border-radius: 6px;
      border-left: 4px solid var(--gold);
    }
    .timeline-item.phase-a { border-left-color: var(--purple); }
    .timeline-item.phase-b { border-left-color: #3b82f6; }
    .timeline-item.phase-c { border-left-color: var(--orange); }
    .timeline-item.phase-d { border-left-color: var(--green); }
    .timeline-item.phase-e { border-left-color: var(--red); }
    .timeline-days { font-weight: 700; font-size: 0.8rem; min-width: 70px; color: var(--gold); }
    .timeline-content { flex: 1; }
    .timeline-title { font-weight: 600; font-size: 0.9rem; }
    .timeline-desc { font-size: 0.75rem; opacity: 0.7; }

    /* Checklist */
    .checklist { display: flex; flex-direction: column; gap: 0.4rem; width: 100%; max-width: 650px; }
    .checklist-item {
      display: flex;
      align-items: flex-start;
      gap: 0.6rem;
      padding: 0.6rem 0.75rem;
      background: rgba(255,255,255,0.05);
      border-radius: 6px;
      border: 1px solid rgba(255,255,255,0.1);
    }
    .check-icon {
      width: 22px;
      height: 22px;
      background: var(--gold);
      color: var(--navy);
      border-radius: 4px;
      display: flex;
      align-items: center;
      justify-content: center;
      font-weight: 700;
      font-size: 0.75rem;
      flex-shrink: 0;
    }
    .checklist-text { font-size: 0.9rem; line-height: 1.4; }

    /* Lessons */
    .lesson-item { display: flex; align-items: flex-start; gap: 0.75rem; margin: 0.5rem 0; max-width: 700px; }
    .lesson-number {
      background: var(--gold);
      color: var(--navy);
      width: 28px;
      height: 28px;
      border-radius: 50%;
      display: flex;
      align-items: center;
      justify-content: center;
      font-weight: 700;
      font-size: 0.85rem;
      flex-shrink: 0;
    }
    .lesson-content h4 { font-size: 1rem; font-weight: 700; margin-bottom: 0.2rem; }
    .lesson-content p { font-size: 0.85rem; opacity: 0.8; }

    /* ====== DECISION TREE ====== */
    .decision-tree {
      width: 100%;
      max-width: 700px;
      background: linear-gradient(135deg, rgba(124,58,237,0.15), rgba(30,39,97,0.25));
      border: 2px solid var(--purple);
      border-radius: 12px;
      padding: 1.5rem;
      margin: 0.75rem 0;
    }
    .decision-header {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      margin-bottom: 1rem;
    }
    .decision-icon {
      width: 40px;
      height: 40px;
      background: var(--purple);
      border-radius: 50%;
      display: flex;
      align-items: center;
      justify-content: center;
      font-size: 1.25rem;
    }
    .decision-title {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.2rem;
      font-weight: 700;
    }
    .decision-xp {
      margin-left: auto;
      background: rgba(212,175,55,0.2);
      padding: 0.25rem 0.75rem;
      border-radius: 12px;
      font-size: 0.75rem;
      color: var(--gold);
      font-weight: 600;
    }
    .decision-scenario {
      background: rgba(0,0,0,0.2);
      padding: 1rem;
      border-radius: 8px;
      margin-bottom: 1rem;
      font-size: 0.95rem;
      line-height: 1.6;
    }
    .decision-question {
      font-weight: 600;
      color: var(--gold);
      margin-bottom: 0.75rem;
      font-size: 1rem;
    }
    .decision-options { display: flex; flex-direction: column; gap: 0.5rem; }
    .decision-option {
      display: flex;
      align-items: flex-start;
      gap: 0.75rem;
      padding: 0.75rem 1rem;
      background: rgba(255,255,255,0.05);
      border: 2px solid rgba(255,255,255,0.15);
      border-radius: 8px;
      cursor: pointer;
      transition: all 0.2s;
    }
    .decision-option:hover { background: rgba(124,58,237,0.2); border-color: var(--purple); }
    .decision-option.selected { background: rgba(124,58,237,0.3); border-color: var(--purple); }
    .decision-option.correct { background: rgba(34,197,94,0.2); border-color: var(--green); }
    .decision-option.incorrect { background: rgba(239,68,68,0.15); border-color: var(--red); }
    .decision-option.disabled { pointer-events: none; opacity: 0.7; }
    .option-letter {
      width: 24px;
      height: 24px;
      background: rgba(255,255,255,0.1);
      border-radius: 50%;
      display: flex;
      align-items: center;
      justify-content: center;
      font-weight: 700;
      font-size: 0.8rem;
      flex-shrink: 0;
    }
    .decision-option.correct .option-letter { background: var(--green); color: white; }
    .decision-option.incorrect .option-letter { background: var(--red); color: white; }
    .option-text { font-size: 0.9rem; }
    .decision-feedback {
      margin-top: 1rem;
      padding: 1rem;
      border-radius: 8px;
      display: none;
    }
    .decision-feedback.show { display: block; }
    .decision-feedback.correct { background: rgba(34,197,94,0.2); border: 1px solid var(--green); }
    .decision-feedback.incorrect { background: rgba(239,68,68,0.15); border: 1px solid var(--red); }
    .feedback-title { font-weight: 700; margin-bottom: 0.5rem; display: flex; align-items: center; gap: 0.5rem; }
    .feedback-text { font-size: 0.9rem; line-height: 1.5; }

    /* ====== PREDICTION ====== */
    .prediction-panel {
      width: 100%;
      max-width: 700px;
      background: linear-gradient(135deg, rgba(212,175,55,0.15), rgba(30,39,97,0.25));
      border: 2px solid var(--gold);
      border-radius: 12px;
      padding: 1.5rem;
      margin: 0.75rem 0;
      text-align: center;
    }
    .prediction-icon { font-size: 2.5rem; margin-bottom: 0.5rem; }
    .prediction-title {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.3rem;
      color: var(--gold);
      margin-bottom: 0.5rem;
    }
    .prediction-subtitle { font-size: 0.9rem; opacity: 0.8; margin-bottom: 1rem; }
    .prediction-buttons {
      display: flex;
      flex-direction: column;
      gap: 0.5rem;
    }
    .predict-btn {
      display: flex;
      align-items: center;
      justify-content: center;
      gap: 0.5rem;
      padding: 0.75rem 1rem;
      border: 2px solid;
      border-radius: 8px;
      font-size: 0.9rem;
      font-weight: 600;
      cursor: pointer;
      transition: all 0.2s;
      background: rgba(0,0,0,0.2);
    }
    .predict-btn.benefit { border-color: var(--green); color: var(--green); }
    .predict-btn.benefit:hover { background: rgba(34,197,94,0.2); }
    .predict-btn.neutral { border-color: var(--light-text); color: var(--light-text); }
    .predict-btn.neutral:hover { background: rgba(148,163,184,0.2); }
    .predict-btn.harm { border-color: var(--red); color: var(--red); }
    .predict-btn.harm:hover { background: rgba(239,68,68,0.2); }
    .predict-btn.selected { transform: scale(1.02); box-shadow: 0 0 15px rgba(255,255,255,0.1); }
    .prediction-result {
      margin-top: 1rem;
      padding: 0.75rem;
      border-radius: 8px;
      display: none;
    }
    .prediction-result.show { display: block; }
    .prediction-result.correct { background: rgba(34,197,94,0.2); border: 1px solid var(--green); }
    .prediction-result.incorrect { background: rgba(239,68,68,0.15); border: 1px solid var(--red); }

    /* ====== QUIZ ====== */
    .quiz-container { width: 100%; max-width: 650px; }
    .quiz-question {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.2rem;
      margin-bottom: 1.25rem;
      text-align: center;
    }
    .quiz-options { display: flex; flex-direction: column; gap: 0.5rem; }
    .quiz-option {
      padding: 0.75rem 1rem;
      background: rgba(255,255,255,0.05);
      border: 2px solid rgba(255,255,255,0.2);
      border-radius: 8px;
      cursor: pointer;
      transition: all 0.2s;
      text-align: left;
      font-size: 0.9rem;
    }
    .quiz-option:hover { background: rgba(212,175,55,0.15); border-color: var(--gold); }
    .quiz-option.correct { background: rgba(34,197,94,0.2); border-color: var(--green); }
    .quiz-option.incorrect { background: rgba(239,68,68,0.15); border-color: var(--red); }
    .quiz-option.disabled { pointer-events: none; }
    .quiz-feedback {
      margin-top: 1rem;
      padding: 1rem;
      border-radius: 8px;
      display: none;
      font-size: 0.9rem;
    }
    .quiz-feedback.show { display: block; }
    .quiz-feedback.correct { background: rgba(34,197,94,0.2); border: 1px solid var(--green); }
    .quiz-feedback.incorrect { background: rgba(239,68,68,0.15); border: 1px solid var(--red); }

    /* Crisis box */
    .crisis-box {
      background: linear-gradient(135deg, rgba(124,58,237,0.2), rgba(30,39,97,0.3));
      border: 2px solid var(--purple);
      border-radius: 12px;
      padding: 1.25rem;
      margin: 0.75rem 0;
      max-width: 750px;
      width: 100%;
    }
    .crisis-header { display: flex; align-items: center; gap: 0.75rem; margin-bottom: 0.75rem; }
    .crisis-number {
      width: 36px;
      height: 36px;
      background: var(--purple);
      color: white;
      border-radius: 50%;
      display: flex;
      align-items: center;
      justify-content: center;
      font-weight: 700;
      font-size: 1.1rem;
    }
    .crisis-title { font-family: 'Cormorant Garamond', serif; font-size: 1.15rem; font-weight: 700; }
    .crisis-day { font-size: 0.75rem; color: var(--purple); }

    /* Animation */
    .slide.active .animate { animation: fadeUp 0.5s ease-out forwards; }
    .slide.active .animate.delay-1 { animation-delay: 0.1s; }
    .slide.active .animate.delay-2 { animation-delay: 0.2s; }
    .slide.active .animate.delay-3 { animation-delay: 0.3s; }
    @keyframes fadeUp {
      from { opacity: 0; transform: translateY(15px); }
      to { opacity: 1; transform: translateY(0); }
    }
    .animate { opacity: 0; }

    /* XP Popup */
    .xp-popup {
      position: fixed;
      top: 50%;
      left: 50%;
      transform: translate(-50%, -50%) scale(0);
      background: linear-gradient(135deg, var(--gold), #f0c040);
      color: var(--navy);
      padding: 1.5rem 2.5rem;
      border-radius: 12px;
      font-family: 'Cormorant Garamond', serif;
      font-size: 2rem;
      font-weight: 700;
      z-index: 1000;
      box-shadow: 0 10px 40px rgba(0,0,0,0.5);
      transition: transform 0.3s ease;
    }
    .xp-popup.show { transform: translate(-50%, -50%) scale(1); }
    .xp-popup .xp-amount { font-size: 3rem; display: block; }

    /* Badge Earned Modal */
    .badge-modal {
      position: fixed;
      top: 0; left: 0; right: 0; bottom: 0;
      background: rgba(0,0,0,0.85);
      display: none;
      justify-content: center;
      align-items: center;
      z-index: 1001;
    }
    .badge-modal.show { display: flex; }
    .badge-modal-content {
      background: linear-gradient(135deg, var(--deep-navy), #0a0f1a);
      border: 2px solid var(--gold);
      border-radius: 16px;
      padding: 2rem;
      text-align: center;
      max-width: 350px;
    }
    .badge-modal-icon { font-size: 4rem; margin-bottom: 1rem; }
    .badge-modal-title {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.5rem;
      color: var(--gold);
      margin-bottom: 0.5rem;
    }
    .badge-modal-desc { font-size: 0.9rem; opacity: 0.8; margin-bottom: 1rem; }
    .badge-modal-close {
      padding: 0.5rem 1.5rem;
      background: var(--gold);
      color: var(--navy);
      border: none;
      border-radius: 6px;
      font-weight: 600;
      cursor: pointer;
    }

    /* Confetti - respects reduced motion */
    .confetti-container {
      position: fixed;
      top: 0; left: 0;
      width: 100%; height: 100%;
      pointer-events: none;
      z-index: 999;
      overflow: hidden;
    }
    .confetti {
      position: absolute;
      width: 10px; height: 10px;
      opacity: 0;
      animation: confetti-fall 3s ease-out forwards;
    }
    @keyframes confetti-fall {
      0% { transform: translateY(-100px) rotate(0deg); opacity: 1; }
      100% { transform: translateY(100vh) rotate(720deg); opacity: 0; }
    }
    @media (prefers-reduced-motion: reduce) {
      *, *::before, *::after {
        animation-duration: 0.01ms !important;
        animation-iteration-count: 1 !important;
        transition-duration: 0.01ms !important;
      }
      .confetti { display: none; }
    }

    /* Combo Counter */
    .combo-display {
      position: fixed;
      top: 80px;
      right: 20px;
      background: linear-gradient(135deg, var(--orange), #ef4444);
      color: white;
      padding: 0.5rem 1rem;
      border-radius: 20px;
      font-weight: 700;
      font-size: 0.9rem;
      z-index: 500;
      transform: scale(0);
      transition: transform 0.3s ease;
      box-shadow: 0 4px 15px rgba(239,68,68,0.4);
    }
    .combo-display.show { transform: scale(1); }
    .combo-display.big { transform: scale(1.2); }

    /* Key Takeaway Card */
    .takeaway-card {
      background: linear-gradient(135deg, rgba(34,197,94,0.15), rgba(30,39,97,0.2));
      border: 1px solid var(--green);
      border-radius: 8px;
      padding: 1rem 1.25rem;
      margin: 0.75rem 0;
      max-width: 700px;
      width: 100%;
    }
    .takeaway-card .takeaway-icon {
      display: inline-block;
      background: var(--green);
      color: white;
      width: 24px;
      height: 24px;
      border-radius: 50%;
      text-align: center;
      line-height: 24px;
      font-size: 0.8rem;
      margin-right: 0.5rem;
    }
    .takeaway-card .takeaway-label {
      font-size: 0.7rem;
      font-weight: 700;
      color: var(--green);
      text-transform: uppercase;
      letter-spacing: 0.05em;
      margin-bottom: 0.35rem;
    }
    .takeaway-card .takeaway-text {
      font-size: 0.9rem;
      line-height: 1.5;
      font-style: italic;
    }

    /* Module Time Estimate */
    .module-time {
      font-size: 0.55rem;
      color: rgba(255,255,255,0.4);
      display: flex;
      align-items: center;
      gap: 0.25rem;
      margin-top: 0.15rem;
    }

    /* Enhanced Focus States for Keyboard Navigation */
    .decision-option:focus-visible,
    .quiz-option:focus-visible,
    .predict-btn:focus-visible {
      outline: 3px solid var(--gold);
      outline-offset: 2px;
    }
    .nav-btn:focus-visible,
    .btn:focus-visible {
      outline: 3px solid var(--gold);
      outline-offset: 2px;
    }

    /* Progress within module */
    .slide-progress-bar {
      position: absolute;
      top: 0;
      left: 0;
      height: 3px;
      background: linear-gradient(90deg, var(--gold), var(--orange));
      transition: width 0.3s ease;
      z-index: 50;
    }

    /* Citation Link Style */
    .citation-link {
      font-size: 0.7rem;
      color: var(--gold);
      opacity: 0.7;
      text-decoration: none;
      display: inline-flex;
      align-items: center;
      gap: 0.25rem;
      margin-top: 0.5rem;
    }
    .citation-link:hover { opacity: 1; text-decoration: underline; }

    /* Mobile Sidebar Toggle */
    @media (max-width: 768px) {
      .sidebar {
        position: fixed;
        left: -300px;
        top: 0;
        bottom: 0;
        z-index: 1000;
        transition: left 0.3s ease;
      }
      .sidebar.open { left: 0; }
      .sidebar-toggle {
        display: flex;
        position: fixed;
        top: 10px;
        left: 10px;
        z-index: 1001;
        width: 40px;
        height: 40px;
        background: var(--gold);
        color: var(--navy);
        border: none;
        border-radius: 8px;
        align-items: center;
        justify-content: center;
        font-size: 1.2rem;
        cursor: pointer;
      }
      .sidebar-overlay {
        display: none;
        position: fixed;
        top: 0; left: 0; right: 0; bottom: 0;
        background: rgba(0,0,0,0.5);
        z-index: 999;
      }
      .sidebar-overlay.show { display: block; }
    }
    @media (min-width: 769px) {
      .sidebar-toggle { display: none; }
      .sidebar-overlay { display: none !important; }
    }

    /* Nav */
    .slide-nav {
      position: absolute;
      bottom: 0; left: 0; right: 0;
      display: flex;
      justify-content: space-between;
      align-items: flex-end;
      padding: 0.75rem 1rem 1.25rem;
      z-index: 100;
      pointer-events: none;
    }
    .nav-btn {
      background: rgba(0,0,0,0.5);
      border: 1px solid rgba(255,255,255,0.2);
      color: white;
      font-size: 1.1rem;
      cursor: pointer;
      opacity: 0.6;
      transition: all 0.2s;
      padding: 0.4rem 0.6rem;
      border-radius: 6px;
      pointer-events: auto;
    }
    .nav-btn:hover { opacity: 1; background: rgba(0,0,0,0.7); border-color: var(--gold); }
    .nav-btn:disabled { opacity: 0.2; cursor: not-allowed; }
    .nav-center { display: flex; flex-direction: column; align-items: center; gap: 0.2rem; pointer-events: auto; }
    .slide-counter { font-size: 0.7rem; opacity: 0.5; }
    .progress-dots { display: flex; gap: 3px; flex-wrap: wrap; max-width: 220px; }
    .progress-dot {
      width: 44px;
      height: 44px;
      display: flex;
      align-items: center;
      justify-content: center;
      cursor: pointer;
      background: none;
      border: none;
      padding: 0;
    }
    .progress-dot::after {
      content: '';
      width: 12px;
      height: 12px;
      border-radius: 50%;
      background: var(--text-muted, rgba(255,255,255,0.25));
      transition: all 0.2s ease;
    }
    .progress-dot.active::after,
    .progress-dot.completed::after {
      background: var(--gold);
      width: 14px;
      height: 14px;
    }

    /* Course Progress Bar */
    .course-progress {
      padding: 0.75rem 1rem;
      border-bottom: 1px solid rgba(212,175,55,0.2);
      background: rgba(0,0,0,0.2);
    }
    .course-progress-label {
      display: flex;
      justify-content: space-between;
      font-size: 0.7rem;
      color: rgba(255,255,255,0.6);
      margin-bottom: 0.35rem;
    }
    .course-progress-bar {
      height: 6px;
      background: rgba(255,255,255,0.1);
      border-radius: 3px;
      overflow: hidden;
    }
    .course-progress-fill {
      height: 100%;
      background: linear-gradient(90deg, var(--green), #22d3ee);
      border-radius: 3px;
      transition: width 0.5s ease;
    }

    /* Learning Objectives */
    .objectives-box {
      background: linear-gradient(135deg, rgba(59,130,246,0.15), rgba(30,39,97,0.25));
      border: 2px solid #3b82f6;
      border-radius: 12px;
      padding: 1.25rem;
      margin: 0.75rem 0;
      max-width: 700px;
      width: 100%;
    }
    .objectives-header {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      margin-bottom: 0.75rem;
    }
    .objectives-icon {
      width: 36px;
      height: 36px;
      background: #3b82f6;
      border-radius: 50%;
      display: flex;
      align-items: center;
      justify-content: center;
      font-size: 1.1rem;
    }
    .objectives-title {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.1rem;
      font-weight: 700;
      color: #60a5fa;
    }
    .objectives-list {
      list-style: none;
      padding: 0;
    }
    .objectives-list li {
      display: flex;
      align-items: flex-start;
      gap: 0.5rem;
      padding: 0.4rem 0;
      font-size: 0.9rem;
    }
    .objectives-list li::before {
      content: '‚óã';
      color: #3b82f6;
      font-weight: bold;
    }
    .objectives-list li.completed::before {
      content: '‚óè';
      color: var(--green);
    }

    /* Module Summary */
    .summary-box {
      background: linear-gradient(135deg, rgba(34,197,94,0.15), rgba(30,39,97,0.25));
      border: 2px solid var(--green);
      border-radius: 12px;
      padding: 1.5rem;
      margin: 0.75rem 0;
      max-width: 700px;
      width: 100%;
      text-align: center;
    }
    .summary-icon { font-size: 2.5rem; margin-bottom: 0.5rem; }
    .summary-title {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.4rem;
      color: var(--green);
      margin-bottom: 0.5rem;
    }
    .summary-stats {
      display: flex;
      justify-content: center;
      gap: 1.5rem;
      margin: 1rem 0;
    }
    .summary-stat {
      text-align: center;
    }
    .summary-stat-value {
      font-size: 1.5rem;
      font-weight: 700;
      color: var(--gold);
    }
    .summary-stat-label {
      font-size: 0.75rem;
      opacity: 0.7;
    }
    .summary-next {
      margin-top: 1rem;
      padding: 0.75rem 1.5rem;
      background: var(--green);
      color: white;
      border: none;
      border-radius: 8px;
      font-weight: 600;
      cursor: pointer;
      transition: all 0.2s;
    }
    .summary-next:hover { transform: scale(1.05); }

    /* Badge Progress Tooltip */
    .badge-progress {
      font-size: 0.55rem;
      color: rgba(255,255,255,0.4);
      position: absolute;
      bottom: -2px;
      right: -2px;
      background: var(--deep-navy);
      padding: 0 3px;
      border-radius: 3px;
    }
    .badge-item { position: relative; }

    /* Glossary Panel */
    .glossary-toggle {
      position: fixed;
      bottom: 1.5rem;
      right: 1.5rem;
      width: 50px;
      height: 50px;
      background: var(--gold);
      color: var(--navy);
      border: none;
      border-radius: 50%;
      font-size: 1.3rem;
      cursor: pointer;
      box-shadow: 0 4px 15px rgba(0,0,0,0.3);
      z-index: 500;
      transition: all 0.2s;
    }
    .glossary-toggle:hover { transform: scale(1.1); }
    .glossary-panel {
      position: fixed;
      bottom: 0;
      right: 0;
      width: 350px;
      max-height: 70vh;
      background: var(--deep-navy);
      border: 1px solid var(--gold);
      border-radius: 12px 0 0 0;
      transform: translateY(100%);
      transition: transform 0.3s ease;
      z-index: 501;
      display: flex;
      flex-direction: column;
    }
    .glossary-panel.open { transform: translateY(0); }
    .glossary-header {
      padding: 1rem;
      border-bottom: 1px solid rgba(212,175,55,0.2);
      display: flex;
      justify-content: space-between;
      align-items: center;
    }
    .glossary-header h3 {
      font-family: 'Cormorant Garamond', serif;
      color: var(--gold);
      margin: 0;
    }
    .glossary-close {
      background: none;
      border: none;
      color: var(--cream);
      font-size: 1.2rem;
      cursor: pointer;
    }
    .glossary-content {
      flex: 1;
      overflow-y: auto;
      padding: 1rem;
    }
    .glossary-item {
      margin-bottom: 1rem;
      padding-bottom: 1rem;
      border-bottom: 1px solid rgba(255,255,255,0.1);
    }
    .glossary-term {
      font-weight: 700;
      color: var(--gold);
      font-size: 0.9rem;
    }
    .glossary-def {
      font-size: 0.8rem;
      color: rgba(255,255,255,0.8);
      margin-top: 0.25rem;
    }

    /* Streak Warning */
    .streak-warning {
      background: rgba(239,68,68,0.2);
      border: 1px solid var(--red);
      color: var(--red);
      animation: pulse-warning 2s infinite;
    }
    @keyframes pulse-warning {
      0%, 100% { opacity: 1; }
      50% { opacity: 0.6; }
    }

    /* Perfect Module Bonus */
    .perfect-bonus {
      background: linear-gradient(135deg, var(--gold), #fbbf24);
      color: var(--navy);
      padding: 0.5rem 1rem;
      border-radius: 20px;
      font-weight: 700;
      display: inline-flex;
      align-items: center;
      gap: 0.5rem;
      margin-top: 0.5rem;
      animation: shine 2s infinite;
    }
    @keyframes shine {
      0%, 100% { box-shadow: 0 0 10px rgba(212,175,55,0.5); }
      50% { box-shadow: 0 0 20px rgba(212,175,55,0.8); }
    }

    /* Focus States for Accessibility */
    .decision-option:focus,
    .quiz-option:focus,
    .predict-btn:focus,
    .btn:focus,
    .nav-btn:focus {
      outline: 2px solid var(--gold);
      outline-offset: 2px;
    }

    /* Print Stylesheet */
    @media print {
      .sidebar, .slide-nav, .stats-panel, .badges-panel, .glossary-toggle, .glossary-panel, .header-actions { display: none !important; }
      .main-content { width: 100%; }
      .slide { position: relative !important; page-break-inside: avoid; padding: 1rem; }
      .slide.active, .slide { opacity: 1 !important; visibility: visible !important; display: block !important; }
      .module-slides { display: block !important; }
    }

    /* Responsive */
    @media (max-width: 900px) {
      .sidebar { width: 70px; }
      .sidebar-header h1, .sidebar-header p, .module-title, .module-subtitle, .module-xp,
      .stats-panel, .badges-panel, .course-progress { display: none; }
      .module-item { padding: 0.6rem; justify-content: center; }
      .glossary-panel { width: 100%; border-radius: 12px 12px 0 0; }
      .progress-dot { width: 44px; height: 44px; }
      .progress-dot::after { width: 8px; height: 8px; }
      .progress-dot.active::after,
      .progress-dot.completed::after { width: 10px; height: 10px; }
    }

    /* Touch feedback */
    @media (hover: none) {
      .decision-option:active { background: rgba(124,58,237,0.3); }
      .quiz-option:active { background: rgba(212,175,55,0.2); }
    }

    /* Reduced motion support */
    @media (prefers-reduced-motion: reduce) {
      *, *::before, *::after {
        animation-duration: 0.01ms !important;
        animation-iteration-count: 1 !important;
        transition-duration: 0.01ms !important;
      }
      .confetti { display: none; }
    }

    /* Skip to content link */
    .skip-link {
      position: absolute;
      top: -40px;
      left: 0;
      background: var(--gold);
      color: var(--navy);
      padding: 0.5rem 1rem;
      z-index: 10000;
      font-weight: 600;
      text-decoration: none;
      border-radius: 0 0 8px 0;
    }
    .skip-link:focus {
      top: 0;
    }

    /* Course completion modal */
    .completion-modal {
      position: fixed;
      top: 0; left: 0; right: 0; bottom: 0;
      background: rgba(0,0,0,0.95);
      display: none;
      justify-content: center;
      align-items: center;
      z-index: 1002;
    }
    .completion-modal.show { display: flex; }
    .completion-content {
      background: linear-gradient(135deg, var(--deep-navy), #0a0f1a);
      border: 3px solid var(--gold);
      border-radius: 20px;
      padding: 2.5rem;
      text-align: center;
      max-width: 450px;
      animation: completion-pop 0.5s ease;
    }
    @keyframes completion-pop {
      0% { transform: scale(0.5); opacity: 0; }
      50% { transform: scale(1.05); }
      100% { transform: scale(1); opacity: 1; }
    }
    .completion-trophy { font-size: 5rem; margin-bottom: 1rem; }
    .completion-title {
      font-family: 'Cormorant Garamond', serif;
      font-size: 2rem;
      color: var(--gold);
      margin-bottom: 0.5rem;
    }
    .completion-subtitle { font-size: 1rem; opacity: 0.8; margin-bottom: 1.5rem; }
    .completion-stats {
      display: flex;
      justify-content: center;
      gap: 1.5rem;
      margin-bottom: 1.5rem;
    }
    .completion-stat { text-align: center; }
    .completion-stat-value {
      font-size: 1.8rem;
      font-weight: 700;
      color: var(--gold);
    }
    .completion-stat-label { font-size: 0.75rem; opacity: 0.7; }
    .completion-close {
      padding: 0.75rem 2rem;
      background: var(--gold);
      color: var(--navy);
      border: none;
      border-radius: 8px;
      font-weight: 700;
      font-size: 1rem;
      cursor: pointer;
    }

    /* Review mistakes button */
    .review-mistakes-btn {
      position: fixed;
      bottom: 1.5rem;
      left: 1.5rem;
      padding: 0.6rem 1rem;
      background: rgba(239,68,68,0.2);
      border: 1px solid var(--red);
      color: var(--red);
      border-radius: 8px;
      font-size: 0.8rem;
      cursor: pointer;
      z-index: 500;
      display: none;
    }
    .review-mistakes-btn.show { display: block; }
    .review-mistakes-btn:hover { background: rgba(239,68,68,0.3); }

    /* Review panel */
    .review-panel {
      position: fixed;
      top: 0; left: 0; right: 0; bottom: 0;
      background: rgba(0,0,0,0.9);
      display: none;
      z-index: 1003;
      overflow-y: auto;
      padding: 2rem;
    }
    .review-panel.show { display: block; }
    .review-header {
      display: flex;
      justify-content: space-between;
      align-items: center;
      margin-bottom: 1.5rem;
      max-width: 700px;
      margin-left: auto;
      margin-right: auto;
    }
    .review-title {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.5rem;
      color: var(--red);
    }
    .review-close {
      background: none;
      border: 1px solid var(--cream);
      color: var(--cream);
      padding: 0.5rem 1rem;
      border-radius: 6px;
      cursor: pointer;
    }
    .review-item {
      background: rgba(255,255,255,0.05);
      border: 1px solid rgba(239,68,68,0.3);
      border-radius: 12px;
      padding: 1.25rem;
      margin-bottom: 1rem;
      max-width: 700px;
      margin-left: auto;
      margin-right: auto;
    }
    .review-module { font-size: 0.75rem; color: var(--gold); margin-bottom: 0.5rem; }
    .review-question { font-weight: 600; margin-bottom: 0.75rem; }
    .review-your-answer { color: var(--red); font-size: 0.9rem; margin-bottom: 0.5rem; }
    .review-correct-answer { color: var(--green); font-size: 0.9rem; margin-bottom: 0.75rem; }
    .review-explanation { font-size: 0.85rem; opacity: 0.8; padding: 0.75rem; background: rgba(0,0,0,0.2); border-radius: 6px; }
  </style>
</head>
<body>
<a class="skip-link" href="#main-content">Skip to content</a>
<div class="course-container">
<!-- SIDEBAR -->
<nav aria-label="Navega√ß√£o do curso" class="sidebar">
<div class="sidebar-header">
<a href="index.html" onmouseout="this.style.color='rgba(212,175,55,0.7)'" onmouseover="this.style.color='#D4AF37'" style="display:block;font-size:0.7rem;color:rgba(212,175,55,0.7);text-decoration:none;margin-bottom:0.5rem;">‚Üê Course Library</a>
<h1>META-SPRINT</h1>
<p>40 dias para evid√™ncias confi√°veis</p>
</div>
<!-- Course Progress -->
<div class="course-progress">
<div class="course-progress-label">
<span>Course Progress</span>
<span id="courseProgressPct">0%</span>
</div>
<div class="course-progress-bar">
<div class="course-progress-fill" id="courseProgressFill" style="width: 0%"></div>
</div>
</div>
<!-- Gamification Stats -->
<div class="stats-panel">
<div class="level-display">
<div aria-label="Level icon" class="level-badge" id="levelIcon" role="img">üìä</div>
<div class="level-info">
<div class="level-title" id="levelTitle">Novice Analyst</div>
<div class="level-subtitle">Level <span id="levelNum">1</span></div>
</div>
</div>
<div aria-label="XP progress" class="xp-bar" role="progressbar">
<div class="xp-fill" id="xpFill" style="width: 0%"></div>
</div>
<div class="xp-text"><span id="xpCurrent">0</span> / <span id="xpNeeded">100</span> XP</div>
<div class="quick-stats">
<div class="quick-stat">
<div class="quick-stat-value" id="correctCount">0</div>
<div class="quick-stat-label">Correct</div>
</div>
<div class="quick-stat">
<div class="quick-stat-value" id="decisionCount">0</div>
<div class="quick-stat-label">Decisions</div>
</div>
<div class="quick-stat">
<div class="quick-stat-value" id="predictCount">0</div>
<div class="quick-stat-label">Predictions</div>
</div>
</div>
</div>
<div class="module-list" id="moduleList" role="list"></div>
<!-- Badges -->
<div class="badges-panel">
<div class="badges-title">Achievements</div>
<div class="badges-grid" id="badgesGrid"></div>
</div>
</nav>
<!-- MAIN -->
<div class="main-content">
<div class="content-header">
<div class="breadcrumb">META-SPRINT / <span id="currentModule">Introduction</span></div>
<div class="header-actions">
<div class="streak-display" id="streakDisplay">
<span class="streak-flame">üî•</span>
<span class="streak-count" id="streakCount">0</span>
<span style="font-size:0.7rem;opacity:0.7">streak</span>
</div>
<button class="btn" onclick="resetProgress()">Reset</button>
<button class="btn primary" onclick="nextSlide()">Continue ‚Üí</button>
</div>
</div>
<div class="content-body">
<div class="slides-container" id="main-content"></div>
</div>
</div>
</div>
<!-- XP Popup -->
<div class="xp-popup" id="xpPopup">
<span class="xp-amount" id="xpAmount">+25</span>
    XP
  </div>
<!-- Badge Modal -->
<div aria-labelledby="badgeModalTitle" aria-modal="true" class="badge-modal" id="badgeModal" role="dialog">
<div class="badge-modal-content">
<div class="badge-modal-icon" id="badgeModalIcon">üèÜ</div>
<div class="badge-modal-title" id="badgeModalTitle">Badge Earned!</div>
<div class="badge-modal-desc" id="badgeModalDesc">Voc√™ desbloqueou uma nova conquista</div>
<button class="badge-modal-close" onclick="closeBadgeModal()">Awesome!</button>
</div>
</div>
<!-- Confetti Container -->
<div class="confetti-container" id="confettiContainer"></div>
<!-- Combo Counter -->
<div class="combo-display" id="comboDisplay">üî• <span id="comboCount">0</span>x Combo!</div>
<!-- Mobile Sidebar Toggle -->
<button aria-expanded="false" aria-label="Toggle menu" class="sidebar-toggle" onclick="toggleSidebar()">‚ò∞</button>
<div class="sidebar-overlay" id="sidebarOverlay" onclick="toggleSidebar()"></div>
<!-- Glossary Toggle -->
<button aria-label="Open glossary" class="glossary-toggle" onclick="toggleGlossary()" title="Quick Reference">üìñ</button>
<!-- Glossary Panel -->
<div aria-label="Glossary" class="glossary-panel" id="glossaryPanel" role="dialog">
<div class="glossary-header">
<h3>Quick Reference</h3>
<button aria-label="Close glossary" class="glossary-close" onclick="toggleGlossary()">√ó</button>
</div>
<div class="glossary-content">
<div class="glossary-item">
<div class="glossary-term">DoD (Definition of Done)</div>
<div class="glossary-def">Binary gate checklist. All items must pass before proceeding to next phase.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">PICOS</div>
<div class="glossary-def">Popula√ß√£o, interven√ß√£o, comparador, resultados, desenho do estudo - estrutura para quest√µes de pesquisa.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">Provenance</div>
<div class="glossary-def">A trilha de auditoria mostrando exatamente de onde veio um n√∫mero (por exemplo, "Tabela 2, p.1234").</div>
</div>
<div class="glossary-item">
<div class="glossary-term">Red-Team</div>
<div class="glossary-def">Daily adversarial checking by 2 rotating members to catch errors in extraction.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">CondGO</div>
<div class="glossary-def">Emergency protocol: 72 hours to fix a failed DoD gate or terminate with documented reasons.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">Surrogate Outcome</div>
<div class="glossary-def">A measurable marker (e.g., cholesterol) used as proxy for patient-important outcomes (e.g., death).</div>
</div>
<div class="glossary-item">
<div class="glossary-term">FREEZE (Day 34)</div>
<div class="glossary-def">Bloqueio de escopo - nenhum novo estudo pode ser adicionado ap√≥s este ponto.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">I¬≤ (I-squared)</div>
<div class="glossary-def">Heterogeneity statistic. Low &lt;30%, Moderate 30-60%, High &gt;60%.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">Analysis Capsule</div>
<div class="glossary-def">Pacote reproduz√≠vel completo: c√≥digo, dados, instru√ß√µes. Qualquer um pode executar e obter resultados id√™nticos.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">Consult Pack</div>
<div class="glossary-def">Documento estruturado com op√ß√µes, evid√™ncias e compensa√ß√µes para tomada de decis√µes em equipe.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">PROSPERO</div>
<div class="glossary-def">Registro internacional para protocolos de revis√£o sistem√°tica. Carimbos de data e hora de seus m√©todos pr√©-especificados.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">PRISMA</div>
<div class="glossary-def">Diretriz de relat√≥rios para revis√µes sistem√°ticas. Inclui o diagrama de fluxo que mostra a sele√ß√£o do estudo.</div>
</div>
</div>
</div>
 Modal de conclus√£o do curso 
<div aria-label="Curso conclu√≠do" class="completion-modal" id="completionModal" role="dialog">
<div class="completion-content">
<div class="completion-trophy">üèÜ</div>
<div class="completion-title">Course Complete!</div>
<div class="completion-subtitle">You've mastered the META-SPRINT methodology</div>
<div class="completion-stats">
<div class="completion-stat">
<div class="completion-stat-value" id="finalXP">0</div>
<div class="completion-stat-label">Total XP</div>
</div>
<div class="completion-stat">
<div class="completion-stat-value" id="finalCorrect">0</div>
<div class="completion-stat-label">Correct Answers</div>
</div>
<div class="completion-stat">
<div class="completion-stat-value" id="finalBadges">0</div>
<div class="completion-stat-label">Badges Earned</div>
</div>
</div>
<p style="font-size:0.9rem;opacity:0.7;margin-bottom:1rem">V√° em frente e produza evid√™ncias confi√°veis!</p>
<div class="completion-actions" style="display: flex; gap: 0.5rem; justify-content: center; flex-wrap: wrap;">
<button class="btn primary" onclick="downloadCertificate()">Download Certificate</button>
<button class="completion-close" onclick="closeCompletionModal()">Continue</button>
</div>
</div>
</div>
 Bot√£o Revisar erros 
<button aria-label="Revisar respostas incorretas" class="review-mistakes-btn" id="reviewMistakesBtn" onclick="showReviewPanel()">
    üìù Review Mistakes
  </button>
<!-- Review Panel -->
<div aria-label="Revisar respostas incorretas" class="review-panel" id="reviewPanel" role="dialog">
<div class="review-header">
<div class="review-title">üìù Revise seus erros</div>
<button class="review-close" onclick="closeReviewPanel()">Close</button>
</div>
<div id="reviewContent"></div>
</div>
<script>
// ===== GAMIFICATION STATE =====
const DEFAULT_STATE = {
  xp: 0,
  level: 1,
  streak: 0,
  lastActive: null,
  correctAnswers: 0,
  decisionsCompleted: 0,
  predictionsCorrect: 0,
  predictionsTotal: 0,
  badges: [],
  completedModules: [],
  perfectModules: [],
  answeredQuestions: {},
  consecutiveCorrect: 0
};

// Safe localStorage with fallback
function safeGetStorage(key, fallback) {
  try {
    const item = localStorage.getItem(key);
    return item ? JSON.parse(item) : fallback;
  } catch (e) {
    console.warn('localStorage unavailable, using session storage');
    return fallback;
  }
}

function safeSetStorage(key, value) {
  try {
    localStorage.setItem(key, JSON.stringify(value));
  } catch (e) {
    console.warn('Could not save to localStorage');
  }
}

// Migration from old storage key to versioned key
(function migrateStorage() {
  try {
    const oldData = localStorage.getItem('metasprintGame');
    if (oldData && !localStorage.getItem('metasprintGame_v1')) {
      localStorage.setItem('metasprintGame_v1', oldData);
      localStorage.removeItem('metasprintGame');
    }
  } catch (e) {}
})();

let gameState = safeGetStorage('metasprintGame_v1', DEFAULT_STATE);

const LEVELS = [
  { level: 1, title: "Novice Analyst", icon: "üìä", xp: 0 },
  { level: 2, title: "Protocol Apprentice", icon: "üìã", xp: 100 },
  { level: 3, title: "Search Specialist", icon: "üîç", xp: 250 },
  { level: 4, title: "Extraction Expert", icon: "üìù", xp: 450 },
  { level: 5, title: "Analysis Adept", icon: "üìà", xp: 700 },
  { level: 6, title: "Quality Guardian", icon: "üõ°Ô∏è", xp: 1000 },
  { level: 7, title: "Evidence Master", icon: "üèÜ", xp: 1400 },
  { level: 8, title: "Meta-Analysis Sage", icon: "üëë", xp: 1900 }
];

const BADGES = [
  { id: "first_blood", icon: "üéØ", name: "First Blood", desc: "Responda sua primeira pergunta corretamente" },
  { id: "perfect_5", icon: "‚≠ê", name: "Five Star", desc: "Get 5 correct answers in a row" },
  { id: "decision_maker", icon: "‚öñÔ∏è", name: "Decision Maker", desc: "Conclua 10 √°rvores de decis√£o" },
  { id: "oracle", icon: "üîÆ", name: "The Oracle", desc: "Predict 5 outcomes correctly" },
  { id: "protocol_pro", icon: "üìã", name: "Protocol Pro", desc: "Conclua o m√≥dulo da Fase A" },
  { id: "search_savant", icon: "üîç", name: "Search Savant", desc: "Conclua o m√≥dulo da Fase B" },
  { id: "data_detective", icon: "üïµÔ∏è", name: "Data Detective", desc: "Conclua o m√≥dulo da Fase C" },
  { id: "stats_wizard", icon: "üßô", name: "Stats Wizard", desc: "Conclua a Fase D m√≥dulo" },
  { id: "finisher", icon: "üèÅ", name: "Finisher", desc: "Concluir o curso inteiro" },
  { id: "streak_3", icon: "üî•", name: "On Fire", desc: "Maintain a 3-day streak" },
  { id: "streak_7", icon: "üí´", name: "Weekly Warrior", desc: "Maintain a 7-day streak" },
  { id: "colchicine_hero", icon: "üíä", name: "Colchicine Hero", desc: "Concluir o estudo de caso" }
];

// ===== MODULES DATA =====
const MODULES = [
  {
    id: 1, title: "Why META-SPRINT?", subtitle: "O custo de evid√™ncias ruins", xp: 150,
    slides: [
      { type: "title", theme: "dark", content: { title: "Why META-SPRINT?", subtitle: "O custo de errar" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "Understand why bad evidence causes real harm",
          "Aprenda com a trag√©dia CAST e Poldermans fraude",
          "Recognize surrogate outcome traps",
          "Understand what provenance verification means"
        ],
        tip: "Este m√≥dulo prepara o cen√°rio para tudo o que se segue."
      }},
      { type: "prediction", theme: "dark", content: {
        icon: "üîÆ", title: "Fa√ßa sua previs√£o",
        subtitle: "Na d√©cada de 1980, foram desenvolvidos medicamentos para suprimir batimentos card√≠acos irregulares (PVCs) ap√≥s ataques card√≠acos. Os medicamentos corrigiram com sucesso as leituras de ECG. O que voc√™ acha que aconteceu com as taxas de mortalidade?",
        options: [
          { id: "benefit", label: "üíö Deaths decreased", text: "As drogas salvaram vidas" },
          { id: "neutral", label: "‚ö™ No change", text: "As mortes permaneceram as mesmas" },
          { id: "harm", label: "‚ù§Ô∏è Deaths increased", text: "As drogas causaram danos" }
        ],
        answer: "harm",
        xp: 30
      }},
      { type: "story", theme: "red-bg", content: {
        label: "A trag√©dia CAST", title: "50,000 Deaths",
        text: "The drugs that 'fixed' the ECG <strong>tripled</strong> death rates. 50,000 Americans died from drugs that made their monitors look better.",
        followup: "Suppressing PVCs was a surrogate outcome‚Äîit looked like benefit but masked real harm."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìä", title: "Cen√°rio: O impressionante N√∫meros",
        xp: 25,
        scenario: "Um novo medicamento para diabetes mostra que reduz a HbA1c (marcador de a√ß√∫car no sangue) em 40% mais do que o tratamento padr√£o. O fabricante deseja acelerar a aprova√ß√£o com base nesses 'dados de efic√°cia impressionantes'.",
        question: "What should regulators demand?",
        options: [
          { letter: "A", text: "Approve it‚Äî40% better HbA1c is significant", correct: false },
          { letter: "B", text: "Require trials showing reduced heart attacks, strokes, or death", correct: true },
          { letter: "C", text: "Aprovar com monitoramento p√≥s-comercializa√ß√£o", correct: false },
          { letter: "D", text: "Request larger HbA1c trials for confirmation", correct: false }
        ],
        feedback: {
          correct: "Correct! HbA1c is a surrogate like PVCs. The CAST tragedy taught us: surrogates can improve while patients die. Demand patient-important outcomes.",
          incorrect: "HbA1c is a surrogate marker. CAST showed us that 'fixing' lab values can mask fatal harm. Always demand patient-important outcomes: death, heart attack, stroke."
        }
      }},
      { type: "stats", theme: "dark", content: {
        title: "A escala de falhas nas evid√™ncias",
        stats: [
          { value: "50,000", label: "CAST drug deaths" },
          { value: "800,000", label: "Poldermans fraud deaths" },
          { value: "70%", label: "Studies unreproducible" }
        ],
        caption: "Esses n√£o s√£o desastres raros. Eles s√£o resultados previs√≠veis de processos interrompidos."
      }},
      { type: "story", theme: "dark", content: {
        label: "O c√°lculo do Vioxx", title: "The Memo They Tried to Hide",
        text: "In 1996, Merck scientists discovered their painkiller Vioxx caused heart attacks. They wrote internal memos. They calculated the excess deaths. They did <strong>nothing</strong>. For eight years, doctors prescribed Vioxx while Merck executives debated how to spin the data.",
        followup: "When the truth emerged in 2004: 88,000 Americans had suffered heart attacks. 38,000 died. One internal email read: 'The cardiovascular events are clearly there.' They knew. They waited. People died."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìß", title: "Cen√°rio: o sinal interno",
        xp: 25,
        scenario: "Voc√™ √© um pesquisador de uma empresa farmac√™utica. Sua an√°lise mostra que seu medicamento de grande sucesso aumenta os eventos card√≠acos em 31%. Seu gerente sugere 'esperar por mais dados' e 'explorar interpreta√ß√µes alternativas' antes de escalar.",
        question: "O que voc√™ deve fazer?",
        options: [
          { letter: "A", text: "Aguarde por mais dados conforme sugerido", correct: false },
          { letter: "B", text: "Relate as descobertas imediatamente ao conselho de seguran√ßa", correct: true },
          { letter: "C", text: "Run alternative analyses to see if the signal disappears", correct: false },
          { letter: "D", text: "Document your concerns in an email but take no action", correct: false }
        ],
        feedback: {
          correct: "Correct! The Vioxx lesson: 'waiting for more data' while people die is a decision that kills. Safety signals require immediate escalation.",
          incorrect: "Cada dia de atraso tem uma contagem de corpos. Os memorandos internos da Vioxx mostraram que eles sabiam ‚Äì mas ‚Äúesperar por mais dados‚Äù matou 38 mil pessoas. Relate sinais de seguran√ßa imediatamente."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "O engano do Tamiflu", title: "¬£ 473 milh√µes para dados ocultos",
        text: "In 2009, governments stockpiled Tamiflu for pandemic flu. The UK spent ¬£473 million. The evidence? Manufacturer-funded trials showing 'reduced complications.' The catch? Roche refused to release the full trial data for <strong>five years</strong>.",
        followup: "When researchers finally obtained the raw data, they found: No evidence Tamiflu reduced hospitalizations. No evidence it prevented complications. Half a billion pounds spent on a promise that couldn't be verified."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "‚ö†Ô∏è", title: "Cen√°rio: os dados de Poldermans",
        xp: 25,
        scenario: "Voc√™ est√° revisando uma meta-an√°lise e percebe que um pesquisador contribuiu com 15 dos 40 inclu√≠dos estudos. Seus dados mostram resultados dramaticamente melhores do que outros. Ningu√©m verificou a exist√™ncia de seus dados brutos.",
        question: "O que voc√™ deve fazer?",
        options: [
          { letter: "A", text: "Inclua todos os estudos - eles foram aprovados na revis√£o por pares", correct: false },
          { letter: "B", text: "Solicite verifica√ß√£o de proveni√™ncia para seus estudos", correct: true },
          { letter: "C", text: "Exclude his studies without explanation", correct: false },
          { letter: "D", text: "Fa√ßa a m√©dia de seus resultados com outros para reduzir o impacto", correct: false }
        ],
        feedback: {
          correct: "Correto! A verifica√ß√£o de proveni√™ncia pergunta 'Posso rastrear este n√∫mero at√© sua origem?' A fraude de Poldermans matou 800.000 pessoas porque ningu√©m fez essa pergunta.",
          incorrect: "Not quite. Peer review doesn't verify raw data exists. You need provenance‚Äîthe trail from number to source document."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "O engano Theranos", title: "One Drop of Blood, Billions in Lies",
        text: "In 2003, a 19-year-old Stanford dropout named <strong>Elizabeth Holmes</strong> made a promise that captivated the world: revolutionary blood tests from a single drop. No more needles. No more vials. Investors poured in $700 million. Walgreens signed a deal to put Theranos machines in 8,200 stores. Holmes graced magazine covers. Her company was valued at $9 billion.",
        followup: "The technology never worked. Not once. Theranos ran patient samples on competitors' machines, then hid the results. When the lies unraveled in 2015, the damage was done: <strong>thousands of patients received incorrect diagnoses</strong>. Cancer missed. HIV false positives. Treatment decisions based on fabricated data. Holmes is now serving 11 years in federal prison. The lesson: extraordinary claims without verifiable evidence aren't innovation‚Äîthey're fraud."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "ü©∏", title: "Cen√°rio: a tecnologia revolucion√°ria",
        xp: 25,
        scenario: "Uma startup afirma que sua IA pode detectar 50 tipos de c√¢ncer a partir de uma √∫nica coleta de sangue com 99% de precis√£o. Eles arrecadaram US$ 500 milh√µes. O endosso de celebridades √© abundante. Mas recusam-se a publicar os seus dados de valida√ß√£o, citando ‚Äúsegredos comerciais‚Äù. Um sistema hospitalar deseja implant√°-lo imediatamente.",
        question: "What should the hospital demand before deployment?",
        options: [
          { letter: "A", text: "Confie na aprova√ß√£o da FDA e implante", correct: false },
          { letter: "B", text: "Require independent validation on their own patient population", correct: true },
          { letter: "C", text: "Comece com um pequeno piloto baseado nos dados da empresa", correct: false },
          { letter: "D", text: "Aguarde publica√ß√µes revisadas por pares", correct: false }
        ],
        feedback: {
          correct: "Correto! Theranos obteve aprova√ß√£o da FDA para um teste, enquanto mentia sobre dezenas de outros. A valida√ß√£o independente em SEUS pacientes n√£o √© negoci√°vel. Segredos comerciais que ocultam dados de valida√ß√£o s√£o sinais de alerta.",
          incorrect: "Theranos fooled Walgreens, investors, and patients. The lesson: no independent validation, no deployment. 'Trust us' is not evidence."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "A cat√°strofe do OxyContin", title: "A p√≠lula que criou uma epidemia",
        text: "In 1996, Purdue Pharma launched OxyContin with a bold claim: their new opioid was <strong>'less than 1% addictive.'</strong> They cited a brief letter to the editor in a 1980 New England Journal of Medicine‚Äîfive sentences about hospital patients, not outpatient prescriptions. Sales reps repeated the claim 500,000 times to doctors. Purdue spent $200 million marketing it as safe.",
        followup: "The Sackler family knew. Internal documents showed they tracked addiction reports. They knew their 12-hour pill was wearing off early, driving patients to take more. They did the math: more pills, more profit. By 2021: <strong>500,000 Americans dead from opioid overdoses</strong>. Purdue pleaded guilty to federal charges‚Äîtwice. The Sacklers paid $6 billion but admitted no personal wrongdoing. One misrepresented paragraph. Half a million graves."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üíä", title: "Cen√°rio: a persegui√ß√£o de cita√ß√µes",
        xp: 25,
        scenario: "Um representante de drogas afirma que seu novo analg√©sico tem 'risco m√≠nimo de depend√™ncia, comprovado na literatura. Eles lhe entregam uma refer√™ncia. Voc√™ descobre que √© uma carta de 5 frases ao editor de 1980, estudando pacientes hospitalizados, n√£o a popula√ß√£o ambulatorial que voc√™ trata.",
        question: "O que voc√™ deve fazer?",
        options: [
          { letter: "A", text: "It's in NEJM, so it's credible enough", correct: false },
          { letter: "B", text: "Demand RCTs with addiction as a pre-specified outcome in relevant populations", correct: true },
          { letter: "C", text: "Prescribe cautiously and monitor patients yourself", correct: false },
          { letter: "D", text: "Wait for colleagues to report problems first", correct: false }
        ],
        feedback: {
          correct: "Correto! A trag√©dia do OxyContin come√ßou com uma carta de 5 frases deturpada como prova. Cartas n√£o s√£o evid√™ncias. Exija testes reais com resultados relevantes em popula√ß√µes relevantes.",
          incorrect: "Purdue construiu um imp√©rio com base em uma carta de 5 frases. 'Est√° publicado' n√£o significa '√© evid√™ncia'. A popula√ß√£o, o design e os resultados devem corresponder √† sua pergunta cl√≠nica."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "O Esc√¢ndalo Surgisphere", title: "O banco de dados que nunca existiu",
        text: "In May 2020, the world was desperate for COVID-19 answers. Then <strong>The Lancet</strong> published a bombshell: hydroxychloroquine increased deaths in COVID patients. The study claimed data from 96,000 patients across 671 hospitals on six continents. The WHO halted trials. Countries banned the drug. The paper had one problem: <strong>the data was fabricated</strong>.",
        followup: "Surgisphere, a tiny company with 11 employees, claimed to have a global hospital database larger than any healthcare system on Earth. One employee was a science fiction author. Another was an adult content model. When journalists asked for verification, the company couldn't produce a single hospital contract. Both The Lancet and NEJM retracted their Surgisphere papers within weeks. During a pandemic, fabricated data hijacked global health policy. The peer reviewers never asked: 'Can we see proof this database exists?'"
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üè•", title: "Scenario: The Impossibly Large Dataset",
        xp: 25,
        scenario: "Um artigo afirma analisar 200.000 pacientes de 1.500 hospitais em 47 pa√≠ses, coletados por uma empresa da qual voc√™ nunca ouviu falar com 6 funcion√°rios. Os resultados mudariam as diretrizes de tratamento. Os revisores pares aprovaram.",
        question: "Antes de citar isso em sua revis√£o sistem√°tica, o que voc√™ deve verificar?",
        options: [
          { letter: "A", text: "Se estiver em um peri√≥dico importante, a revis√£o por pares foi suficiente", correct: false },
          { letter: "B", text: "Entre em contato com a empresa de dados e solicite documenta√ß√£o de parcerias hospitalares", correct: true },
          { letter: "C", text: "Check if other researchers have cited it positively", correct: false },
          { letter: "D", text: "Procure estat√≠sticas anomalias nas tabelas publicadas", correct: false }
        ],
        feedback: {
          correct: "Correto! A Surgisphere enganou o The Lancet e o NEJM durante uma pandemia. A verifica√ß√£o da proveni√™ncia ‚Äì ‚Äúprovar que estes dados existem‚Äù ‚Äì teria detectado o problema. Revistas de prest√≠gio n√£o s√£o proveni√™ncia.",
          incorrect: "The Lancet e NEJM foram enganados. A revis√£o por pares n√£o verifica a exist√™ncia de bancos de dados. Antes de confiar em dados extraordin√°rios, verifique se a fonte pode provar que s√£o reais."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "O desastre Fen-Phen", title: "As p√≠lulas diet√©ticas que destru√≠ram cora√ß√µes",
        text: "In 1992, a researcher combined two FDA-approved drugs‚Äîfenfluramine and phentermine‚Äîfor weight loss. The combination was never tested together. The results seemed miraculous: patients lost weight effortlessly. Doctors prescribed it to <strong>6 million Americans</strong>. Weight loss clinics sprouted everywhere. Women's magazines celebrated the breakthrough.",
        followup: "Then the Mayo Clinic noticed something terrifying. Young, healthy women were developing a rare heart valve disease. One cardiologist saw 24 cases in a single year‚Äîhe'd seen only a handful in his entire career. The FDA investigated: <strong>30% of fen-phen users had abnormal heart valves</strong>. The combination was destroying hearts. By the time it was pulled in 1997, the damage was catastrophic. American Home Products paid $13 billion in settlements. The lesson: combining 'safe' drugs without testing the combination is not science‚Äîit's an uncontrolled experiment on patients."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üíî", title: "Cen√°rio: a combina√ß√£o off-label",
        xp: 25,
        scenario: "Um colega mostra resultados impressionantes de perda de peso de combinar dois medicamentos aprovados de uma forma que nunca foi testada em ensaios. 'Ambos s√£o aprovados pela FDA, ent√£o a combina√ß√£o deve ser segura.' Eles querem publicar uma s√©rie de casos e recomendar o protocolo.",
        question: "Qual ‚Äã‚Äã√© a falha cr√≠tica neste racioc√≠nio?",
        options: [
          { letter: "A", text: "As s√©ries de casos s√£o muito pequenas para publica√ß√£o", correct: false },
          { letter: "B", text: "Drug interactions can create harms not present in either drug alone", correct: true },
          { letter: "C", text: "Off-label use requires special FDA permission", correct: false },
          { letter: "D", text: "Weight loss drugs are too controversial", correct: false }
        ],
        feedback: {
          correct: "Correto! Fen-phen combinou duas drogas ‚Äúseguras‚Äù em uma combina√ß√£o destruidora do cora√ß√£o. As intera√ß√µes medicamentosas n√£o s√£o previs√≠veis a partir de perfis individuais. Combina√ß√µes n√£o testadas requerem seus pr√≥prios testes.",
          incorrect: "A fenfluramina era 'segura'. Fentermina era ‚Äúsegura‚Äù. Juntos, eles destru√≠ram v√°lvulas card√≠acas em 30% dos usu√°rios. As combina√ß√µes precisam de suas pr√≥prias evid√™ncias - suposi√ß√µes matam."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "A trag√©dia do DES", title: "A droga que assombrou tr√™s gera√ß√µes",
        text: "In 1938, scientists synthesized DES‚Äîa synthetic estrogen. By 1941, doctors were prescribing it to pregnant women to prevent miscarriages. It seemed logical: estrogen supports pregnancy. <strong>5 million American women</strong> took it between 1940 and 1971. Nobody ran a controlled trial. Nobody tracked the babies.",
        followup: "In 1971, a physician noticed something impossible: <strong>young women in their teens and twenties were developing a rare vaginal cancer</strong> that typically struck women over 50. He traced it back: their mothers had all taken DES during pregnancy. The drug hadn't caused immediate harm‚Äîit had planted a time bomb in the womb. DES daughters had higher rates of infertility, miscarriage, and cancer. DES granddaughters‚Äîthe third generation‚Äîshowed elevated cancer risks too. One untested assumption. Three generations of harm. The first controlled trial of DES, run in 1953, showed it <strong>didn't even prevent miscarriages</strong>‚Äîthe original indication was worthless."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "ü§∞", title: "Cen√°rio: O tratamento l√≥gico",
        xp: 25,
        scenario: "Um tratamento biologicamente plaus√≠vel para complica√ß√µes na gravidez tem sido usado h√° 15 anos sem danos imediatos √≥bvios. N√£o existem ensaios controlados. Um colega diz: 'Us√°mo-lo em milhares de pacientes - se causasse problemas, j√° saber√≠amos.'",
        question: "What critical assumption does this reasoning miss?",
        options: [
          { letter: "A", text: "15 years isn't long enough to judge safety", correct: false },
          { letter: "B", text: "Pregnancy exposures can cause harms that only appear decades later in offspring", correct: true },
          { letter: "C", text: "Observational experience is never valid", correct: false },
          { letter: "D", text: "Colleagues might be hiding adverse events", correct: false }
        ],
        feedback: {
          correct: "Correct! DES taught us the cruelest lesson: pregnancy exposures can cause cancers that appear 20-30 years later in children and grandchildren. 'No immediate harm' is not 'no harm.'",
          incorrect: "DES parecia seguro durante 30 anos - at√© que as suas filhas come√ßaram a desenvolver cancro quando eram adolescentes. Alguns danos levam d√©cadas para se manifestarem. O acompanhamento a longo prazo da prole √© essencial para exposi√ß√µes durante a gravidez."
        }
      }},
      { type: "refrain", theme: "black", content: { text: "Evid√™ncias ruins matam. O META-SPRINT existe para produzir evid√™ncias nas quais voc√™ pode confiar." }},
      { type: "quiz", theme: "dark", content: {
        question: "Why did the CAST drugs increase deaths despite 'working' on ECGs?",
        options: [
          { text: "As leituras de ECG foram medidas incorretamente", correct: false },
          { text: "A supress√£o de PVCs foi um substituto, n√£o um resultado real", correct: true },
          { text: "Os tamanhos das amostras eram muito pequenos", correct: false },
          { text: "Os medicamentos estavam contaminados", correct: false }
        ],
        xp: 20,
        feedback: {
          correct: "Exactly. PVC suppression was a surrogate outcome‚Äîit looked like benefit but masked real harm.",
          incorrect: "Os medicamentos funcionaram exatamente como pretendido nos ECGs. O problema foi que ECGs 'consertados' n√£o significavam vidas salvas."
        }
      }}
    ]
  },
  {
    id: 2, title: "A Estrutura de 40 Dias", subtitle: "Five phases, five gates", xp: 120,
    slides: [
      { type: "title", theme: "dark", content: { title: "40 Days, 5 Gates", subtitle: "Um sprint estruturado para evid√™ncias confi√°veis" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "Learn the five phases of META-SPRINT",
          "Understand Definition of Done (DoD) gates",
          "Conhe√ßa a estrutura da equipe e o comprometimento de tempo di√°rio"
        ],
        tip: "The framework overview - you'll learn each phase in detail later."
      }},
      { type: "timeline", theme: "dark", content: {
        title: "Os Cinco Fases",
        items: [
          { days: "Days 1-3", title: "Phase A: Protocol", desc: "Bloqueie sua pergunta e m√©todos", phase: "a" },
          { days: "Days 4-10", title: "Phase B: Search", desc: "Encontre e filtre literatura", phase: "b" },
          { days: "Days 11-28", title: "Phase C: Extraction", desc: "Extraia dados com verifica√ß√£o", phase: "c" },
          { days: "Days 29-33", title: "Phase D: Analysis", desc: "Execute e verifique a an√°lise", phase: "d" },
          { days: "Days 34-40", title: "Phase E: Submit", desc: "Write, audit, submit", phase: "e" }
        ]
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üö™", title: "Scenario: The 'Almost Done' Gate",
        xp: 25,
        scenario: "√â o dia 3. Sua equipe completou 7 de 8 itens da lista de verifica√ß√£o do DoD-A. O item que falta: o registro do protocolo no PROSPERO est√° 'revis√£o pendente' (geralmente leva de 24 a 48 horas).",
        question: "Voc√™ deve passar no DoD-A?",
        options: [
          { letter: "A", text: "Yes‚Äî7/8 is close enough, proceed to search", correct: false },
          { letter: "B", text: "No‚Äîwait for registration before passing gate", correct: true },
          { letter: "C", text: "Sim - registre-se mais tarde e atualize o protocolo", correct: false },
          { letter: "D", text: "Skip registration‚Äîit's just bureaucracy", correct: false }
        ],
        feedback: {
          correct: "Correct! Gates are binary: pass or fail. 'Almost done' with protocol isn't done. Incomplete PICOS led to 50,000 CAST deaths.",
          incorrect: "Os port√µes s√£o bin√°rios. Sem cr√©dito parcial. O registro marca suas promessas ‚Äì sem ele, voc√™ n√£o pode provar que n√£o alterou os resultados depois de ver os dados."
        }
      }},
      { type: "concept", theme: "dark", content: {
        title: "Definition of Done (DoD)",
        subtitle: "Binary gates: Pass or Fail",
        text: "Cada fase termina com uma porta DoD ‚Äì uma lista de verifica√ß√£o que deve estar 100% conclu√≠da. Sem cr√©dito parcial. N√£o 'quase pronto'.",
        highlight: "The CAST lesson: 'Almost done' with protocol isn't done."
      }},
      { type: "story", theme: "red-bg", content: {
        label: "As diretrizes que mataram", title: "800.000 mortes por um fraudador",
        text: "Durante anos, as diretrizes cl√≠nicas recomendaram betabloqueadores antes da cirurgia para prevenir ataques card√≠acos. A evid√™ncia? Em grande parte de Don Poldermans ‚Äì o pesquisador que contribuiu com 15 estudos para a meta-an√°lise. Seus dados mostraram benef√≠cios dram√°ticos. Seus dados foram fabricados.",
        followup: "When the fraud was discovered and his studies removed, the math changed. Beta-blockers didn't prevent heart attacks during surgery‚Äîthey caused them. Researchers calculated: following guidelines based on Poldermans' fraud may have killed <strong>800,000 patients</strong> over a decade. One man's lies. Global guidelines. Mass harm."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìã", title: "Cen√°rio: O Colaborador Dominante",
        xp: 25,
        scenario: "Voc√™ est√° atualizando uma diretriz cl√≠nica. Sua revis√£o sistem√°tica inclui 40 estudos. Um pesquisador contribuiu com 15 deles ‚Äì e seus estudos mostram efeitos dramaticamente maiores do que os de todos os outros. Seu trabalho nunca foi replicado de forma independente.",
        question: "What should the guideline committee do?",
        options: [
          { letter: "A", text: "Inclua todos os estudos - a revis√£o por pares garante a qualidade", correct: false },
          { letter: "B", text: "Execute a an√°lise de sensibilidade com e sem seus estudos", correct: true },
          { letter: "C", text: "Exclude his studies as obvious outliers", correct: false },
          { letter: "D", text: "Weight his studies lower due to 'heterogeneity'", correct: false }
        ],
        feedback: {
          correct: "Correct! Sensitivity analysis would have shown Poldermans' outsized influence. When one researcher dominates a field, verify their work independently before basing guidelines on it.",
          incorrect: "The Poldermans lesson: one dominant contributor can corrupt an entire field. Sensitivity analysis (with/without their studies) reveals dangerous dependencies."
        }
      }},
      { type: "stats", theme: "light", content: {
        title: "Os n√∫meros META-SPRINT",
        stats: [
          { value: "40", label: "Days total" },
          { value: "5", label: "Quality gates" },
          { value: "12", label: "Team members" },
          { value: "2h", label: "Max daily work" }
        ]
      }},
      { type: "quiz", theme: "dark", content: {
        question: "What happens if a DoD gate fails?",
        options: [
          { text: "Voc√™ pode prosseguir de qualquer maneira com um aviso", correct: false },
          { text: "You must fix all items before proceeding", correct: true },
          { text: "You skip to the next phase and return later", correct: false },
          { text: "O projeto √© cancelado automaticamente", correct: false }
        ],
        xp: 15,
        feedback: {
          correct: "Right! Gates are non-negotiable. All items must pass before moving forward.",
          incorrect: "As portas s√£o bin√°rias ‚Äì voc√™ n√£o pode prosseguir at√© que todos os itens sejam conclu√≠dos. Isso evita a acumula√ß√£o de erros."
        }
      }}
    ]
  },
  {
    id: 3, title: "Phase A: Protocol", subtitle: "Dias 1-3: Bloqueie suas promessas", xp: 180,
    slides: [
      { type: "title", theme: "purple-bg", content: { title: "Phase A: Protocol", subtitle: "Dias 1-3: Bloqueie suas promessas antes de ver os dados" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "Understand why protocol registration prevents outcome switching",
          "Learn to write unambiguous PICOS criteria",
          "Master the DoD-A checklist requirements",
          "Recognize the danger of surrogate outcomes"
        ],
        tip: "Conclua todos os cen√°rios de decis√£o para ganhar o selo Protocol Pro!"
      }},
      { type: "story", theme: "dark", content: {
        label: "A epidemia de mudan√ßa de resultados", title: "31% of Trials Cheat",
        text: "Um estudo PLOS descobriu que 31% dos ensaios cl√≠nicos alteraram seus resultados prim√°rios entre o registro e a publica√ß√£o ‚Äì sempre em dire√ß√µes que faziam com que os resultados parecessem melhores."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üîÑ", title: "Cen√°rio: A mudan√ßa tentadora",
        xp: 25,
        scenario: "Seu protocolo de meta-an√°lise especificou 'mortalidade por todas as causas' como o resultado prim√°rio. Ap√≥s a extra√ß√£o, voc√™ encontra apenas 4 estudos relatando mortalidade, mas 12 relatam ‚Äúeventos cardiovasculares‚Äù. Seu orientador sugere mudar os resultados prim√°rios 'j√° que os dados suportam melhor.'",
        question: "O que voc√™ deve fazer?",
        options: [
          { letter: "A", text: "Switch to cardiovascular events‚Äîmore data is better", correct: false },
          { letter: "B", text: "Keep mortality as primary, add CV events as secondary", correct: true },
          { letter: "C", text: "Report both as co-primary outcomes", correct: false },
          { letter: "D", text: "Revise o protocolo e registre-se novamente antes de continuar", correct: false }
        ],
        feedback: {
          correct: "Correto! O protocolo protege voc√™ de voc√™ mesmo. 31% dos ensaios mudam os resultados ‚Äì √© assim que os ensaios negativos se tornam ‚Äúpositivos‚Äù. Mantenha seu prim√°rio original.",
          incorrect: "Trocar os resultados depois de ver os dados √© exatamente como 31% dos testes trapaceiam. Seu protocolo √© sua promessa. Os eventos CV podem ser uma an√°lise secund√°ria."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "O Revers√£o da TRH", title: "Two Million Women",
        text: "Durante quarenta anos, os m√©dicos prescreveram terapia de reposi√ß√£o hormonal para prevenir doen√ßas card√≠acas em mulheres na menopausa. Estudos observacionais mostraram 50% menos ataques card√≠acos. Parecia √≥bvio. Estava errado.",
        followup: "In 2002, the Women's Health Initiative RCT was stopped early. HRT <strong>increased</strong> heart attacks by 29%. Increased strokes by 41%. Increased breast cancer by 26%. Two million women had been taking a drug that harmed them, prescribed based on evidence that looked good but wasn't."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üî¨", title: "Cen√°rio: A Tenta√ß√£o Observacional",
        xp: 25,
        scenario: "Voc√™ est√° escrevendo um protocolo para uma revis√£o sistem√°tica de uma nova interven√ß√£o. 50 estudos observacionais mostram benef√≠cios dram√°ticos. Existem apenas 3 pequenos ensaios cl√≠nicos randomizados com resultados mistos. A sua equipa sugere concentrar-se apenas em estudos observacionais ‚Äúonde os dados s√£o mais fortes‚Äù.",
        question: "Como voc√™ deve estruturar o protocolo?",
        options: [
          { letter: "A", text: "Include only observational studies‚Äîlarger sample sizes", correct: false },
          { letter: "B", text: "Analyze RCTs and observational separately, RCTs primary", correct: true },
          { letter: "C", text: "Reunir RCTs e estudos observacionais juntos", correct: false },
          { letter: "D", text: "Excluir totalmente estudos observacionais", correct: false }
        ],
        feedback: {
          correct: "Correct! HRT observational studies showed 50% benefit; the RCT showed 29% harm. Confounding bias in observational studies can create illusions. RCTs must be primary.",
          incorrect: "The HRT reversal: observational studies said 'benefit,' the RCT said 'harm.' Healthy women chose HRT‚Äîconfounding created an illusion. RCTs break confounding."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "A Hist√≥ria do Estudo 329", title: "Ghostwritten Lies",
        text: "In 2001, SmithKline Beecham published Study 329: paroxetine was 'safe and effective' for adolescent depression. Doctors prescribed it to millions of teenagers. But the published paper was ghostwritten. The actual data showed something else entirely.",
        followup: "The raw data: paroxetine was <strong>no better than placebo</strong> for depression. Worse: it increased suicidal thinking in adolescents by 200%. The ghostwriters had cherry-picked outcomes, hidden adverse events, and turned failure into success. It took 14 years to get the truth published."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìã", title: "Cen√°rio: O Dilema do Ponto Temporal",
        xp: 30,
        scenario: "You're writing the protocol for a colchicine meta-analysis. Trials report MACE at 30 days, 90 days, 1 year, and 3 years. Two team members disagree: one wants 'longest follow-up,' another wants 'fixed 1-year for all.'",
        question: "Qual √© a melhor abordagem?",
        options: [
          { letter: "A", text: "Use longest follow-up per trial (maximizes data)", correct: false },
          { letter: "B", text: "Use fixed 1-year for all (cleaner comparison)", correct: false },
          { letter: "C", text: "Write a specific rule: 'Longest ‚â•1 year, else longest available'", correct: true },
          { letter: "D", text: "Decida mais tarde quando voc√™ ver quais dados existem", correct: false }
        ],
        feedback: {
          correct: "Excelente! Uma regra espec√≠fica e pr√©-especificada evita ambiguidade. A op√ß√£o C equilibra a maximiza√ß√£o dos dados com a interpretabilidade.",
          incorrect: "Both A and B have merit, but they're still ambiguous. A specific rule like 'longest ‚â•1 year where available, else longest available' prevents disagreement during extraction."
        }
      }},
      { type: "checklist", theme: "dark", content: {
        title: "DoD-A Checklist",
        items: [
          "PICOS + inclusion/exclusion defined",
          "Primary outcome specified",
          "Timepoint rule documented",
          "Model choice (fixed/random)",
          "Sensitivity set defined",
          "Secondary outcomes labelled exploratory",
          "Protocol registered (PROSPERO/protocols.io)",
          "Signed by Integrator + non-integrator"
        ]
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üî¨", title: "Cen√°rio: A armadilha substituta",
        xp: 25,
        scenario: "Seu consultor cl√≠nico sugere usar a ‚Äúredu√ß√£o do colesterol‚Äù como resultado prim√°rio porque mais estudos relatam isso. Mas a sua pergunta original era sobre ‚Äúmorte cardiovascular‚Äù.",
        question: "O que voc√™ deve fazer?",
        options: [
          { letter: "A", text: "Switch to cholesterol‚Äîmore data is better", correct: false },
          { letter: "B", text: "Keep cardiovascular death as primary", correct: true },
          { letter: "C", text: "Use both as co-primary outcomes", correct: false },
          { letter: "D", text: "Add cholesterol as exploratory sensitivity", correct: false }
        ],
        feedback: {
          correct: "Correct! The CAST tragedy taught us: surrogate outcomes (like cholesterol) can mask real harm. Keep patient-important outcomes primary.",
          incorrect: "Cholesterol is a surrogate‚Äîit can improve while patients die (as in CAST). The Vioxx lesson: stick to patient-important outcomes."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "O esc√¢ndalo Macchiarini", title: "The Surgeon Who Implanted Death",
        text: "Paolo Macchiarini was called a miracle worker. The Italian surgeon claimed he could grow synthetic tracheas and implant them in dying patients. <strong>The Lancet</strong> published his 'breakthroughs.' The Karolinska Institute‚Äîhome of the Nobel Prize‚Äîhired him. Patients flew from around the world seeking his revolutionary procedure.",
        followup: "One by one, his patients died. Of the eight who received his synthetic tracheas, <strong>seven died</strong>‚Äîmost within two years, suffocating as the plastic scaffolds disintegrated inside their throats. Karolinska's own doctors raised alarms. They were ignored. When a documentary exposed the truth, investigators found: falsified ethics approvals, fabricated patient outcomes, and co-authors who had never seen the data. The prestigious institute that awards the Nobel Prize had harbored a fraud who killed patients for fame. The Lancet retracted multiple papers. Macchiarini was convicted of assault. The lesson: prestige protects nothing. Only verification protects patients."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üèõÔ∏è", title: "Cen√°rio: O inovador de prest√≠gio",
        xp: 25,
        scenario: "Um c√©lebre cirurgi√£o de uma institui√ß√£o mundialmente famosa publica resultados revolucion√°rios nas principais revistas. Sua t√©cnica poderia salvar milhares de pessoas. Colegas juniores expressam preocupa√ß√µes sobre os resultados dos pacientes, mas a lideran√ßa s√™nior as considera invejosas. Uma equipe de document√°rio solicita entrevistas.",
        question: "O que a institui√ß√£o deve fazer?",
        options: [
          { letter: "A", text: "Protect the surgeon's reputation‚Äîbad press harms everyone", correct: false },
          { letter: "B", text: "Immediately audit all patient outcomes with independent reviewers", correct: true },
          { letter: "C", text: "Wait for peer-reviewed rebuttals before acting", correct: false },
          { letter: "D", text: "Let the surgeon respond to critics in his own publications", correct: false }
        ],
        feedback: {
          correct: "Correto! O maior fracasso de Karolinska foi ignorar os avisos internos para proteger o prest√≠gio. Auditorias independentes de resultados ‚Äì e n√£o gest√£o de reputa√ß√£o ‚Äì protegem os pacientes. Os colegas juniores muitas vezes veem o que os l√≠deres n√£o veem.",
          incorrect: "O Instituto Karolinska escolheu a reputa√ß√£o em vez dos pacientes. Sete pessoas morreram. Quando pessoas internas levantarem preocupa√ß√µes, audite imediatamente. Prest√≠gio n√£o √© evid√™ncia de seguran√ßa."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "A fraude de Hwang Woo-suk", title: "The Pride of a Nation, Built on Lies",
        text: "In 2004, South Korean scientist <strong>Hwang Woo-suk</strong> announced he had cloned human embryos and created patient-specific stem cells‚Äîa breakthrough that could cure Parkinson's, diabetes, and paralysis. He was a national hero. The government issued postage stamps in his honor. Schools taught his achievements. His papers in <strong>Science</strong> were celebrated as Nobel-worthy.",
        followup: "A junior researcher noticed the photos looked wrong. The same cells appeared in multiple images, supposedly from different experiments. When Science investigated, the fa√ßade crumbled: the breakthrough data was fabricated. Hwang had pressured junior researchers‚Äîmostly women‚Äîto donate eggs under ethically questionable conditions. He had fabricated results to meet impossible expectations. The 'cloned' stem cells never existed. South Korea's national pride evaporated overnight. Hwang was convicted of embezzlement and bioethics violations. He had spent $40 million in government funds on research that produced nothing but lies."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üî¨", title: "Cen√°rio: A Prioridade Nacional",
        xp: 25,
        scenario: "O principal cientista do seu pa√≠s reivindica um avan√ßo revolucion√°rio. O governo est√° financiando uma expans√£o massiva. Os concorrentes internacionais est√£o correndo para replicar. Um membro j√∫nior do laborat√≥rio diz discretamente que os dados da imagem parecem manipulados, mas teme retalia√ß√£o por falar abertamente.",
        question: "What is the correct first step?",
        options: [
          { letter: "A", text: "Proteja a identidade do denunciante enquanto solicita an√°lise de imagem independente", correct: true },
          { letter: "B", text: "Confrontar o cientista s√™nior diretamente com as preocupa√ß√µes", correct: false },
          { letter: "C", text: "Wait for international labs to attempt replication", correct: false },
          { letter: "D", text: "Report to government funders immediately", correct: false }
        ],
        feedback: {
          correct: "Correto! A an√°lise forense de imagens por analistas independentes ‚Äì sem expor o denunciante ‚Äì √© o caminho seguro. A fraude de Hwang foi detectada por an√°lise de imagem. Os investigadores juniores que se manifestam precisam de prote√ß√£o.",
          incorrect: "O confronto direto p√µe em perigo os denunciantes e permite a destrui√ß√£o de provas. A fraude de Hwang foi detectada pela an√°lise de imagens mostrando c√©lulas duplicadas. An√°lise forense independente e depois escalada."
        }
      }},
      { type: "concept", theme: "light", content: {
        title: "A regra das duas assinaturas",
        subtitle: "Why two people must sign",
        text: "The Poldermans fraud succeeded because one researcher controlled everything. Single points of authority enable fraud.",
        highlight: "Two signatures means two people verified."
      }},
      { type: "quiz", theme: "dark", content: {
        question: "Why must the protocol be registered BEFORE DoD-A passes?",
        options: [
          { text: "It's a journal requirement only", correct: false },
          { text: "Ele marca a data e hora de suas promessas antes de ver os dados", correct: true },
          { text: "Faz com que a revis√£o pare√ßa mais profissional", correct: false },
          { text: "It's optional for non-Cochrane reviews", correct: false }
        ],
        xp: 20,
        feedback: {
          correct: "Exatamente! O registro cria um carimbo de data/hora. Sem isso, voc√™ n√£o pode provar que n√£o mudou os resultados depois de ver o que funcionou.",
          incorrect: "O registro registra a data e hora de seus m√©todos pr√©-especificados. 31% dos ensaios alteram os resultados ‚Äì o registo prova que n√£o o fez."
        }
      }}
    ]
  },
  {
    id: 4, title: "Phase B: Search", subtitle: "Days 4-10: Document everything", xp: 150,
    slides: [
      { type: "title", theme: "dark", content: { title: "Phase B: Search & Screen", subtitle: "Days 4-10: Systematic, documented, reproducible" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "Understand why search strings must be saved verbatim",
          "Learn calibration requirements for dual screening",
          "Master PRISMA reporting requirements",
          "Know when exclusion reasons are required"
        ],
        tip: "Conclua este m√≥dulo para ganhar o distintivo Search Savant!"
      }},
      { type: "story", theme: "dark", content: {
        label: "A Retra√ß√£o Cochrane", title: "Every Character Matters",
        text: "Uma revis√£o Cochrane foi retirada quando os auditores n√£o conseguiram reproduzir a pesquisa. 'Usamos o PubMed' n√£o √© um m√©todo."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üíæ", title: "Cen√°rio: A Pesquisa Reconstru√≠da",
        xp: 25,
        scenario: "You're at Day 8. A team member admits they didn't save the exact search string from last week‚Äîbut they 'remember most of it' and have reconstructed it. The search yielded 2,400 results then; the reconstructed search yields 2,380.",
        question: "O que voc√™ deve fazer?",
        options: [
          { letter: "A", text: "Accept it‚Äî20 missing records won't matter", correct: false },
          { letter: "B", text: "Execute novamente e documente a nova pesquisa como oficial", correct: true },
          { letter: "C", text: "Use a pesquisa reconstru√≠da e observe suas limita√ß√µes", correct: false },
          { letter: "D", text: "Contact the database to get search history", correct: false }
        ],
        feedback: {
          correct: "Correto! Uma pesquisa que n√£o pode ser reproduzida n√£o √© evid√™ncia. Documente a nova pesquisa como oficial, anote o desvio e proceda com m√©todos transparentes.",
          incorrect: "The Cochrane retraction: 'We used PubMed' isn't a method. You need the exact string, exact date, exact filters. Start fresh with documented methods."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "As prova√ß√µes enterradas", title: "Para onde foram 74 estudos?",
        text: "Em 2008, os pesquisadores pesquisaram todos os ensaios registrados de antidepressivos. Eles encontraram 74 ensaios. Em seguida, eles procuraram publica√ß√µes. Apenas 38 foram publicados. Os outros 36? Enterrado. Escondido. Desapareceu.",
        followup: "Every single buried trial showed negative results. Every published trial showed positive results. The published literature told doctors: 'Antidepressants work 94% of the time.' The truth: they worked 51% of the time. Half the evidence had simply vanished."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üîé", title: "Cen√°rio: os registros ausentes",
        xp: 25,
        scenario: "Sua pesquisa na literatura publicada encontra 12 ensaios sobre um novo medicamento ‚Äì todos positivos. Voc√™ verifica os registros de ensaios e encontra 8 ensaios registrados adicionais que nunca foram publicados. A empresa afirma que os ensaios n√£o publicados tiveram 'problemas de qualidade de dados'.",
        question: "O que voc√™ deve fazer?",
        options: [
          { letter: "A", text: "Inclua apenas os 12 ensaios publicados - eles t√™m dados utiliz√°veis", correct: false },
          { letter: "B", text: "Solicite dados n√£o publicados aos contatos do registro e √† FDA", correct: true },
          { letter: "C", text: "Note the 8 missing trials as a limitation", correct: false },
          { letter: "D", text: "Exclua o medicamento de sua revis√£o devido a preconceitos preocupa√ß√µes", correct: false }
        ],
        feedback: {
          correct: "Correct! The buried trials lesson: 48% of antidepressant data was hidden. Request unpublished data from registries, FDA, authors. Half the truth is a lie.",
          incorrect: "36 of 74 antidepressant trials were buried‚Äîall negative. Published-only evidence showed 94% efficacy; true efficacy was 51%. Always hunt for unpublished data."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "O esc√¢ndalo da reboxetina", title: "A droga que nunca funcionou",
        text: "Reboxetine was approved in Europe for depression. Published trials showed it worked. Doctors prescribed it. Then researchers obtained the unpublished data. <strong>74% of the patient data had never been published.</strong>",
        followup: "Os dados ocultos mostraram: A reboxetina n√£o era melhor que o placebo. Foi pior do que outros antidepressivos. Teve mais efeitos colaterais. Os pacientes sofreram durante anos com um medicamento que os reguladores aprovaram com base em evid√™ncias escolhidas a dedo."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üîç", title: "Cen√°rio: O desacordo na triagem",
        xp: 25,
        scenario: "Seus dois avaliadores revisaram independentemente 50 t√≠tulos/resumos para calibra√ß√£o. Concordaram em apenas 28 (concord√¢ncia de 56%). A meta √© ‚â•80%.",
        question: "What should happen next?",
        options: [
          { letter: "A", text: "Proceed anyway‚Äî56% is acceptable for complex topics", correct: false },
          { letter: "B", text: "Discuss disagreements, revise criteria, re-calibrate on new 25", correct: true },
          { letter: "C", text: "Have a third person break all ties", correct: false },
          { letter: "D", text: "Switch to single-screener with random verification", correct: false }
        ],
        feedback: {
          correct: "Certo! Baixa concord√¢ncia significa que seus crit√©rios s√£o amb√≠guos. Discuta, revise, repita at√© chegar a ‚â•80%.",
          incorrect: "56% de concord√¢ncia significa que seus crit√©rios s√£o amb√≠guos. Voc√™ est√° essencialmente selecionando aleatoriamente. Discuta, revise, recalibre."
        }
      }},
      { type: "checklist", theme: "dark", content: {
        title: "DoD-B Checklist",
        items: [
          "Search strings saved verbatim",
          "Search dates + limits recorded",
          "M√©todo de elimina√ß√£o registrado",
          "Screening calibration (‚â•80%)",
          "PRISMA counts live",
          "Screening log exportable"
        ]
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìä", title: "Cen√°rio: O quebra-cabe√ßa PRISMA",
        xp: 25,
        scenario: "Your PRISMA shows: Identified: 2,400 | After dedup: 1,800 | Screened: 1,800 | Full-text: 150 | Included: 45. A peer reviewer asks: 'What happened to the 1,650 excluded at screening?'",
        question: "Qual √© a resposta correta?",
        options: [
          { letter: "A", text: "'They didn't meet criteria'‚Äîno need for details", correct: false },
          { letter: "B", text: "Provide counts by exclusion reason", correct: false },
          { letter: "C", text: "Explain that screening exclusions don't need reasons", correct: true },
          { letter: "D", text: "Go back and document each exclusion reason", correct: false }
        ],
        feedback: {
          correct: "Correct! Title/abstract screening exclusions don't require individual reasons (too many). Full-text exclusions DO need documented reasons.",
          incorrect: "Screening exclusions (title/abstract) don't require individual reasons‚Äîthere are too many. But FULL-TEXT exclusions must have documented reasons."
        }
      }},
      { type: "stats", theme: "dark", content: {
        title: "PRISMA Requirements",
        stats: [
          { value: "100%", label: "Numbers add up" },
          { value: "Every", label: "Full-text exclusion documented" },
          { value: "Zero", label: "Black boxes" }
        ]
      }},
      { type: "story", theme: "dark", content: {
        label: "A falta Metade", title: "Estudos secretos do Neurontin",
        text: "A Pfizer promoveu o Neurontin para transtorno bipolar, enxaquecas e dor ‚Äì usos nunca aprovados pelo FDA. Documentos internos revelaram que haviam encomendado estudos. Quando os resultados foram negativos, os estudos simplesmente... desapareceram.",
        followup: "A literatura publicada mostrou que Neurontin funcionou para usos off-label. A literatura n√£o publicada mostrou que n√£o. Os m√©dicos viram apenas metade das evid√™ncias e chegaram √† conclus√£o √≥bvia ‚Äì errada. A Pfizer pagou US$ 430 milh√µes em multas. Mas os pacientes que receberam tratamento ineficaz? Eles pagaram mais."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìÅ", title: "Cen√°rio: A oferta da empresa",
        xp: 25,
        scenario: "Uma empresa farmac√™utica oferece compartilhar seu 'banco de dados interno completo' para sua revis√£o sistem√°tica. Eles prometem todos os dados do teste, mas apenas se voc√™ assinar um acordo de confidencialidade que o impede de publicar quaisquer resultados individuais do teste sem a aprova√ß√£o deles.",
        question: "O que voc√™ deve fazer?",
        options: [
          { letter: "A", text: "Aceitar ‚Äì obter os dados √© o que importa", correct: false },
          { letter: "B", text: "Aceite, mas observe a restri√ß√£o em seus m√©todos", correct: false },
          { letter: "C", text: "Recusar e solicitar dados atrav√©s de canais oficiais em vez disso", correct: true },
          { letter: "D", text: "Aceite esta revis√£o, lute pela transpar√™ncia mais tarde", correct: false }
        ],
        feedback: {
          correct: "Correct! Neurontin's lesson: companies hide what they don't want seen. Confidentiality agreements can be weaponized. Request data through FDA, EMA, or AllTrials instead.",
          incorrect: "O esc√¢ndalo Neurontin: as empresas suprimiram ensaios negativos. Os acordos de confidencialidade d√£o-lhes poder de veto sobre o que voc√™ denuncia. Mantenha a independ√™ncia."
        }
      }},
      { type: "quiz", theme: "dark", content: {
        question: "Why must search dates be recorded?",
        options: [
          { text: "Para os registros do peri√≥dico", correct: false },
          { text: "Os bancos de dados s√£o atualizados diariamente - seus dados s√£o seu carimbo de dados e hora", correct: true },
          { text: "To calculate how long the search took", correct: false },
          { text: "It's optional metadata", correct: false }
        ],
        xp: 15,
        feedback: {
          correct: "Exatamente! Uma pesquisa na segunda-feira encontra estudos diferentes dos de ter√ßa-feira. Suas datas definem qual universo voc√™ pesquisou.",
          incorrect: "Os bancos de dados s√£o atualizados constantemente. Seus dados de pesquisa √© o carimbo de dados e hora do universo liter√°rio que voc√™ pesquisou."
        }
      }}
    ]
  },
  {
    id: 5, title: "Phase C: Extraction", subtitle: "Days 11-28: Provenance for every number", xp: 200,
    slides: [
      { type: "title", theme: "dark", content: { title: "Phase C: Extraction", subtitle: "Days 11-28: Every number needs a source" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "Understand what provenance means and why it matters",
          "Learn the Red-Team daily checking system",
          "Handle conflicting numbers with pre-specified rules",
          "Recognize the COLCOT near-disaster pattern"
        ],
        tip: "O estudo de caso COLCOT mostra como um bra√ßo trocado quase reverteu as conclus√µes."
      }},
      { type: "prediction", theme: "dark", content: {
        icon: "üîÆ", title: "O ensaio COLCOT",
        subtitle: "The largest trial (n=4,745) in a colchicine meta-analysis. The extractor pulls data from Figure 3 showing colchicine vs placebo events. Quick forest plot shows colchicine INCREASES events, while all other trials show benefit. What happened?",
        options: [
          { id: "benefit", label: "üìä Statistical fluke", text: "Random variation‚Äîinclude as-is" },
          { id: "neutral", label: "‚ùì Erro de entrada de dados", text: "Wrong numbers typed" },
          { id: "harm", label: "üîÑ Arms swapped", text: "Intervention/control mixed up" }
        ],
        answer: "harm",
        xp: 30
      }},
      { type: "story", theme: "red-bg", content: {
        label: "O COLCOT Quase desastre", title: "One Swapped Arm",
        text: "The extractor assumed left bar = intervention. It was right = intervention. One error in one critical field would have reversed the entire conclusion.",
        followup: "A verifica√ß√£o di√°ria do Red Team detectou isso. √â por isso que estudos influentes s√£o verificados."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üî¥", title: "Scenario: Red-Team Finds an Error",
        xp: 30,
        scenario: "A verificadora do time vermelho F√°tima descobre que os bra√ßos do COLCOT foram trocados. Este √© o maior ensaio (40% do peso total). O extrator defende: 'O n√∫mero era amb√≠guo.'",
        question: "What should happen?",
        options: [
          { letter: "A", text: "Corrigir com proced√™ncia da Tabela 2, corre√ß√£o de log", correct: true },
          { letter: "B", text: "Exclude COLCOT‚Äîtoo risky to include", correct: false },
          { letter: "C", text: "Expand audit to ALL studies immediately", correct: false },
          { letter: "D", text: "Ask the original authors to clarify", correct: false }
        ],
        feedback: {
          correct: "Correto! Corre√ß√£o com proced√™ncia (Tabela 2 confirma aloca√ß√£o), registre a corre√ß√£o. Erro √∫nico de causa clara n√£o requer auditoria expandida.",
          incorrect: "N√£o exclua dados v√°lidos ou auditoria excessivamente expandida para um √∫nico erro de causa clara. Corrija com a proveni√™ncia, registre-o e informe o extrator."
        }
      }},
      { type: "concept", theme: "dark", content: {
        title: "O sistema Red-Team",
        subtitle: "Daily adversarial checking",
        text: "Todos os dias, a partir do dia 11, dois membros rotativos da equipe passam de 12 a 15 minutos verificando estudos selecionados automaticamente.<",
        highlight: "A detec√ß√£o de Boldt: sua fraude (mais de 90 estudos) foi detectada quando um a equipe vermelha notou taxas de recrutamento imposs√≠veis."
      }},
      { type: "story", theme: "red-bg", content: {
        label: "O desastre de Boldt", title: "Noventa estudos de mentiras",
        text: "Joachim Boldt foi o pesquisador mais prol√≠fico em anestesia. Ele publicou mais de 90 estudos sobre fluidos coloidais. Seu trabalho moldou as diretrizes cl√≠nicas em todo o mundo. Ent√£o algu√©m percebeu: um hospital afirmou recrutar 800 pacientes em condi√ß√µes que afetavam apenas 200 pacientes por ano.",
        followup: "Investigation revealed: No ethics approval existed. Patient records couldn't be found. Co-authors had never seen the data. <strong>Ninety studies</strong> were retracted‚Äîthe largest fraud in medical history. Clinical guidelines had to be rewritten. The question that would have stopped him? 'Can you show me the source documents?'"
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üî¢", title: "Cen√°rio: Os n√∫meros imposs√≠veis",
        xp: 25,
        scenario: "Durante a extra√ß√£o, voc√™ percebe que um estudo recrutou 450 pacientes com uma condi√ß√£o rara de um √∫nico hospital em 18 meses. A epidemiologia publicada sugere que o hospital atende cerca de 50 desses pacientes por ano.",
        question: "O que voc√™ deve fazer?",
        options: [
          { letter: "A", text: "Incluir o estudo - o sucesso do recrutamento varia", correct: false },
          { letter: "B", text: "Sinalizar para verifica√ß√£o: verificar a aprova√ß√£o √©tica e os registros do paciente", correct: true },
          { letter: "C", text: "Exclude as a statistical outlier", correct: false },
          { letter: "D", text: "Enviar um e-mail aos autores para esclarecer o recrutamento m√©todos", correct: false }
        ],
        feedback: {
          correct: "Correto! Boldt foi pego porque as taxas de recrutamento eram imposs√≠veis. Quando os n√∫meros n√£o fazem sentido, verifique se existem documentos originais antes de incluir o estudo.",
          incorrect: "Foi assim que Boldt foi capturado: 800 pacientes de condi√ß√µes que afetam 200/ano. N√∫meros imposs√≠veis sinalizam fraude potencial. Verifique a aprova√ß√£o √©tica e se existem dados brutos."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "A fraude de Wakefield", title: "12 Children, 12 Million Harmed",
        text: "Em 1998, Andrew Wakefield publicou um estudo com 12 crian√ßas ligando a vacina MMR ao autismo. As taxas de vacina√ß√£o despencaram. Os surtos de sarampo voltaram. Crian√ßas morreram de doen√ßas evit√°veis.",
        followup: "It took 12 years to prove the fraud. Wakefield had been paid ¬£435,643 by lawyers to produce evidence for lawsuits. He had manipulated data. He had undisclosed conflicts. But for a decade, his 12-patient study outweighed millions of patients in honest research. One fraudulent paper. Thousands of preventable infections."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìù", title: "Cen√°rio: Proveni√™ncia Desaparecida",
        xp: 25,
        scenario: "An extractor recorded 'events: 45/230' for a study but didn't note the source (table/figure/page). When you check the PDF, you find events reported in Table 2 (45/230), Figure 1 (42/228), and text (43/225).",
        question: "Qual ‚Äã‚Äã√© a a√ß√£o correta?",
        options: [
          { letter: "A", text: "Use any number‚Äîthey're close enough", correct: false },
          { letter: "B", text: "Use the most conservative estimate (42/228)", correct: false },
          { letter: "C", text: "Entre em contato com os autores para esclarecer", correct: false },
          { letter: "D", text: "Apply pre-specified hierarchy (e.g., Table > Figure > Text)", correct: true }
        ],
        feedback: {
          correct: "Correto! Seu protocolo deve especificar uma hierarquia para n√∫meros conflitantes. Aplique-o de forma consistente e documente a fonte.",
          incorrect: "Voc√™ precisa de uma regra pr√©-especificada para esta situa√ß√£o. 'Mais conservador' √© uma regra, mas deveria estar no seu protocolo. Sem proced√™ncia, voc√™ n√£o pode verificar nada."
        }
      }},
      { type: "checklist", theme: "dark", content: {
        title: "DoD-C Checklist",
        items: [
          "Extraction template frozen",
          "RoB tool + decision rules written",
          "Critical fields verified by second person",
          "Overlap rules applied",
          "Arbitration process operating"
        ]
      }},
      { type: "story", theme: "red-bg", content: {
        label: "A Fraude da Anestesia Reuben", title: "The Most Prolific Faker in Medicine",
        text: "Scott Reuben was anesthesiology's rising star. Between 1996 and 2008, he published prolifically on postoperative pain management. His studies shaped how surgeons treated patients after operations. Drug companies funded his research. <strong>Pfizer paid him consulting fees</strong> while he published studies showing their drugs worked brilliantly.",
        followup: "In 2009, an anonymous tip led to investigation. Reuben hadn't just manipulated data‚Äî<strong>he had never enrolled a single patient</strong>. Studies claiming to follow hundreds of patients were pure invention. He fabricated everything: consent forms, patient records, outcomes. Twenty-one papers were retracted. Clinical guidelines based on his 'research' had to be rewritten. The patients who received treatment recommendations based on his fabrications? They were experiments in a trial that never happened, with no informed consent, following protocols invented by a liar."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üë§", title: "Cen√°rio: O Pesquisador Prol√≠fico",
        xp: 25,
        scenario: "Voc√™ percebe que um pesquisador publicou 15 ensaios em sua √°rea em 3 anos - mais do que qualquer departamento poderia realisticamente realizar. Todos apresentam resultados positivos para medicamentos fabricados por seus financiadores. Nenhum outro centro replicou suas descobertas. Sua institui√ß√£o nunca auditou seus dados.",
        question: "O que voc√™ deve fazer antes de incluir os estudos dele em sua revis√£o?",
        options: [
          { letter: "A", text: "Include them‚Äîthey're peer-reviewed and published", correct: false },
          { letter: "B", text: "Request verification of ethics approval and patient enrollment records", correct: true },
          { letter: "C", text: "Execute a an√°lise de sensibilidade com e sem seus estudos", correct: false },
          { letter: "D", text: "Weight his studies lower due to potential bias", correct: false }
        ],
        feedback: {
          correct: "Correto! Reuben publicou 21 ensaios fabricados ao longo de 12 anos. Ningu√©m verificou se existiam pacientes. Solicite documenta√ß√£o do conselho de √©tica e verifica√ß√£o de inscri√ß√£o ‚Äî os fabricantes n√£o podem produzi-los.",
          incorrect: "Scott Reuben inventou 21 estudos com pacientes imagin√°rios. A revis√£o por pares n√£o pegou. A an√°lise de sensibilidade n√£o detecta fabrica√ß√£o. Verifique se os pacientes existiam."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "A Decep√ß√£o VIGOR", title: "The Three Heart Attacks They Hid",
        text: "Merck knew Vioxx caused heart attacks. Their own trial‚ÄîVIGOR‚Äîshowed it clearly. But the published paper in the <strong>New England Journal of Medicine</strong> had a secret: Merck scientists had chosen a data cutoff date that excluded <strong>three additional heart attacks</strong> that occurred in the Vioxx group.",
        followup: "Those three heart attacks mattered. Including them would have changed the safety signal from 'possibly concerning' to 'clearly dangerous.' Instead, the published paper suggested the increased heart attacks might be because the comparison drug (naproxen) was protective‚Äînot because Vioxx was deadly. The NEJM editors only learned of the missing data years later. They published an 'expression of concern,' calling it 'inaccurate and incomplete.' By then, tens of thousands had suffered heart attacks. The data cutoff wasn't a scientific decision. It was a marketing decision disguised as methodology."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìÖ", title: "Cen√°rio: o corte estrat√©gico",
        xp: 25,
        scenario: "Voc√™ est√° extraindo dados e percebe que a data limite de dados de um estudo foi duas semanas antes da data final declarada do estudo. Os m√©todos n√£o explicam o porqu√™. Os eventos que ocorrem ap√≥s o corte n√£o s√£o relatados. O momento coincide convenientemente com o momento em que os sinais de seguran√ßa se tornariam estatisticamente significativos.",
        question: "O que voc√™ deve documentar e solicitar?",
        options: [
          { letter: "A", text: "Use os dados publicados - os autores escolheram seu ponto de corte", correct: false },
          { letter: "B", text: "Note unexplained cutoff in Risk of Bias; request complete data from authors/FDA", correct: true },
          { letter: "C", text: "Excluir o estudo por relato incompleto", correct: false },
          { letter: "D", text: "Impute likely events based on trends before cutoff", correct: false }
        ],
        feedback: {
          correct: "Correto! O corte VIGOR escondeu tr√™s ataques card√≠acos que mudaram tudo. Documente pontos de corte inexplic√°veis ‚Äã‚Äãcomo de alto risco de vi√©s e busque ativamente dados completos de registros ou da FDA.",
          incorrect: "O ponto de corte VIGOR da Merck n√£o era metodologia ‚Äì era oculta√ß√£o. Cortes inexplic√°veis ‚Äã‚Äãs√£o sinais de alerta. Documente o risco e obtenha dados completos atrav√©s dos canais oficiais."
        }
      }},
      { type: "quiz", theme: "dark", content: {
        question: "What is 'provenance' in META-SPRINT?",
        options: [
          { text: "O pa√≠s onde um estudo foi conduzido", correct: false },
          { text: "A citation showing where a number came from", correct: true },
          { text: "A fonte de financiamento de um ensaio", correct: false },
          { text: "A data em que um estudo foi publicado", correct: false }
        ],
        xp: 20,
        feedback: {
          correct: "Right! Provenance like 'Table 2, p.1234' creates an audit trail. No provenance = no trust.",
          incorrect: "Provenance means the exact source: 'Table 2, p.1234.' It's your evidence trail for every extracted number."
        }
      }},
      { type: "summary", theme: "green-bg", content: {
        summary: "You've mastered extraction fundamentals: provenance, Red-Team checking, and handling conflicting data. Next: making your analysis reproducible."
      }}
    ]
  },
  {
    id: 6, title: "Phase D: Analysis", subtitle: "Dias 29-33: Reprodut√≠vel resultados", xp: 180,
    slides: [
      { type: "title", theme: "green-bg", content: { title: "Phase D: Analysis", subtitle: "Days 29-33: If you can't reproduce it, neither can anyone else" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "Understand rerun equivalence tolerances",
          "Aprenda a lidar com discrep√¢ncias de an√°lise",
          "Know how to document influential studies",
          "Domine o conceito de c√°psulas de an√°lise"
        ],
        tip: "A reprodutibilidade n√£o √© negoci√°vel. Complete isso para obter o selo Stats Wizard!"
      }},
      { type: "stats", theme: "dark", content: {
        title: "A Crise de Reprodutibilidade",
        stats: [
          { value: "70%", label: "Failed to reproduce others" },
          { value: "50%", label: "Failed to reproduce self" }
        ],
        caption: "Nature (2016): Most researchers can't reproduce published findings."
      }},
      { type: "story", theme: "red-bg", content: {
        label: "A Verifica√ß√£o da Realidade da Amgen", title: "47 of 53 Failed",
        text: "Em 2012, os cientistas da Amgen tentaram reproduzir 53 estudos 'marcos' sobre o c√¢ncer - artigos que moldaram a pesquisa sobre o c√¢ncer, lan√ßaram ensaios cl√≠nicos e consumiram bilh√µes em financiamento. Eles trabalharam diretamente com autores originais. Eles usaram os mesmos m√©todos.",
        followup: "Result: <strong>47 of 53 studies could not be reproduced.</strong> 89% failure rate. Years of research built on foundations that didn't exist. Clinical trials started based on findings that weren't real. The cancer research community had been chasing phantoms."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üî¨", title: "Cen√°rio: O Papel Marco",
        xp: 25,
        scenario: "Um estudo pr√©-cl√≠nico 'referencial' de um peri√≥dico importante forma a base para um novo tratamento. Tr√™s tentativas de replica√ß√£o por laborat√≥rios independentes falharam. Os autores originais dizem que os replicadores ‚Äún√£o tinham conhecimento t√©cnico‚Äù. Ningu√©m viu os dados brutos originais.",
        question: "Como as diretrizes deveriam tratar essas evid√™ncias?",
        options: [
          { letter: "A", text: "Trust the original‚Äîit's in a top journal", correct: false },
          { letter: "B", text: "Downgrade certainty until reproducibility is demonstrated", correct: true },
          { letter: "C", text: "Weight original and replications equally", correct: false },
          { letter: "D", text: "Wait for a fourth replication attempt", correct: false }
        ],
        feedback: {
          correct: "Correct! The Amgen lesson: 89% of landmark cancer studies couldn't be reproduced. If it can't be replicated, it's not evidence‚Äîit's a hypothesis.",
          incorrect: "47 de 53 estudos importantes n√£o conseguiram reproduzir. O prest√≠gio do jornal n√£o √© igual √† verdade. Achados irreprodut√≠veis nunca devem constituir a base das diretrizes de tratamento."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "O esc√¢ndalo de Duke", title: "O g√™nio que nunca existiu",
        text: "Anil Potti, da Duke University, desenvolveu um teste gen√¥mico para personalizar o tratamento do c√¢ncer. Seus artigos foram publicados nas principais revistas. Os ensaios cl√≠nicos inscreveram pacientes. Ele foi celebrado como um vision√°rio.",
        followup: "Then two statisticians noticed: the data was impossible. Gene signatures were backwards. Spreadsheets had been manipulated. Potti had invented his credentials. Over 100 cancer patients had been enrolled in trials based on fraudulent science. Some received treatments that harmed them based on data that never existed."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üîÑ", title: "Cen√°rio: A incompatibilidade de nova execu√ß√£o",
        xp: 30,
        scenario: "Audit 2: Two analysts independently rerun the analysis. Analyst A: I¬≤=34.2%. Analyst B: I¬≤=31.8%. The tolerance is 1%. Difference: 2.4%.",
        question: "What should happen?",
        options: [
          { letter: "A", text: "Matencie os resultados - ambos s√£o razo√°veis", correct: false },
          { letter: "B", text: "Use the more conservative estimate", correct: false },
          { letter: "C", text: "Line-by-line comparison to find the discrepancy", correct: true },
          { letter: "D", text: "Trigger CondGO (emergency mode)", correct: false }
        ],
        feedback: {
          correct: "Correct! Line-by-line comparison found one SE rounded to 2 decimals instead of 4. Fix the source, rerun, verify match.",
          incorrect: "N√£o calcule a m√©dia nem aceite incompatibilidades. Encontre a fonte da discrep√¢ncia. Neste caso: um SE foi arredondado incorretamente."
        }
      }},
      { type: "concept", theme: "dark", content: {
        title: "Rerun Equivalence Tolerances",
        subtitle: "Two runs must match exactly",
        checkpoints: [
          { day: "Study count", event: "Exactly identical" },
          { day: "Effect sizes", event: "‚â§0.001 (log scale)" },
          { day: "Pooled effect", event: "‚â§0.001" },
          { day: "I¬≤ heterogeneity", event: "Within 1%" }
        ]
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìà", title: "Cen√°rio: O estudo influente",
        xp: 25,
        scenario: "A an√°lise de deixar um de fora mostra que a remo√ß√£o do ensaio COLCOT altera o RR agrupado de 0,65 (significativo) para 0,78 (ainda significativo). COLCOT contribui com 40% do peso.",
        question: "O que voc√™ deve documentar?",
        options: [
          { letter: "A", text: "Nothing‚Äîresult is still significant", correct: false },
          { letter: "B", text: "Document that COLCOT is influential but robust", correct: true },
          { letter: "C", text: "Exclude COLCOT as an outlier", correct: false },
          { letter: "D", text: "Downgrade certainty to VERY LOW", correct: false }
        ],
        feedback: {
          correct: "Correto! Documente estudos influentes e observe que as conclus√µes s√£o robustas. N√£o exclua dados bons s√≥ porque s√£o influentes.",
          incorrect: "Voc√™ deve documentar estudos influentes. Aqui, a remo√ß√£o do COLCOT muda a magnitude, mas n√£o a dire√ß√£o ‚Äì essa √© uma descoberta robusta. N√£o exclua bons dados."
        }
      }},
      { type: "checklist", theme: "dark", content: {
        title: "DoD-D Checklist",
        items: [
          "Capsule runs end-to-end",
          "Forest + heterogeneity outputs",
          "Sensitivity set executed",
          "Estudos influentes documentados",
          "Audit 2 completed",
          "Rerun equivalence satisfied"
        ]
      }},
      { type: "story", theme: "red-bg", content: {
        label: "O encobrimento da BMP-2", title: "Paid Authors, Hidden Harms",
        text: "A Medtronic pagou US$ 210 milh√µes a cirurgi√µes que escreveram artigos sobre seu produto de crescimento √≥sseo BMP-2. Todos os artigos publicados diziam que era seguro e eficaz. Cada artigo foi escrito por autores com v√≠nculos financeiros n√£o revelados. Nenhum relatou os eventos adversos que a Medtronic tinha conhecimento.",
        followup: "When independent researchers obtained FDA adverse event reports, they found: <strong>10-50x higher complication rates</strong> than published papers claimed. Cancers. Sterility. Chronic pain. The published literature was a marketing document. The real evidence was in FDA files no one had read."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üí∞", title: "Cen√°rio: As taxas de consultoria",
        xp: 25,
        scenario: "You're extracting data from 15 studies on a medical device. You notice all 15 lead authors have received consulting fees from the manufacturer. The amounts range from $50,000 to $500,000 per author. All 15 studies show benefit; no harms are reported.",
        question: "O que voc√™ deve documentar em sua revis√£o?",
        options: [
          { letter: "A", text: "Nothing‚Äîdisclosed conflicts aren't bias", correct: false },
          { letter: "B", text: "Document conflicts and check FDA adverse event database", correct: true },
          { letter: "C", text: "Exclude all studies due to conflict of interest", correct: false },
          { letter: "D", text: "Run sensitivity analysis by funding source", correct: false }
        ],
        feedback: {
          correct: "Correct! BMP-2 lesson: all published papers hid harms that FDA reports revealed. Always cross-check industry-funded device/drug studies against regulatory databases.",
          incorrect: "The BMP-2 cover-up: $210M paid to authors who reported no harms; FDA data showed 10-50x higher complication rates. Industry conflicts require regulatory cross-checking."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "O desastre do quadril de metal contra metal", title: "As articula√ß√µes que envenenaram os pacientes",
        text: "In the 2000s, device manufacturers promised a revolution: metal-on-metal hip implants that would last forever. DePuy's ASR hip was the flagship. <strong>93,000 patients</strong> worldwide received them. The company cited laboratory testing showing excellent wear characteristics. Surgeons believed the marketing.",
        followup: "Inside patients' bodies, reality was different. The metal surfaces ground against each other, releasing cobalt and chromium ions into tissues. Patients developed <strong>metallosis</strong>‚Äîmetal poisoning causing tissue death, bone destruction, and chronic pain. Some developed neurological symptoms as cobalt reached their brains. The failure rate reached <strong>40% at 5 years</strong>‚Äîcatastrophic for a device meant to last decades. DePuy had internal data showing problems but kept selling. When the hip was finally recalled in 2010, Johnson & Johnson paid $2.5 billion in settlements. The laboratory tests that 'proved' safety had never predicted what happens inside a living, moving human body."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "ü¶¥", title: "Cen√°rio: as evid√™ncias laboratoriais",
        xp: 25,
        scenario: "Um novo implante cir√∫rgico apresenta excelentes resultados em testes de desgaste em laborat√≥rio e estudos em animais. O fabricante quer pular os testes em humanos em grande escala e ir diretamente ao mercado com vigil√¢ncia p√≥s-comercializa√ß√£o. 'Os testes de bancada provam que funciona', argumentam eles.",
        question: "Qual ‚Äã‚Äã√© a falha cr√≠tica neste racioc√≠nio?",
        options: [
          { letter: "A", text: "Animal studies should be longer before human use", correct: false },
          { letter: "B", text: "Laboratory conditions cannot replicate the biological environment inside patients", correct: true },
          { letter: "C", text: "Post-marketing surveillance is sufficient for rare harms", correct: false },
          { letter: "D", text: "Os testes de bancada s√≥ s√£o v√°lidos para medicamentos, n√£o para dispositivos", correct: false }
        ],
        feedback: {
          correct: "Correto! Quadris de metal com metal passaram em todos os testes de laborat√≥rio ‚Äì depois envenenaram pacientes com √≠ons met√°licos, nenhum simulador previu. O corpo n√£o √© um laborat√≥rio. Os testes em humanos em condi√ß√µes reais s√£o insubstitu√≠veis.",
          incorrect: "Os testes de laborat√≥rio de DePuy mostraram que o quadril duraria para sempre. Dentro dos pacientes, destruiu tecidos e liberou √≠ons met√°licos. Condi√ß√µes de laborat√≥rio ‚â† realidade biol√≥gica. Grandes ensaios em humanos com longo acompanhamento s√£o essenciais."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "O desastre do Essure", title: "A contracep√ß√£o permanente que destruiu vidas",
        text: "Bayer's Essure promised women permanent contraception without surgery‚Äîtiny metal coils inserted through the cervix that would block the fallopian tubes. The <strong>FDA approved it based on 2 years of data from 518 women</strong>. What could go wrong with a simple, non-surgical procedure?",
        followup: "Thousands of women reported devices migrating through their bodies, perforating organs, causing chronic pain, autoimmune reactions, and‚Äîdevastatingly‚Äî<strong>unintended pregnancies, including ectopic pregnancies that can be fatal</strong>. Women needed hysterectomies to remove devices they'd been told were 'permanent solutions.' A Facebook group for Essure victims grew to over 30,000 members. The FDA eventually added a black box warning, then restricted sales. Bayer stopped selling it in 2018. The lesson: 2 years of follow-up in 518 women was never enough to detect rare complications from a permanent implant. Approval timelines should match device permanence."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "‚ö†Ô∏è", title: "Cen√°rio: O dispositivo permanente",
        xp: 25,
        scenario: "Um dispositivo implant√°vel permanente est√° buscando a aprova√ß√£o da FDA com base no acompanhamento de 3 anos em 600 pacientes. O dispositivo deve permanecer nos pacientes por toda a vida. Nenhum evento adverso grave foi relatado ainda. A empresa argumenta que isso prova seguran√ßa a longo prazo.",
        question: "What should regulators require before approval?",
        options: [
          { letter: "A", text: "Post-marketing surveillance with mandatory reporting", correct: false },
          { letter: "B", text: "Follow-up duration proportional to intended implant life; registry with long-term tracking", correct: true },
          { letter: "C", text: "Approval is appropriate‚Äî3 years is standard for devices", correct: false },
          { letter: "D", text: "Additional laboratory durability testing", correct: false }
        ],
        feedback: {
          correct: "Correto! O Essure foi aprovado com base em dados de 2 anos para um dispositivo permanente. As complica√ß√µes surgiram ao longo dos anos. Os implantes permanentes precisam de acompanhamento proporcional √† sua perman√™ncia ‚Äì e registros obrigat√≥rios de longo prazo.",
          incorrect: "Os dados de 2 anos do Essure n√£o identificaram complica√ß√µes que destru√≠ram a sa√∫de das mulheres. Um dispositivo permanente necessita de um acompanhamento proporcionalmente longo. A vigil√¢ncia p√≥s-comercializa√ß√£o detecta problemas tarde demais."
        }
      }},
      { type: "quiz", theme: "dark", content: {
        question: "O que √© uma 'c√°psula de an√°lise'?",
        options: [
          { text: "A summary of key findings", correct: false },
          { text: "C√≥digo + dados + instru√ß√µes que qualquer pessoa pode executar", correct: true },
          { text: "A sa√≠da do gr√°fico de floresta", correct: false },
          { text: "Um dado compactado arquivo", correct: false }
        ],
        xp: 20,
        feedback: {
          correct: "Exatamente! Uma c√°psula √© tudo o que voc√™ precisa para reproduzir sua an√°lise. C√≥digo, dados, ambiente - tudo versionado.",
          incorrect: "A capsule is a complete reproducible package: code, data, instructions. Anyone can run it and get identical results."
        }
      }}
    ]
  },
  {
    id: 7, title: "Phase E & CondGO", subtitle: "Days 34-40: Ship or emergency", xp: 180,
    slides: [
      { type: "title", theme: "red-bg", content: { title: "Phase E: Submission", subtitle: "Dias 34 a 40: O FREEZE e o CondGO" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "Entenda o FREEZE e por que ele √© essencial",
          "Learn when CondGO is triggered",
          "Know the three CondGO exit options",
          "Master the DoD-E final checklist"
        ],
        tip: "O protocolo de emerg√™ncia que evita 'cuidaremos disso mais tarde' desastres."
      }},
      { type: "concept", theme: "dark", content: {
        title: "O CONGELAMENTO (Dia 34)",
        subtitle: "Nenhum novo estudo ap√≥s este ponto",
        text: "Scope is locked. Only corrections to existing data allowed.",
        highlight: "O Esc√¢ndalo BMP: A ind√∫stria continuou 'encontrando' novos estudos que favoreciam seu produto. O congelamento evita o aumento do escopo armado."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìö", title: "Scenario: New Study After Freeze",
        xp: 25,
        scenario: "√â dia 36. Um colega lhe envia um RCT rec√©m-publicado que atende perfeitamente aos seus crit√©rios. √â um teste grande e de alta qualidade.",
        question: "What do you do?",
        options: [
          { letter: "A", text: "Add it‚Äîquality evidence shouldn't be excluded", correct: false },
          { letter: "B", text: "Note it as a limitation, don't add", correct: true },
          { letter: "C", text: "Add it but run sensitivity with/without", correct: false },
          { letter: "D", text: "Request deadline extension to include it", correct: false }
        ],
        feedback: {
          correct: "Correto! Ap√≥s o congelamento, observe novos estudos como limita√ß√µes. Adicion√°-los abre a porta para a inclus√£o seletiva.",
          incorrect: "Congelar significa congelar. Adicionar 'apenas este bom estudo' √© exatamente como o aumento do escopo corrompe as avalia√ß√µes. Nota como limita√ß√£o."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "A linha do tempo da Avandia", title: "Seven Years of Silence",
        text: "GSK viu sinais cardiovasculares em 2000. Eles escolheram 'observar e esperar' sem prazo. Sete anos depois, a meta-an√°lise de Nissen exp√¥s o dano.",
        followup: "CondGO exists because 'we'll deal with it eventually' kills people."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "‚è∞", title: "Cen√°rio: A Revis√£o Indefinida",
        xp: 25,
        scenario: "Sua revis√£o sistem√°tica encontrou um sinal de seguran√ßa potencial: o medicamento X mostra 28% de aumento de eventos card√≠acos em compara√ß√£o ao placebo. Seu supervisor sugere 'manter a descoberta interna at√© que coletemos mais dados' sem um cronograma espec√≠fico.",
        question: "Em que voc√™ deve insistir?",
        options: [
          { letter: "A", text: "Agree‚Äîpremature publication could cause panic", correct: false },
          { letter: "B", text: "Set a fixed deadline: publish or escalate within 30 days", correct: true },
          { letter: "C", text: "Compartilhe primeiro com o fabricante do medicamento sua opini√£o", correct: false },
          { letter: "D", text: "Run additional analyses to confirm the signal", correct: false }
        ],
        feedback: {
          correct: "Correct! The Avandia lesson: 'watch and wait with no deadline' killed 83,000 people. CondGO principle: safety signals need hard deadlines, not open-ended deliberation.",
          incorrect: "GSK 'watched and waited' on Avandia for seven years. 83,000 heart attacks later, we learned: indefinite timelines kill. Set hard deadlines for safety decisions."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "A hist√≥ria completa da Avandia", title: "A planilha Eles Enterrado",
        text: "Em 1999, a pr√≥pria an√°lise da GlaxoSmithKline mostrou que Avandia aumentou os ataques card√≠acos em 31%. Um estat√≠stico de uma empresa criou uma planilha. Os executivos viram isso. Eles calcularam o passivo. Eles continuaram vendendo.",
        followup: "For seven years, Avandia remained a blockbuster drug. $3 billion per year in sales. The spreadsheet stayed hidden. When Steven Nissen published his meta-analysis in 2007, the world learned what GSK had known since 1999: Avandia caused an estimated <strong>83,000 heart attacks</strong>. The delay wasn't oversight‚Äîit was a decision."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìà", title: "Cen√°rio: A Decis√£o Empresarial",
        xp: 25,
        scenario: "Sua an√°lise mostra que um medicamento aumenta os eventos adversos em 25%. A droga gera US$ 2 bilh√µes em receita anual. Legal calcula que poss√≠veis a√ß√µes judiciais podem custar US$ 500 milh√µes. Um executivo s√™nior sugere que ‚Äúa matem√°tica favorece a continuidade das vendas‚Äù.",
        question: "Qual √© a resposta √©tica?",
        options: [
          { letter: "A", text: "Esta √© uma decis√£o de neg√≥cios, n√£o cient√≠fica", correct: false },
          { letter: "B", text: "Report the finding to regulators immediately", correct: true },
          { letter: "C", text: "Seek independent confirmation before acting", correct: false },
          { letter: "D", text: "Adicione avisos ao r√≥tulo e continue as vendas", correct: false }
        ],
        feedback: {
          correct: "Correto! A planilha da Avandia mostrou danos em 1999. A GSK fez as ‚Äúmatem√°ticas‚Äù e continuou vendendo. A resposta √©tica nunca tem a ver com receitas ‚Äì trata-se da seguran√ßa do paciente.",
          incorrect: "GSK calculated liability vs. revenue and chose sales. 83,000 heart attacks later: the 'business decision' was mass harm. Safety findings require immediate regulatory disclosure."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "A li√ß√£o da talidomida", title: "10,000 Children",
        text: "Em 1957, uma empresa alem√£ comercializou a talidomida como um comprimido para dormir seguro para mulheres gr√°vidas. ‚ÄúNenhuma evid√™ncia de dano‚Äù, disseram eles. Eles n√£o procuraram por mal. Eles n√£o exigiram provas. Eles haviam assumido.",
        followup: "Within four years: 10,000 children born with severe limb deformities. Many more died before birth. One woman, Frances Kelsey at the FDA, had demanded proper evidence before approving it in America. She was called 'bureaucratic.' Her skepticism saved thousands of American children. Evidence isn't bureaucracy. Evidence is protection."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üö®", title: "Scenario: CondGO Trigger",
        xp: 30,
        scenario: "Day 33. DoD-D fails: Audit 2 found that reruns don't match within tolerance, and you can't identify the source of discrepancy after 4 hours.",
        question: "What happens now?",
        options: [
          { letter: "A", text: "Estender o prazo em uma semana", correct: false },
          { letter: "B", text: "Trigger CondGO: 72 hours to fix or decide", correct: true },
          { letter: "C", text: "Envie mesmo assim com uma nota sobre discrep√¢ncia", correct: false },
          { letter: "D", text: "Abandonar o projeto", correct: false }
        ],
        feedback: {
          correct: "Correct! CondGO gives exactly 72 hours to fix using allowed actions, or make a termination decision.",
          incorrect: "CondGO is triggered. 72 hours, bounded actions only. No extensions. Fix it or face the decision to stop."
        }
      }},
      { type: "concept", theme: "dark", content: {
        title: "CondGO Rules",
        subtitle: "72 hours, bounded actions",
        allowed: ["Correct extraction errors", "Fix conversions", "Resolve overlaps", "Repair audit pack"],
        forbidden: ["New outcomes", "Post-hoc subgroups", "Novos estudos ap√≥s congelamento"]
      }},
      { type: "checklist", theme: "dark", content: {
        title: "DoD-E Checklist",
        items: [
          "Lista de verifica√ß√£o PRISMA conclu√≠da",
          "Todos os ap√™ndices preenchidos",
          "Two reruns equivalent",
          "Clinical Summary included",
          "Registro de desvio conclu√≠do",
          "GRADE assessment done",
          "Audit-Grade Index: 9/9"
        ]
      }},
      { type: "quiz", theme: "dark", content: {
        question: "Quais s√£o as op√ß√µes de sa√≠da do CondGO?",
        options: [
          { text: "Continue, Pause, or Restart", correct: false },
          { text: "Pass, Submit minimal, or Terminate", correct: true },
          { text: "Extend 24h, 48h, or 72h", correct: false },
          { text: "N√£o h√° sa√≠das ‚Äì voc√™ deve consertar", correct: false }
        ],
        xp: 20,
        feedback: {
          correct: "Right! PASS (fixed), Submit minimal version, or Terminate with Failure Log. No middle ground.",
          incorrect: "CondGO has exactly three exits: fix it (PASS), submit minimal version, or terminate and archive with Failure Log."
        }
      }}
    ]
  },
  {
    id: 8, title: "Caso: Revis√£o de Colchicina", subtitle: "4 crises, 0 failures", xp: 250,
    slides: [
      { type: "title", theme: "purple-bg", content: { title: "A Revis√£o da Colchicina", subtitle: "Um sprint de 40 dias com 4 crises e 0 falhas" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "See META-SPRINT in action through a real case",
          "Learn how each crisis was resolved",
          "Understand why the system worked",
          "Apply lessons to your own reviews"
        ],
        tip: "Este estudo de caso une tudo. Ganhe o distintivo de Her√≥i da Colchicina!"
      }},
      { type: "stats", theme: "dark", content: {
        title: "The Question",
        subtitle: "Does colchicine reduce cardiac events after heart attack?",
        stats: [
          { value: "8", label: "RCTs" },
          { value: "11,774", label: "Patients" },
          { value: "40", label: "Days" },
          { value: "4", label: "Crises" }
        ]
      }},
      { type: "decision", theme: "dark", content: {
        icon: "1Ô∏è‚É£", title: "Crise 1: O Dilema do Ponto Temporal",
        xp: 25,
        scenario: "Day 2. Trials report MACE at 30 days, 90 days, 1 year, 3 years. Protocol says 'longest follow-up' but reviewers disagree on interpretation.",
        question: "Como voc√™ resolveria isso?",
        options: [
          { letter: "A", text: "Vote on which interpretation to use", correct: false },
          { letter: "B", text: "Prepare o Consult Pack com op√ß√µes e compensa√ß√µes", correct: true },
          { letter: "C", text: "Let the Integrator decide alone", correct: false },
          { letter: "D", text: "Use both interpretations as sensitivity", correct: false }
        ],
        feedback: {
          correct: "Correct! The Consult Pack forces structured thinking. They chose: 'Longest ‚â•1 year, else longest available.'",
          incorrect: "Foi preparado um Consult Pack com evid√™ncias e op√ß√µes. 15 minutos de discuss√£o estruturada evitaram horas de retrabalho."
        }
      }},
      { type: "decision", theme: "red-bg", content: {
        icon: "2Ô∏è‚É£", title: "Crise 2: Os bra√ßos trocados",
        xp: 30,
        scenario: "Day 14. Red-team pulls COLCOT (n=4,745). Forest plot shows colchicine INCREASES events‚Äîopposite of all other trials. Investigation reveals: Figure 3 bars were unlabeled, extractor assumed wrong direction.",
        question: "O que salvou esta revis√£o?",
        options: [
          { letter: "A", text: "A intui√ß√£o do integrador", correct: false },
          { letter: "B", text: "A microverifica√ß√£o di√°ria do Red-Team", correct: true },
          { letter: "C", text: "Revis√£o por pares antes da publica√ß√£o", correct: false },
          { letter: "D", text: "Statistical outlier detection", correct: false }
        ],
        feedback: {
          correct: "Exatamente! O sistema Red-Team captou o que a revis√£o colaborativa teria perdido. Estudos influentes s√£o verificados pelo advers√°rio.",
          incorrect: "A verifica√ß√£o di√°ria do Red-Team detectou isso. Fatima notou que a dire√ß√£o do COLCOT era oposta ‚Äì imposs√≠vel se o medicamento realmente funcionasse de maneira diferente em um ensaio."
        }
      }},
      { type: "decision", theme: "dark", content: {
        icon: "3Ô∏è‚É£", title: "Crise 3: A ideia post-hoc",
        xp: 25,
        scenario: "Day 22. Clinical advisor suggests: 'Three trials used 0.5mg, five used 1mg. Shouldn't you analyze by dose?' He's probably right scientifically.",
        question: "Qual √© a resposta correta?",
        options: [
          { letter: "A", text: "Change primary analysis to split by dose", correct: false },
          { letter: "B", text: "Ignore the suggestion‚Äîtoo late to change", correct: false },
          { letter: "C", text: "Add as exploratory sensitivity, label post-hoc", correct: true },
          { letter: "D", text: "Volte e adicione dose ao protocolo", correct: false }
        ],
        feedback: {
          correct: "Perfect! Good ideas after Day 3 go in sensitivity, clearly labelled post-hoc. Primary analysis stays protected.",
          incorrect: "O protocolo protege voc√™ de voc√™ mesmo. Adicione-a como an√°lise de SENSIBILIDADE e rotule-a como 'explorat√≥ria, post-hoc'."
        }
      }},
      { type: "decision", theme: "dark", content: {
        icon: "4Ô∏è‚É£", title: "Crise 4: A incompatibilidade de repeti√ß√£o",
        xp: 25,
        scenario: "Day 31. Audit 2 reruns: Analyst A gets I¬≤=34.2%, Analyst B gets I¬≤=31.8%. Tolerance is 1%. Difference: 2.4%.",
        question: "Qual foi a causa raiz?",
        options: [
          { letter: "A", text: "Different software versions", correct: false },
          { letter: "B", text: "One SE rounded to 2 decimals instead of 4", correct: true },
          { letter: "C", text: "Different random seeds", correct: false },
          { letter: "D", text: "Erro de digita√ß√£o na inclus√£o do estudo", correct: false }
        ],
        feedback: {
          correct: "Right! Line-by-line found Nidorf 2020 SE: 0.0847 vs 0.08. A 0.0047 difference created 2.4% I¬≤ change.",
          incorrect: "Line-by-line comparison found one SE was rounded to 2 decimals (0.08) instead of 4 (0.0847). 'Close enough' isn't."
        }
      }},
      { type: "stats", theme: "green-bg", content: {
        title: "The Result",
        stats: [
          { value: "RR 0.65", label: "95% CI: 0.49‚Äì0.88" },
          { value: "I¬≤ 34%", label: "Low-moderate" },
          { value: "9/9", label: "Audit-Grade" }
        ],
        caption: "Colchicine reduces major cardiac events by ~35%. The system caught all 4 crises."
      }},
      { type: "lesson", theme: "dark", content: {
        title: "Por que o sistema funcionou",
        lessons: [
          { title: "Crisis 1 ‚Üí Consult Pack", desc: "Structured discussion prevented rework" },
          { title: "Crisis 2 ‚Üí Red-Team", desc: "Adversarial checking caught the swap" },
          { title: "Crisis 3 ‚Üí Deviation Log", desc: "Good ideas captured safely" },
          { title: "Crisis 4 ‚Üí Rerun Tolerance", desc: "Precision requirements caught silent errors" }
        ]
      }},
      { type: "story", theme: "dark", content: {
        label: "O ensaio VIGOR", title: "Os ataques card√≠acos desaparecidos",
        text: "In 2000, Merck published the VIGOR trial for Vioxx. The paper showed a 4-fold increase in heart attacks compared to naproxen. But here's what they didn't tell you: three more heart attacks occurred <strong>after the data cutoff</strong>. Merck scientists knew about them. They didn't include them.",
        followup: "Why did it matter? Including those three heart attacks would have changed the risk ratio from concerning to alarming. Instead, the published paper suggested the difference might be because naproxen protected hearts‚Äînot because Vioxx damaged them. The data cutoff date was a decision. That decision cost lives."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "‚úÇÔ∏è", title: "Cen√°rio: o corte conveniente",
        xp: 25,
        scenario: "Voc√™ est√° extraindo dados de um teste. O protocolo especificava acompanhamento de at√© 12 meses. O artigo publicado relata apenas dados de 6 meses. Uma nota de rodap√© diz que ‚Äúeventos adicionais ocorreram ap√≥s 6 meses, mas n√£o foram inclu√≠dos na an√°lise prim√°ria‚Äù.",
        question: "O que voc√™ deve fazer?",
        options: [
          { letter: "A", text: "Use os dados de 6 meses conforme publicados", correct: false },
          { letter: "B", text: "Entre em contato com os autores para obter dados completos de acompanhamento", correct: true },
          { letter: "C", text: "Excluir o estudo devido a relat√≥rios seletivos", correct: false },
          { letter: "D", text: "Observe a discrep√¢ncia na sua avalia√ß√£o de risco de vi√©s", correct: false }
        ],
        feedback: {
          correct: "Correct! The VIGOR lesson: data cutoffs can hide safety signals. Three missing heart attacks changed Vioxx from 'concerning' to 'alarming.' Always seek complete data.",
          incorrect: "O estudo VIGOR excluiu ataques card√≠acos p√≥s-corte que teriam mudado as conclus√µes. Cortes convenientes podem ocultar sinais cr√≠ticos de seguran√ßa. Obtenha dados completos."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "A trag√©dia do teste hormonal", title: "Primodos e as crian√ßas que ele danificou",
        text: "In the 1960s and 70s, doctors prescribed <strong>Primodos</strong>‚Äîa high-dose hormone pill‚Äîas a pregnancy test. Take two pills; if you bleed, you're not pregnant. Simple. Convenient. Millions of women used it. <strong>No one ran trials to check if it harmed unborn babies.</strong>",
        followup: "Then the birth defects appeared. Cleft palates. Heart malformations. Limb abnormalities. Women who had taken Primodos and were actually pregnant‚Äîthe test had failed‚Äîgave birth to damaged children. Decades later, researchers analyzed the data: exposure to Primodos was associated with a <strong>40% increase in congenital abnormalities</strong>. The manufacturer had received reports of problems for years. They kept selling. An official UK review in 2017 found 'clear evidence' of an association. The lesson: 'it seems to work' is not evidence. 'It seems safe' is not safety data. Pregnancy exposures demand the highest burden of proof."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üß™", title: "Cen√°rio: O Teste Conveniente",
        xp: 25,
        scenario: "Um novo teste de gravidez caseiro utiliza um novo produto qu√≠mico que fornece resultados em segundos, em vez de minutos. Tem sido usado por milh√µes de pessoas sem danos agudos aparentes. No entanto, algumas mulheres testam com anteced√™ncia suficiente para que o produto qu√≠mico possa afetar o desenvolvimento de embri√µes naquelas que est√£o realmente gr√°vidas.",
        question: "What evidence should exist before widespread marketing?",
        options: [
          { letter: "A", text: "Absence of reported harms is sufficient for a diagnostic test", correct: false },
          { letter: "B", text: "Long-term follow-up of pregnancy outcomes in exposed women vs. controls", correct: true },
          { letter: "C", text: "Estudos de teratologia animal s√£o suficientes para exposi√ß√µes curtas", correct: false },
          { letter: "D", text: "Post-marketing surveillance will detect any problems", correct: false }
        ],
        feedback: {
          correct: "Correto! Os danos do Primodos n√£o foram detectados durante d√©cadas porque ningu√©m rastreou os resultados da gravidez. Qualquer exposi√ß√£o durante uma potencial gravidez necessita de um acompanhamento sistem√°tico dos resultados ‚Äì e n√£o de uma vigil√¢ncia passiva.",
          incorrect: "Primodos prejudicaram beb√™s durante anos enquanto 'ningu√©m notava'. As exposi√ß√µes durante a gravidez necessitam de acompanhamento proativo dos resultados. A vigil√¢ncia p√≥s-comercializa√ß√£o falha no caso de defeitos cong√©nitos ‚Äì a liga√ß√£o √© dif√≠cil de provar mais tarde."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "A cat√°strofe de Baycol", title: "A estatina que dissolveu os m√∫sculos",
        text: "In 1997, Bayer launched cerivastatin (Baycol) to compete in the lucrative statin market. It was the most potent statin ever‚Äîlowering cholesterol more effectively than competitors. Bayer pushed aggressive dosing. They promoted combining it with gemfibrozil for even greater cholesterol reduction. Sales reached $500 million annually.",
        followup: "Patients started dying. Their muscles were dissolving‚Äîa condition called <strong>rhabdomyolysis</strong>. Breakdown products overwhelmed kidneys. By the time Bayer withdrew Baycol in 2001, at least <strong>100 patients had died and over 1,500 were hospitalized</strong>. Internal documents revealed Bayer knew the risk was higher than competitors. They knew the gemfibrozil combination was especially dangerous. They kept promoting both. The 'most effective' statin became the deadliest. More aggressive isn't always better‚Äîsometimes it's fatal."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìà", title: "Cen√°rio: A Abordagem Agressiva",
        xp: 25,
        scenario: "Um novo medicamento apresenta efeitos mais poderosos do que os tratamentos existentes em doses mais elevadas. O fabricante pretende comercializar a dose eficaz mais elevada como padr√£o. Os concorrentes utilizam doses mais baixas com bons perfis de seguran√ßa. Alguns relat√≥rios iniciais mencionam eventos adversos graves relacionados aos m√∫sculos.",
        question: "What should guide dosing recommendations?",
        options: [
          { letter: "A", text: "Maximum efficacy should be the goal‚Äîthat's why patients take medication", correct: false },
          { letter: "B", text: "Lowest effective dose with systematic safety monitoring; investigate all serious events", correct: true },
          { letter: "C", text: "Match competitor dosing for market positioning", correct: false },
          { letter: "D", text: "Let prescribers choose based on patient cholesterol levels", correct: false }
        ],
        feedback: {
          correct: "Correto! A dosagem agressiva de Baycol matou pacientes. Os eventos musculares eram sinais de alerta. A dose eficaz mais segura ‚Äì e n√£o a mais poderosa ‚Äì deve ser padr√£o. Os primeiros acontecimentos graves exigem investiga√ß√£o e n√£o demiss√£o.",
          incorrect: "Baycol era a estatina ‚Äúmais potente‚Äù ‚Äì e a mais mortal. Mais n√£o √© melhor quando a margem entre efic√°cia e toxicidade diminui. Os primeiros eventos adversos graves s√£o sinais, n√£o ru√≠do."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "A quase falta", title: "What If We Hadn't Checked?",
        text: "In the colchicine review, COLCOT contributed 40% of the total weight. If the swapped arms had gone undetected, the meta-analysis would have concluded: <strong>'Colchicine appears to INCREASE cardiac events.'</strong> The opposite of reality.",
        followup: "Os m√©dicos podem ter recusado um tratamento eficaz. Pacientes que poderiam ter sido ajudados teriam sido negados. Um erro de extra√ß√£o, n√£o detectado, poderia ter revertido a pr√°tica cl√≠nica. A verifica√ß√£o do Time Vermelho durou 15 minutos. O custo de perd√™-lo? Incalcul√°vel."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "‚öñÔ∏è", title: "Cen√°rio: a pergunta de 15 minutos",
        xp: 25,
        scenario: "Sua equipe est√° atrasada. O maior ensaio (45% do peso total) n√£o foi verificado pelo Red-Team. Algu√©m sugere pular 'porque a extra√ß√£o foi feita pela pessoa mais experiente'.",
        question: "O que voc√™ deve fazer?",
        options: [
          { letter: "A", text: "Skip it‚Äîexperience reduces error rates", correct: false },
          { letter: "B", text: "Verify it‚Äîinfluential studies always get checked", correct: true },
          { letter: "C", text: "Spot-check one data point instead of full verification", correct: false },
          { letter: "D", text: "Trust but add a note about limited verification time", correct: false }
        ],
        feedback: {
          correct: "Correto! O quase acidente da colchicina: 15 minutos de verifica√ß√£o do Red Team detectaram um erro que teria revertido as conclus√µes. A experi√™ncia n√£o elimina erros ‚Äì a verifica√ß√£o sim.",
          incorrect: "O erro COLCOT foi cometido por um extrator experiente. A verifica√ß√£o do Time Vermelho durou 15 minutos. Ignorar a verifica√ß√£o de estudos influentes corre o risco de erros catastr√≥ficos."
        }
      }}
    ]
  },
  {
    id: 9, title: "Final Assessment", subtitle: "Prove seu dom√≠nio", xp: 300,
    slides: [
      { type: "title", theme: "dark", content: { title: "Final Assessment", subtitle: "Apply everything you've learned" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "Apply META-SPRINT principles to complex scenarios",
          "Demonstrate understanding of protocol integrity",
          "Handle crisis situations correctly",
          "Uphold ethical reporting standards"
        ],
        tip: "Tr√™s cen√°rios desafiadores. Responda tudo corretamente para obter o b√¥nus do m√≥dulo perfeito!"
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üéØ", title: "Final Scenario 1: The Protocol Pressure",
        xp: 40,
        scenario: "Seu supervisor deseja come√ßar a triagem amanh√£. O protocolo est√° redigido mas ainda n√£o registado no PROSPERO (demora 24-48h). 'Basta come√ßar, podemos nos registrar mais tarde.'",
        question: "What do you do?",
        options: [
          { letter: "A", text: "Start screening‚Äîregistration is just paperwork", correct: false },
          { letter: "B", text: "Aguarde o registro antes de qualquer coleta de dados", correct: true },
          { letter: "C", text: "Start screening but don't record results yet", correct: false },
          { letter: "D", text: "Submit to a faster registry service", correct: false }
        ],
        feedback: {
          correct: "Correto! O registro carimba suas promessas. Come√ßar antes do registro permite a troca de resultados ‚Äì o problema dos 31%.",
          incorrect: "O registro deve acontecer ANTES de qualquer coleta de dados. Isso evita o problema de mudan√ßa de resultado de 31%."
        }
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üî•", title: "Cen√°rio Final 2: A Crise",
        xp: 40,
        scenario: "Day 33. Your rerun shows RR=0.72. Collaborator's shows RR=0.68. Both significant but outside tolerance. You have 6 hours until DoD-D deadline.",
        question: "Qual ‚Äã‚Äã√© a sua primeira a√ß√£o?",
        options: [
          { letter: "A", text: "M√©dia para 0,70 e prossiga", correct: false },
          { letter: "B", text: "Line-by-line input comparison", correct: true },
          { letter: "C", text: "Trigger CondGO immediately", correct: false },
          { letter: "D", text: "Ask both analysts to re-run again", correct: false }
        ],
        feedback: {
          correct: "Correto! A compara√ß√£o linha por linha encontra a origem da discrep√¢ncia. Em 6 horas, voc√™ pode consertar sem precisar do CondGO.",
          incorrect: "First: find the source of discrepancy. Line-by-line comparison. Most mismatches have fixable causes."
        }
      }},
      { type: "decision", theme: "dark", content: {
        icon: "‚öñÔ∏è", title: "Final Scenario 3: The Ethical Edge",
        xp: 40,
        scenario: "Sua meta-an√°lise mostra que o medicamento X √© prejudicial (RR 1,35, CI 1,10-1,65). A empresa farmac√™utica que financiou sua revis√£o pede que voc√™ a 'reformule' como 'n√£o significativamente ben√©fica'.",
        question: "Como voc√™ responde?",
        options: [
          { letter: "A", text: "They're technically correct‚Äîreframe as requested", correct: false },
          { letter: "B", text: "Report the finding accurately: harm detected", correct: true },
          { letter: "C", text: "Compromise: say 'insufficient evidence of benefit'", correct: false },
          { letter: "D", text: "Add sensitivity analyses until harm disappears", correct: false }
        ],
        feedback: {
          correct: "Correct! RR 1.35 with CI excluding 1.0 is harm. Report it accurately. The Avandia story: suppressing harm signals kills patients.",
          incorrect: "RR 1.35 (CI 1.10-1.65) = statistically significant HARM. Report it accurately. The Avandia scandal: silence killed tens of thousands."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "O custo da espera", title: "What Silence Buys",
        text: "Between 2000 and 2004, while Merck debated what to do about Vioxx, <strong>25,000 people died</strong> from heart attacks caused by a drug they trusted. Between 1999 and 2007, while GSK buried the Avandia spreadsheet, <strong>83,000 people suffered heart attacks</strong> from a diabetes drug that was supposed to help them.",
        followup: "N√£o foram acidentes. Eles n√£o eram incognosc√≠veis. Foram o resultado previs√≠vel de sistemas sem prazos, de provas sem verifica√ß√£o e de pessoas que decidiram que ‚Äúesperar para ver‚Äù era mais seguro do que ‚Äúparar e verificar‚Äù. Cada dia de atraso teve uma contagem de corpos."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìÖ", title: "Cen√°rio: O atraso confort√°vel",
        xp: 30,
        scenario: "Sua revis√£o sistem√°tica encontrou evid√™ncias claras de danos. A sua institui√ß√£o pretende ‚Äúaguardar o feedback da revis√£o pelos pares‚Äù antes de fazer qualquer declara√ß√£o p√∫blica. O processo de revis√£o por pares normalmente leva de 6 a 12 meses.",
        question: "O que voc√™ deve fazer?",
        options: [
          { letter: "A", text: "Aguarde pela revis√£o por pares ‚Äì o processo adequado √© importante", correct: false },
          { letter: "B", text: "Post a preprint immediately while pursuing publication", correct: true },
          { letter: "C", text: "Share findings privately with key opinion leaders", correct: false },
          { letter: "D", text: "Accelerate peer review by submitting to multiple journals", correct: false }
        ],
        feedback: {
          correct: "Correct! Vioxx: 4 years of 'waiting' = 25,000 deaths. Avandia: 7 years = 83,000 heart attacks. When evidence shows harm, delay is not neutral‚Äîit's harmful. Preprint immediately.",
          incorrect: "Vioxx and Avandia: 'waiting' killed over 100,000 people combined. When evidence shows harm, every day of delay has a body count. Preprint findings immediately."
        }
      }},
      { type: "story", theme: "green-bg", content: {
        label: "O outro caminho", title: "Frances Kelsey's 19 Months",
        text: "In 1960, the FDA received an application to approve thalidomide in America. One reviewer‚ÄîFrances Kelsey‚Äîrefused to approve it. The manufacturer pressured her. Her colleagues questioned her. She held firm for <strong>19 months</strong>, demanding evidence of safety.",
        followup: "While she waited, 10,000 children were born with deformities in countries that had approved the drug. American children were spared‚Äînot by luck, but by one person who demanded proof before action. Kelsey proved that asking for evidence isn't obstruction. It's protection. META-SPRINT exists to make that protection systematic."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üõ°Ô∏è", title: "Cen√°rio: a press√£o para aprovar",
        xp: 30,
        scenario: "Voc√™ est√° revisando um novo tratamento. O fabricante afirma que as suas ‚Äúexig√™ncias excessivas de provas‚Äù est√£o a atrasar o acesso a um medicamento potencialmente salvador de vidas. Seus colegas sugerem que voc√™ est√° ‚Äúsendo muito cauteloso‚Äù. Advogados da ind√∫stria sugerem a√ß√£o legal por 'obstru√ß√£o'.",
        question: "What should guide your decision?",
        options: [
          { letter: "A", text: "Speed up approval‚Äîpatients are waiting", correct: false },
          { letter: "B", text: "Maintain evidence standards regardless of pressure", correct: true },
          { letter: "C", text: "Compromisso com aprova√ß√£o condicional", correct: false },
          { letter: "D", text: "Escalate to supervisors to share responsibility", correct: false }
        ],
        feedback: {
          correct: "Correto! Frances Kelsey foi chamada de ‚Äúburocr√°tica‚Äù durante 19 meses, enquanto 10 mil crian√ßas em outros pa√≠ses foram prejudicadas. Ela salvou milhares de crian√ßas americanas. Os padr√µes de evid√™ncia salvam vidas.",
          incorrect: "Kelsey foi pressionado durante 19 meses para aprovar a talidomida. A sua 'obstru√ß√£o' salvou milhares de crian√ßas. Press√£o e urg√™ncia n√£o s√£o evid√™ncias. Os padr√µes protegem os pacientes."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "O desastre de Rezulin", title: "O medicamento para diabetes que destruiu f√≠gados",
        text: "In 1997, Warner-Lambert launched troglitazone (Rezulin) as a revolutionary diabetes treatment. The FDA approved it despite a medical officer's objections about liver toxicity signals. <strong>Within months, reports of liver failure poured in.</strong> The UK banned it in December 1997. Japan banned it in 2000.",
        followup: "The FDA kept Rezulin on the American market until March 2000‚Äî<strong>three years after the UK acted</strong>. During those three years, at least 90 Americans died of liver failure from a drug banned elsewhere. FDA's own scientists had warned of the danger. They were overruled. When Rezulin was finally withdrawn, internal documents revealed Warner-Lambert had hidden early liver toxicity data and downplayed risks. The gap between the UK ban and US withdrawal: three years. The cost: dozens of preventable deaths. Different regulators, same data, vastly different responses."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üåç", title: "Cen√°rio: a diverg√™ncia regulat√≥ria",
        xp: 30,
        scenario: "Um medicamento que voc√™ est√° analisando em uma meta-an√°lise foi retirado da Europa por quest√µes de seguran√ßa 2 anos atr√°s, mas continua dispon√≠vel em seu pa√≠s. Os reguladores locais citam ‚Äúevid√™ncias insuficientes de danos √† nossa popula√ß√£o‚Äù. Ensaios europeus mostraram sinais claros de toxicidade hep√°tica.",
        question: "Como isso deve afetar sua revis√£o sistem√°tica?",
        options: [
          { letter: "A", text: "Use apenas dados do seu pa√≠s ‚Äì as decis√µes regulat√≥rias variam", correct: false },
          { letter: "B", text: "Inclua todos os dados e relate com destaque a diverg√™ncia regulat√≥ria na discuss√£o", correct: true },
          { letter: "C", text: "Exclude the drug entirely due to safety concerns", correct: false },
          { letter: "D", text: "Trust your local regulators' interpretation", correct: false }
        ],
        feedback: {
          correct: "Correto! Rezulin matou americanos durante 3 anos depois que o Reino Unido agiu. A sua an√°lise deve incluir todos os dados de seguran√ßa e destacar as diverg√™ncias regulamentares. Os leitores precisam de informa√ß√µes completas, n√£o filtradas por fronteiras geogr√°ficas.",
          incorrect: "Rezulin was banned in UK in 1997; Americans died until 2000. Regulatory decisions aren't evidence‚Äîthey're interpretations. Include all data and report divergences so readers can judge."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "O Esc√¢ndalo Ketek", title: "The Antibiotic Built on Fabricated Trials",
        text: "In 2004, the FDA approved telithromycin (Ketek) for respiratory infections. The approval relied heavily on a large trial‚ÄîStudy 3014‚Äîconducted by Dr. Anne Kirkman-Campbell. She enrolled <strong>407 patients in just 9 months</strong> from a solo practice. Impossible numbers, but the FDA didn't question them.",
        followup: "Dr. Kirkman-Campbell was later convicted of fraud. She had <strong>fabricated patient enrollment entirely</strong>‚Äîsome 'patients' were relatives who never had infections. But her fake data had already supported FDA approval. When real-world use began, Ketek caused liver failures, some fatal. An FDA reviewer had flagged Study 3014's impossible enrollment before approval‚Äîshe was overruled. The drug that was approved based partly on invented patients went on to harm real ones. The question no one asked: 'How can one doctor enroll 400 patients in conditions that would take a large hospital years?'"
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üî¢", title: "Cen√°rio: O Super-Inscrito",
        xp: 30,
        scenario: "Um ensaio cl√≠nico fundamental inclui dados de um m√©dico individual que inscreveu 350 pacientes em 6 meses - mais do que os pr√≥ximos 10 locais combinados. Os relat√≥rios de monitoramento do local s√£o marcados como 'satisfat√≥rios'. O ensaio mostra forte efic√°cia.",
        question: "What verification should occur before regulatory decisions?",
        options: [
          { letter: "A", text: "O monitoramento do local foi aprovado, ent√£o os dados s√£o verificados", correct: false },
          { letter: "B", text: "Audit source documents: patient records, consent forms, medical histories", correct: true },
          { letter: "C", text: "Execute a an√°lise com e sem os dados deste local", correct: false },
          { letter: "D", text: "Entre em contato com o investigador para obter explica√ß√£o sobre o alto n√∫mero de inscri√ß√µes", correct: false }
        ],
        feedback: {
          correct: "Correto! Kirkman-Campbell passou no monitoramento do local enquanto fabricava 407 pacientes. A verifica√ß√£o do documento original ‚Äì registros reais de pacientes ‚Äì a teria pegado. Os dados de inscri√ß√£o auto-relatados e a monitoriza√ß√£o ‚Äúsatisfat√≥ria‚Äù n√£o significam nada.",
          incorrect: "Dr. Kirkman-Campbell's site passed monitoring. Her patients didn't exist. Source document audits‚Äînot self-reports‚Äîcatch fabrication. Impossible enrollment rates demand verification of original records."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "The Promise", title: "O que a evid√™ncia confi√°vel cria",
        text: "In 1987, the ISIS-2 trial showed aspirin reduces death after heart attack by 23%. The evidence was solid. The methods were transparent. The data was verifiable. Since then, aspirin after heart attack has saved an estimated <strong>100,000 lives per year</strong>.",
        followup: "That's what honest evidence creates: treatments that work, given to people who need them, saving lives that would otherwise be lost. Every protocol you register, every number you verify, every gate you pass‚Äîyou're building the foundation for the next ISIS-2. The next treatment that actually works. The next million lives saved."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üåü", title: "Cen√°rio: sua primeira revis√£o",
        xp: 30,
        scenario: "Voc√™ est√° prestes a iniciar sua primeira revis√£o sistem√°tica. Um colega s√™nior oferece um conselho: ‚ÄúN√£o se preocupe muito com todos esses protocolos e listas de verifica√ß√£o. Basta fazer um bom trabalho e as evid√™ncias falar√£o por si.'",
        question: "Como voc√™ deve responder?",
        options: [
          { letter: "A", text: "Follow their advice‚Äîexperience beats process", correct: false },
          { letter: "B", text: "Follow META-SPRINT rigorously‚Äîsystems prevent disasters", correct: true },
          { letter: "C", text: "Adapte o processo √† sua situa√ß√£o espec√≠fica", correct: false },
          { letter: "D", text: "Use uma vers√£o mais leve para sua primeira revis√£o e depois melhore", correct: false }
        ],
        feedback: {
          correct: "Correto! Boas inten√ß√µes n√£o evitam erros. As evid√™ncias da aspirina do ISIS-2 salvaram 100.000 vidas/ano porque eram rigorosas. A fraude de Poldermans matou 800 mil pessoas porque ningu√©m verificou. Os sistemas, e n√£o as inten√ß√µes, protegem os pacientes.",
          incorrect: "'Bom trabalho' sem sistemas levou a Poldermans, CAST, Vioxx, Avandia. O ISIS-2 economizou milh√µes devido a m√©todos rigorosos. A diferen√ßa entre 100.000 salvos e 800.000 mortos √© a verifica√ß√£o sistem√°tica."
        }
      }},
      { type: "stats", theme: "green-bg", content: {
        title: "Course Complete!",
        stats: [
          { value: "5", label: "Phases mastered" },
          { value: "5", label: "Gates understood" },
          { value: "8", label: "Modules completed" },
          { value: "‚àû", label: "Patients protected" }
        ],
        caption: "Agora voc√™ entende como produzir evid√™ncias que salvam vidas."
      }},
      { type: "refrain", theme: "black", content: { text: "V√° construir confian√ßa. 40 dias. 5 port√µes. Evid√™ncias que importam." }}
    ]
  }
];

// ===== NAVIGATION STATE =====
let currentModule = 0;
let currentSlide = 0;
let consecutiveCorrect = gameState.consecutiveCorrect || 0;

// ===== SAVE/LOAD =====
function saveGame() {
  safeSetStorage('metasprintGame_v1', gameState);
}

function resetProgress() {
  if (confirm('Reset all progress and achievements?')) {
    gameState = { ...DEFAULT_STATE, answeredQuestions: {}, badges: [], completedModules: [], perfectModules: [], consecutiveCorrect: 0 };
    consecutiveCorrect = 0;
    saveGame();
    currentModule = 0;
    currentSlide = 0;
    renderAll();
  }
}

// ===== GLOSSARY =====
function toggleGlossary() {
  document.getElementById('glossaryPanel').classList.toggle('open');
}

// ===== COURSE PROGRESS =====
function updateCourseProgress() {
  const totalModules = MODULES.length;
  const completedCount = gameState.completedModules.length;
  const pct = Math.round((completedCount / totalModules) * 100);
  const fillEl = document.getElementById('courseProgressFill');
  const pctEl = document.getElementById('courseProgressPct');
  if (fillEl) fillEl.style.width = pct + '%';
  if (pctEl) pctEl.textContent = pct + '%';
}

// ===== MODULE QUESTION TRACKING =====
function getModuleQuestionIds(moduleIndex) {
  const mod = MODULES[moduleIndex];
  const ids = [];
  mod.slides.forEach((slide, si) => {
    if (slide.type === 'decision') ids.push(`dec_${moduleIndex}_${si}`);
    if (slide.type === 'quiz') ids.push(`quiz_${moduleIndex}_${si}`);
    if (slide.type === 'prediction') ids.push(`pred_${moduleIndex}_${si}`);
  });
  return ids;
}

function checkPerfectModule(moduleIndex) {
  const mod = MODULES[moduleIndex];
  const questionIds = getModuleQuestionIds(moduleIndex);
  if (questionIds.length === 0) return false;

  let allCorrect = true;
  questionIds.forEach(id => {
    const answer = gameState.answeredQuestions[id];
    if (answer === undefined || answer === null) { allCorrect = false; return; }

    // Find the slide and check if answer was correct
    const parts = id.split('_');
    const slideIndex = parseInt(parts[2]);
    const slide = mod.slides[slideIndex];

    if (slide.type === 'decision') {
      const correctOpt = slide.content.options.find(o => o.correct);
      if (answer !== correctOpt?.letter) allCorrect = false;
    } else if (slide.type === 'quiz') {
      const correctIdx = slide.content.options.findIndex(o => o.correct);
      if (answer !== correctIdx) allCorrect = false;
    } else if (slide.type === 'prediction') {
      if (answer !== slide.content.answer) allCorrect = false;
    }
  });

  return allCorrect;
}

// ===== XP & LEVELING =====
function addXP(amount) {
  gameState.xp += amount;
  checkLevelUp();
  saveGame();
  updateStatsDisplay();
  showXPPopup(amount);
}

function checkLevelUp() {
  for (let i = LEVELS.length - 1; i >= 0; i--) {
    if (gameState.xp >= LEVELS[i].xp && gameState.level < LEVELS[i].level) {
      gameState.level = LEVELS[i].level;
      showLevelUp(LEVELS[i]);
      break;
    }
  }
}

function showXPPopup(amount) {
  const popup = document.getElementById('xpPopup');
  document.getElementById('xpAmount').textContent = `+${amount}`;
  popup.classList.add('show');
  setTimeout(() => popup.classList.remove('show'), 1500);
}

function showLevelUp(levelData) {
  triggerConfetti();
  showBadgeModal({ icon: levelData.icon, name: `Level ${levelData.level}`, desc: levelData.title });
}

// ===== BADGES =====
function awardBadge(badgeId) {
  if (gameState.badges.includes(badgeId)) return;
  gameState.badges.push(badgeId);
  saveGame();
  const badge = BADGES.find(b => b.id === badgeId);
  if (badge) showBadgeModal(badge);
  updateBadges();
}

function awardBadgeIfNew(id, icon, name, desc) {
  if (gameState.badges.includes(id)) return;
  gameState.badges.push(id);
  saveGame();
  showBadgeModal({ icon, name, desc });
  updateBadges();
}

function showBadgeModal(badge) {
  const modal = document.getElementById('badgeModal');
  // Remove any existing focus trap handler before adding a new one
  if (modal._focusTrapHandler) {
    modal.removeEventListener('keydown', modal._focusTrapHandler);
  }
  document.getElementById('badgeModalIcon').textContent = badge.icon;
  document.getElementById('badgeModalTitle').textContent = badge.name;
  document.getElementById('badgeModalDesc').textContent = badge.desc;
  modal.classList.add('show');
  triggerConfetti();

  // Focus trap for accessibility
  const focusableElements = modal.querySelectorAll('button, [tabindex]:not([tabindex="-1"])');
  if (focusableElements.length > 0) {
    focusableElements[0].focus();
  }
  const trapHandler = function(e) {
    if (e.key === 'Escape') {
      closeBadgeModal();
      return;
    }
    if (e.key === 'Tab') {
      const firstFocusable = focusableElements[0];
      const lastFocusable = focusableElements[focusableElements.length - 1];
      if (e.shiftKey && document.activeElement === firstFocusable) {
        e.preventDefault();
        lastFocusable.focus();
      } else if (!e.shiftKey && document.activeElement === lastFocusable) {
        e.preventDefault();
        firstFocusable.focus();
      }
    }
  };
  modal._focusTrapHandler = trapHandler;
  modal.addEventListener('keydown', trapHandler);
}

function closeBadgeModal() {
  const modal = document.getElementById('badgeModal');
  if (modal._focusTrapHandler) {
    modal.removeEventListener('keydown', modal._focusTrapHandler);
    delete modal._focusTrapHandler;
  }
  modal.classList.remove('show');
}

// ===== STREAK =====
function updateStreak() {
  const today = new Date().toDateString();
  if (gameState.lastActive !== today) {
    const yesterday = new Date(Date.now() - 86400000).toDateString();
    if (gameState.lastActive === yesterday) {
      gameState.streak++;
      if (gameState.streak >= 3) awardBadge('streak_3');
      if (gameState.streak >= 7) awardBadge('streak_7');
    } else if (gameState.lastActive) {
      gameState.streak = 1;
    } else {
      gameState.streak = 1;
    }
    gameState.lastActive = today;
    saveGame();
  }
}

// ===== CONFETTI =====
function triggerConfetti() {
  // Respect reduced motion preference
  if (window.matchMedia('(prefers-reduced-motion: reduce)').matches) return;

  const container = document.getElementById('confettiContainer');
  const colors = ['#D4AF37', '#22c55e', '#3b82f6', '#f59e0b', '#ef4444', '#7c3aed'];
  for (let i = 0; i < 50; i++) {
    const confetti = document.createElement('div');
    confetti.className = 'confetti';
    confetti.style.left = Math.random() * 100 + '%';
    confetti.style.background = colors[Math.floor(Math.random() * colors.length)];
    confetti.style.animationDelay = Math.random() * 0.5 + 's';
    confetti.style.transform = `rotate(${Math.random() * 360}deg)`;
    container.appendChild(confetti);
    setTimeout(() => confetti.remove(), 3500);
  }
}

// ===== COMBO COUNTER =====
function updateComboDisplay() {
  const comboEl = document.getElementById('comboDisplay');
  const countEl = document.getElementById('comboCount');

  if (consecutiveCorrect >= 2) {
    countEl.textContent = consecutiveCorrect;
    comboEl.classList.add('show');

    // Animate for big combos
    if (consecutiveCorrect >= 5) {
      comboEl.classList.add('big');
      setTimeout(() => comboEl.classList.remove('big'), 300);
    }
  } else {
    comboEl.classList.remove('show');
  }
}

// ===== MOBILE SIDEBAR =====
function toggleSidebar() {
  const sidebar = document.querySelector('.sidebar');
  const overlay = document.getElementById('sidebarOverlay');
  sidebar.classList.toggle('open');
  overlay.classList.toggle('show');
  var btn = document.querySelector('.sidebar-toggle, .hamburger, .mobile-menu-btn'); if (btn) btn.setAttribute('aria-expanded', btn.getAttribute('aria-expanded') === 'true' ? 'false' : 'true');
}

// ===== RENDER =====
function renderAll() {
  updateStreak();
  renderSidebar();
  renderSlides();
  updateStatsDisplay();
  updateBadges();
  updateCourseProgress();
}

function updateStatsDisplay() {
  const levelData = LEVELS.find(l => l.level === gameState.level) || LEVELS[0];
  const nextLevel = LEVELS.find(l => l.level === gameState.level + 1);

  document.getElementById('levelIcon').textContent = levelData.icon;
  document.getElementById('levelTitle').textContent = levelData.title;
  document.getElementById('levelNum').textContent = gameState.level;

  const currentXP = gameState.xp - levelData.xp;
  const neededXP = nextLevel ? (nextLevel.xp - levelData.xp) : 500;
  const pct = Math.min(100, (currentXP / neededXP) * 100);

  document.getElementById('xpFill').style.width = pct + '%';
  document.getElementById('xpCurrent').textContent = currentXP;
  document.getElementById('xpNeeded').textContent = neededXP;

  document.getElementById('correctCount').textContent = gameState.correctAnswers;
  document.getElementById('decisionCount').textContent = gameState.decisionsCompleted;
  document.getElementById('predictCount').textContent = gameState.predictionsCorrect;
  document.getElementById('streakCount').textContent = gameState.streak;

  const streakEl = document.getElementById('streakDisplay');
  streakEl.classList.toggle('active', gameState.streak > 0);
}

function updateBadges() {
  const grid = document.getElementById('badgesGrid');
  grid.innerHTML = BADGES.map(b => {
    const earned = gameState.badges.includes(b.id);
    let progress = '';

    // Show progress for certain badges
    if (!earned) {
      if (b.id === 'oracle') progress = `${gameState.predictionsCorrect}/5`;
      if (b.id === 'decision_maker') progress = `${gameState.decisionsCompleted}/10`;
      if (b.id === 'streak_3') progress = `${Math.min(gameState.streak, 3)}/3`;
      if (b.id === 'streak_7') progress = `${Math.min(gameState.streak, 7)}/7`;
      if (b.id === 'finisher') progress = `${gameState.completedModules.length}/${MODULES.length}`;
    }

    return `
      <button class="badge-item ${earned ? 'earned' : ''}" data-tooltip="${b.name}: ${b.desc}" aria-label="${b.name}: ${b.desc}${earned ? ' (Earned)' : ''}">
        ${b.icon}
        ${progress && !earned ? `<span class="badge-progress">${progress}</span>` : ''}
      </button>
    `;
  }).join('');
}

function renderSidebar() {
  const list = document.getElementById('moduleList');
  list.innerHTML = MODULES.map((mod, i) => {
    const completed = gameState.completedModules.includes(mod.id);
    const locked = i > 0 && !gameState.completedModules.includes(MODULES[i-1].id);
    // Estimate ~1.5 min per slide
    const estMins = Math.round(mod.slides.length * 1.5);
    return `
      <div class="module-item ${i === currentModule ? 'active' : ''} ${completed ? 'completed' : ''} ${locked ? 'locked' : ''}"
           onclick="${locked ? '' : `goToModule(${i})`}"
           role="button"
           tabindex="${locked ? -1 : 0}"
           aria-label="${mod.title}${completed ? ' (completed)' : ''}${locked ? ' (locked)' : ''}">
        <div class="module-number">${completed ? '‚úì' : (locked ? 'üîí' : mod.id)}</div>
        <div class="module-info">
          <div class="module-title">${mod.title}</div>
          <div class="module-subtitle">${mod.subtitle}</div>
          <div class="module-xp">+${mod.xp} XP</div>
          <div class="module-time">‚è±Ô∏è ~${estMins} min</div>
        </div>
      </div>
    `;
  }).join('');
}

function renderSlides() {
  const container = document.getElementById('main-content');
  container.innerHTML = MODULES.map((mod, mi) => {
    const progressPct = ((currentSlide + 1) / mod.slides.length) * 100;
    return `
    <div class="module-slides ${mi === currentModule ? 'active' : ''}" data-module="${mi}">
      <div class="slide-progress-bar" style="width: ${mi === currentModule ? progressPct : 0}%"></div>
      ${mod.slides.map((slide, si) => renderSlide(slide, si, mi)).join('')}
      <div class="slide-nav">
        <button class="nav-btn" onclick="prevSlide()" aria-label="Previous slide" ${currentSlide === 0 ? 'disabled' : ''}>‚Üê</button>
        <div class="nav-center">
          <div class="slide-counter">${currentSlide + 1} / ${mod.slides.length}</div>
          <div class="progress-dots">
            ${mod.slides.map((_, i) => `<button class="progress-dot ${i === currentSlide ? 'active' : ''}" type="button" onclick="goToSlide(${i})" aria-label="Go to slide ${i + 1}" ${i === currentSlide ? 'aria-current="true"' : ''}></button>`).join('')}
          </div>
        </div>
        <button class="nav-btn" onclick="nextSlide()" aria-label="Next slide">‚Üí</button>
      </div>
    </div>
  `;
  }).join('');
  document.getElementById('currentModule').textContent = MODULES[currentModule].title;
  updateSlideVisibility();
}

function renderSlide(slide, index, moduleIndex) {
  const theme = slide.theme || 'dark';
  let html = `<div class="slide ${theme} ${index === currentSlide ? 'active' : ''}" data-slide="${index}">`;

  switch(slide.type) {
    case 'title':
      html += `<div class="content"><h1 class="title gold animate">${slide.content.title}</h1><p class="subtitle animate delay-1">${slide.content.subtitle}</p></div>`;
      break;

    case 'objectives':
      html += `<div class="content">
        <div class="objectives-box animate">
          <div class="objectives-header">
            <div class="objectives-icon">üéØ</div>
            <div class="objectives-title">Learning Objectives</div>
          </div>
          <ul class="objectives-list">
            ${slide.content.objectives.map(obj => `<li>${obj}</li>`).join('')}
          </ul>
        </div>
        ${slide.content.tip ? `<p class="subtitle animate delay-1" style="font-size:0.85rem;max-width:600px">${slide.content.tip}</p>` : ''}
      </div>`;
      break;

    case 'summary':
      const modXP = MODULES[moduleIndex]?.xp || 0;
      const isPerfect = checkPerfectModule(moduleIndex);
      html += `<div class="content">
        <div class="summary-box animate">
          <div class="summary-icon">üéâ</div>
          <div class="summary-title">Module Complete!</div>
          <div class="summary-stats">
            <div class="summary-stat">
              <div class="summary-stat-value">+${modXP}</div>
              <div class="summary-stat-label">XP Earned</div>
            </div>
            <div class="summary-stat">
              <div class="summary-stat-value">${gameState.correctAnswers}</div>
              <div class="summary-stat-label">Total Correct</div>
            </div>
          </div>
          ${isPerfect ? `<div class="perfect-bonus animate delay-1">‚≠ê PERFECT MODULE +${Math.round(modXP * 0.5)} XP ‚≠ê</div>` : ''}
          <p class="subtitle" style="margin-top:1rem;font-size:0.85rem">${slide.content.summary || '√ìtimo trabalho! Continue para o pr√≥ximo m√≥dulo.'}</p>
          <button class="summary-next animate delay-2" onclick="nextSlide()">Continue to Next Module ‚Üí</button>
        </div>
      </div>`;
      break;

    case 'story':
      html += `<div class="content">
        <article class="story-box ${slide.content.success ? 'success' : ''} animate" role="article" aria-label="Case study: ${slide.content.label}">
          <div class="story-label">${slide.content.label}</div>
          ${slide.content.title ? `<h2 class="title gold" style="font-size:1.8rem;margin-bottom:0.75rem">${slide.content.title}</h2>` : ''}
          <p class="story-text">${slide.content.text}</p>
          ${slide.content.followup ? `<p class="story-text" style="margin-top:0.75rem;font-style:italic;opacity:0.9">${slide.content.followup}</p>` : ''}
        </article>
      </div>`;
      break;

    case 'stats':
      html += `<div class="content">
        ${slide.content.title ? `<h2 class="title gold animate">${slide.content.title}</h2>` : ''}
        ${slide.content.subtitle ? `<p class="subtitle animate delay-1">${slide.content.subtitle}</p>` : ''}
        <div class="stats-grid animate delay-2">
          ${slide.content.stats.map(s => `<div class="stat-box"><div class="stat-value gold">${s.value}</div><div class="stat-label">${s.label}</div></div>`).join('')}
        </div>
        ${slide.content.caption ? `<p class="subtitle animate delay-3" style="font-size:0.85rem;margin-top:0.75rem">${slide.content.caption}</p>` : ''}
      </div>`;
      break;

    case 'refrain':
      html += `<div class="content" style="justify-content:center;height:100%"><p class="refrain animate">"${slide.content.text}"</p></div>`;
      break;

    case 'lesson':
      html += `<div class="content">
        <h2 class="title ${theme === 'light' ? 'navy' : 'gold'} animate">${slide.content.title}</h2>
        <div class="animate delay-1">
          ${slide.content.lessons.map((l, i) => `
            <div class="lesson-item">
              <div class="lesson-number">${i + 1}</div>
              <div class="lesson-content"><h4>${l.title}</h4><p>${l.desc}</p></div>
            </div>
          `).join('')}
        </div>
      </div>`;
      break;

    case 'timeline':
      html += `<div class="content">
        <h2 class="title gold animate">${slide.content.title}</h2>
        <div class="timeline animate delay-1">
          ${slide.content.items.map(item => `
            <div class="timeline-item phase-${item.phase || ''}">
              <div class="timeline-days">${item.days}</div>
              <div class="timeline-content">
                <div class="timeline-title">${item.title}</div>
                <div class="timeline-desc">${item.desc}</div>
              </div>
            </div>
          `).join('')}
        </div>
      </div>`;
      break;

    case 'checklist':
      html += `<div class="content">
        <h2 class="title gold animate">${slide.content.title}</h2>
        <div class="checklist animate delay-1">
          ${slide.content.items.map(item => `
            <div class="checklist-item">
              <div class="check-icon">‚úì</div>
              <div class="checklist-text">${item}</div>
            </div>
          `).join('')}
        </div>
      </div>`;
      break;

    case 'concept':
      html += `<div class="content">
        <h2 class="title ${theme === 'light' ? 'navy' : 'gold'} animate">${slide.content.title}</h2>
        ${slide.content.subtitle ? `<p class="subtitle animate delay-1">${slide.content.subtitle}</p>` : ''}
        ${slide.content.text ? `<div class="card ${theme === 'light' ? '' : 'navy-bg'} animate delay-2"><p class="card-text">${slide.content.text}</p></div>` : ''}
        ${slide.content.highlight ? `<div class="story-box warning animate delay-3"><div class="story-label">Key Insight</div><p class="story-text">${slide.content.highlight}</p></div>` : ''}
        ${slide.content.checkpoints ? `
          <div class="timeline animate delay-2" style="margin-top:0.75rem">
            ${slide.content.checkpoints.map(cp => `
              <div class="timeline-item"><div class="timeline-days">${cp.day}</div><div class="timeline-content"><div class="timeline-title">${cp.event}</div></div></div>
            `).join('')}
          </div>
        ` : ''}
        ${slide.content.allowed ? `
          <div class="card green-border animate delay-2" style="margin-top:0.75rem">
            <div class="card-label" style="color:var(--green)">‚úì Allowed</div>
            <ul style="margin-left:1.25rem;font-size:0.9rem">${slide.content.allowed.map(a => `<li>${a}</li>`).join('')}</ul>
          </div>
          <div class="card red-border animate delay-3">
            <div class="card-label" style="color:var(--red)">‚úó Forbidden</div>
            <ul style="margin-left:1.25rem;font-size:0.9rem">${slide.content.forbidden.map(f => `<li>${f}</li>`).join('')}</ul>
          </div>
        ` : ''}
      </div>`;
      break;

    case 'takeaway':
      html += `<div class="content">
        <div class="takeaway-card animate">
          <div class="takeaway-label"><span class="takeaway-icon">üí°</span>Key Takeaway</div>
          <p class="takeaway-text">${slide.content.text}</p>
        </div>
      </div>`;
      break;

    case 'prediction':
      const pid = `pred_${moduleIndex}_${index}`;
      const answered = gameState.answeredQuestions[pid];
      html += `<div class="content">
        <div class="prediction-panel animate" id="${pid}_panel">
          <div class="prediction-icon">${slide.content.icon}</div>
          <div class="prediction-title">${slide.content.title}</div>
          <p class="prediction-subtitle">${slide.content.subtitle}</p>
          <div class="prediction-buttons" id="${pid}_buttons">
            ${slide.content.options.map(opt => `
              <button class="predict-btn ${opt.id === 'benefit' ? 'benefit' : opt.id === 'harm' ? 'harm' : 'neutral'} ${answered === opt.id ? 'selected' : ''}"
                      onclick="makePrediction('${pid}', '${opt.id}', '${slide.content.answer}', ${slide.content.xp})"
                      ${answered ? 'disabled' : ''}>
                ${opt.label}<br><small>${opt.text}</small>
              </button>
            `).join('')}
          </div>
          <div class="prediction-result ${answered ? 'show' : ''} ${answered === slide.content.answer ? 'correct' : 'incorrect'}" id="${pid}_result">
            ${answered === slide.content.answer ? '‚úì Sua intui√ß√£o estava certa!' : answered ? '‚úó Os dados surpreenderam voc√™ - √© bom saber!' : ''}
          </div>
        </div>
      </div>`;
      break;

    case 'decision':
      const did = `dec_${moduleIndex}_${index}`;
      const decAnswered = gameState.answeredQuestions[did];
      html += `<div class="content">
        <div class="decision-tree animate">
          <div class="decision-header">
            <div class="decision-icon">${slide.content.icon}</div>
            <div><div class="decision-title">${slide.content.title}</div></div>
            <div class="decision-xp">+${slide.content.xp} XP</div>
          </div>
          <div class="decision-scenario">${slide.content.scenario}</div>
          <div class="decision-question">${slide.content.question}</div>
          <div class="decision-options" id="${did}_options">
            ${slide.content.options.map((opt, oi) => `
              <div class="decision-option ${decAnswered === opt.letter ? (opt.correct ? 'correct' : 'incorrect') : ''} ${decAnswered && opt.correct ? 'correct' : ''} ${decAnswered ? 'disabled' : ''}"
                   onclick="makeDecision('${did}', '${opt.letter}', ${opt.correct}, ${slide.content.xp})"
                   tabindex="${decAnswered ? -1 : 0}"
                   role="button"
                   aria-label="Option ${opt.letter}: ${opt.text}"
                   onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();makeDecision('${did}', '${opt.letter}', ${opt.correct}, ${slide.content.xp});}">
                <div class="option-letter">${opt.letter}</div>
                <div class="option-text">${opt.text}</div>
              </div>
            `).join('')}
          </div>
          <div class="decision-feedback ${decAnswered ? 'show' : ''} ${decAnswered && slide.content.options.find(o => o.letter === decAnswered)?.correct ? 'correct' : 'incorrect'}" id="${did}_feedback">
            <div class="feedback-title">${decAnswered && slide.content.options.find(o => o.letter === decAnswered)?.correct ? '‚úì Correct!' : '‚úó Not quite'}</div>
            <div class="feedback-text">${decAnswered && slide.content.options.find(o => o.letter === decAnswered)?.correct ? slide.content.feedback.correct : slide.content.feedback.incorrect}</div>
          </div>
        </div>
      </div>`;
      break;

    case 'quiz':
      const qid = `quiz_${moduleIndex}_${index}`;
      const qAnswered = gameState.answeredQuestions[qid];
      html += `<div class="content">
        <div class="quiz-container animate">
          <p class="quiz-question">${slide.content.question}</p>
          <div class="quiz-options" id="${qid}_options">
            ${slide.content.options.map((opt, i) => `
              <div class="quiz-option ${qAnswered === i ? (opt.correct ? 'correct' : 'incorrect') : ''} ${qAnswered !== undefined && opt.correct ? 'correct' : ''} ${qAnswered !== undefined ? 'disabled' : ''}"
                   onclick="answerQuiz('${qid}', ${i}, ${opt.correct}, ${slide.content.xp || 20})">
                ${opt.text}
              </div>
            `).join('')}
          </div>
          <div class="quiz-feedback ${qAnswered !== undefined ? 'show' : ''} ${qAnswered !== undefined && slide.content.options[qAnswered]?.correct ? 'correct' : 'incorrect'}" id="${qid}_feedback">
            ${qAnswered !== undefined ? (slide.content.options[qAnswered]?.correct ? slide.content.feedback.correct : slide.content.feedback.incorrect) : ''}
          </div>
        </div>
      </div>`;
      break;
  }

  html += '</div>';
  return html;
}

function updateSlideVisibility() {
  const moduleSlides = document.querySelector(`.module-slides[data-module="${currentModule}"]`);
  if (!moduleSlides) return;
  moduleSlides.querySelectorAll('.slide').forEach((slide, i) => slide.classList.toggle('active', i === currentSlide));
  const counter = moduleSlides.querySelector('.slide-counter');
  if (counter) counter.textContent = `${currentSlide + 1} / ${MODULES[currentModule].slides.length}`;
  moduleSlides.querySelectorAll('.progress-dot').forEach((dot, i) => dot.classList.toggle('active', i === currentSlide));
  const prevBtn = moduleSlides.querySelector('.nav-btn:first-child');
  if (prevBtn) prevBtn.disabled = currentSlide === 0;
}

// ===== INTERACTIONS =====
function makePrediction(pid, choice, answer, xp) {
  if (gameState.answeredQuestions[pid]) return;
  gameState.answeredQuestions[pid] = choice;
  gameState.predictionsTotal++;

  const correct = choice === answer;
  if (correct) {
    gameState.predictionsCorrect++;
    addXP(xp);
    if (gameState.predictionsCorrect >= 5) awardBadge('oracle');
  }
  saveGame();
  renderSlides();
}

function makeDecision(did, choice, correct, xp) {
  if (gameState.answeredQuestions[did]) return;
  gameState.answeredQuestions[did] = choice;
  gameState.decisionsCompleted++;

  if (correct) {
    gameState.correctAnswers++;
    consecutiveCorrect++;
    addXP(xp);
    if (gameState.correctAnswers === 1) awardBadge('first_blood');
    if (consecutiveCorrect >= 5) awardBadge('perfect_5');
    if (gameState.decisionsCompleted >= 10) awardBadge('decision_maker');
  } else {
    consecutiveCorrect = 0;
  }
  gameState.consecutiveCorrect = consecutiveCorrect;
  saveGame();
  renderSlides();
  updateReviewButton();
  updateComboDisplay();
}

function answerQuiz(qid, choice, correct, xp) {
  if (gameState.answeredQuestions[qid] !== undefined) return;
  gameState.answeredQuestions[qid] = choice;

  if (correct) {
    gameState.correctAnswers++;
    consecutiveCorrect++;
    addXP(xp);
    if (gameState.correctAnswers === 1) awardBadge('first_blood');
    if (consecutiveCorrect >= 5) awardBadge('perfect_5');
  } else {
    consecutiveCorrect = 0;
  }
  gameState.consecutiveCorrect = consecutiveCorrect;
  saveGame();
  renderSlides();
  updateReviewButton();
  updateComboDisplay();
}

// ===== NAVIGATION =====
function goToModule(index) {
  if (index > 0 && !gameState.completedModules.includes(MODULES[index-1].id)) return;
  currentModule = index;
  currentSlide = 0;
  renderSlides();
  renderSidebar();
}

function goToSlide(index) {
  currentSlide = index;
  updateSlideVisibility();
}

function nextSlide() {
  const mod = MODULES[currentModule];
  if (currentSlide < mod.slides.length - 1) {
    currentSlide++;
    updateSlideVisibility();
  } else {
    completeModule();
  }
}

function prevSlide() {
  if (currentSlide > 0) {
    currentSlide--;
    updateSlideVisibility();
  }
}

function completeModule() {
  const mod = MODULES[currentModule];
  if (!gameState.completedModules.includes(mod.id)) {
    gameState.completedModules.push(mod.id);
    addXP(mod.xp);

    // Check for perfect module (all questions correct)
    if (checkPerfectModule(currentModule) && !gameState.perfectModules.includes(mod.id)) {
      gameState.perfectModules.push(mod.id);
      const bonusXP = Math.round(mod.xp * 0.5);
      addXP(bonusXP);
      showPerfectBonus(bonusXP);
    }

    // Check for module-specific badges
    if (mod.id === 3) awardBadge('protocol_pro');
    if (mod.id === 4) awardBadge('search_savant');
    if (mod.id === 5) awardBadge('data_detective');
    if (mod.id === 6) awardBadge('stats_wizard');
    if (mod.id === 8) awardBadge('colchicine_hero');
    if (gameState.completedModules.length === MODULES.length) {
      awardBadge('finisher');
      setTimeout(showCompletionModal, 500);
    }

    saveGame();
    triggerConfetti();
    updateCourseProgress();
  }

  if (currentModule < MODULES.length - 1) {
    goToModule(currentModule + 1);
  }
}

function showPerfectBonus(xp) {
  const popup = document.getElementById('xpPopup');
  document.getElementById('xpAmount').innerHTML = `+${xp}<br><small style="font-size:0.8rem">PERFECT!</small>`;
  popup.classList.add('show');
  setTimeout(() => {
    popup.classList.remove('show');
    document.getElementById('xpAmount').textContent = '+0';
  }, 2000);
}

// ===== CERTIFICATE DOWNLOAD =====
function downloadCertificate() {
  const courseName = 'META-SPRINT: 40 dias para evid√™ncias confi√°veis';
  const completionDate = new Date().toLocaleDateString('en-US', { year: 'numeric', month: 'long', day: 'numeric' });
  const level = LEVELS[gameState.level - 1] || LEVELS[0];
  const badgeCount = gameState.badges.length;
  const totalXP = gameState.xp;

  const certHTML = `
<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>Certificate of Completion - ${courseName}</title>
  <style>
    @import url('https://fonts.googleapis.com/css2?family=Cormorant+Garamond:wght@400;600;700&family=Source+Sans+Pro:wght@400;600&display=swap');
    * { margin: 0; padding: 0; box-sizing: border-box; }
    body { font-family: 'Source Sans Pro', sans-serif; background: #f5f5f5; padding: 20px; }
    .certificate {
      max-width: 800px; margin: 0 auto; background: linear-gradient(135deg, #1E2761 0%, #141B3D 100%);
      border: 8px solid #D4AF37; border-radius: 12px; padding: 60px 50px; text-align: center;
      box-shadow: 0 20px 60px rgba(0,0,0,0.3);
    }
    .cert-header { font-family: 'Cormorant Garamond', serif; color: #D4AF37; font-size: 1rem; letter-spacing: 0.3em; text-transform: uppercase; margin-bottom: 10px; }
    .cert-title { font-family: 'Cormorant Garamond', serif; color: #FAF8F5; font-size: 3rem; font-weight: 700; margin-bottom: 30px; }
    .cert-subtitle { color: rgba(255,255,255,0.8); font-size: 1.1rem; margin-bottom: 40px; }
    .cert-course { font-family: 'Cormorant Garamond', serif; color: #D4AF37; font-size: 2rem; font-weight: 600; margin-bottom: 15px; padding: 20px; border-top: 1px solid rgba(212,175,55,0.3); border-bottom: 1px solid rgba(212,175,55,0.3); }
    .cert-stats { display: flex; justify-content: center; gap: 40px; margin: 30px 0; }
    .cert-stat { text-align: center; }
    .cert-stat-value { font-family: 'Cormorant Garamond', serif; font-size: 2rem; color: #D4AF37; font-weight: 700; }
    .cert-stat-label { font-size: 0.8rem; color: rgba(255,255,255,0.6); text-transform: uppercase; letter-spacing: 0.1em; }
    .cert-date { color: rgba(255,255,255,0.7); font-size: 0.95rem; margin-top: 40px; }
    .cert-footer { margin-top: 40px; padding-top: 30px; border-top: 1px solid rgba(212,175,55,0.2); }
    .cert-issuer { color: rgba(255,255,255,0.5); font-size: 0.85rem; }
    .cert-badge { display: inline-block; margin-top: 15px; padding: 8px 20px; background: rgba(212,175,55,0.2); border: 1px solid rgba(212,175,55,0.4); border-radius: 20px; color: #D4AF37; font-size: 0.9rem; }
    @media print {
      body { background: white; padding: 0; }
      .certificate { box-shadow: none; }
    }
  </style>
</head>
<body>
  <div class="certificate">
    <div class="cert-header">Synthesis Course Collection</div>
    <div class="cert-title">Certificate of Completion</div>
    <div class="cert-subtitle">This certifies successful completion of</div>
    <div class="cert-course">${courseName}</div>
    <div class="cert-stats">
      <div class="cert-stat">
        <div class="cert-stat-value">${totalXP.toLocaleString()}</div>
        <div class="cert-stat-label">Total XP Earned</div>
      </div>
      <div class="cert-stat">
        <div class="cert-stat-value">${badgeCount}</div>
        <div class="cert-stat-label">Badges Earned</div>
      </div>
      <div class="cert-stat">
        <div class="cert-stat-value">${level.title}</div>
        <div class="cert-stat-label">Final Level</div>
      </div>
    </div>
    <div class="cert-date">Completed on ${completionDate}</div>
    <div class="cert-footer">
      <div class="cert-issuer">Synthesis Course Collection ‚Äî Evidence Synthesis & Meta-Analysis Training</div>
      <div class="cert-badge">Verified Completion</div>
    </div>
  </div>
  <script>window.onload = () => window.print();<\/script>
</body>
</html>`;

  const blob = new Blob([certHTML], { type: 'text/html' });
  const url = URL.createObjectURL(blob);
  const a = document.createElement('a');
  a.href = url;
  a.download = 'Certificate-META-SPRINT-Course.html';
  document.body.appendChild(a);
  a.click();
  document.body.removeChild(a);
  URL.revokeObjectURL(url);
}

// ===== KEYBOARD =====
document.addEventListener('keydown', (e) => {
  // Close modals with Escape
  if (e.key === 'Escape') {
    closeBadgeModal();
    document.getElementById('glossaryPanel').classList.remove('open');
    document.getElementById('completionModal').classList.remove('show');
    document.getElementById('reviewPanel').classList.remove('show');
    // Close mobile sidebar
    document.querySelector('.sidebar').classList.remove('open');
    document.getElementById('sidebarOverlay').classList.remove('show');
    return;
  }
  // Keyboard support for interactive elements (check first to avoid intercepting their keys)
  if ((e.target.classList.contains('module-item') || e.target.classList.contains('decision-option') || e.target.classList.contains('quiz-option')) && (e.key === 'Enter' || e.key === ' ')) {
    e.preventDefault();
    e.target.click();
    return;
  }
  // Don't navigate if review panel is open
  if (document.getElementById('reviewPanel').classList.contains('show')) return;
  // Navigation
  if (e.key === 'ArrowRight' || e.key === ' ') { e.preventDefault(); nextSlide(); }
  else if (e.key === 'ArrowLeft') { e.preventDefault(); prevSlide(); }
});

// ===== TOUCH/SWIPE =====
let touchStartX = 0;
let touchEndX = 0;

document.addEventListener('touchstart', (e) => {
  touchStartX = e.changedTouches[0].screenX;
}, { passive: true });

document.addEventListener('touchend', (e) => {
  touchEndX = e.changedTouches[0].screenX;
  handleSwipe();
}, { passive: true });

function handleSwipe() {
  const swipeThreshold = 50;
  const diff = touchStartX - touchEndX;
  if (Math.abs(diff) < swipeThreshold) return;

  if (diff > 0) {
    // Swipe left = next; guard against swiping past last slide of completed module
    const mod = MODULES[currentModule];
    if (currentSlide >= mod.slides.length - 1 && gameState.completedModules.includes(mod.id)) return;
    nextSlide();
  } else {
    // Swipe right = prev
    prevSlide();
  }
}

// ===== STREAK WARNING =====
function checkStreakWarning() {
  const today = new Date().toDateString();
  const streakEl = document.getElementById('streakDisplay');
  if (gameState.lastActive && gameState.lastActive !== today && gameState.streak > 0) {
    // User has a streak but hasn't engaged today
    const lastDate = new Date(gameState.lastActive);
    const now = new Date();
    const hoursSince = (now - lastDate) / (1000 * 60 * 60);
    if (hoursSince > 20 && hoursSince < 48) {
      // Streak at risk!
      streakEl.classList.add('streak-warning');
      streakEl.title = 'Complete uma li√ß√£o hoje para manter sua sequ√™ncia!';
    }
  }
}

// ===== COMPLETION MODAL =====
function showCompletionModal() {
  document.getElementById('finalXP').textContent = gameState.xp;
  document.getElementById('finalCorrect').textContent = gameState.correctAnswers;
  document.getElementById('finalBadges').textContent = gameState.badges.length;
  document.getElementById('completionModal').classList.add('show');
  triggerConfetti();
  setTimeout(triggerConfetti, 500);
  setTimeout(triggerConfetti, 1000);
}

function closeCompletionModal() {
  document.getElementById('completionModal').classList.remove('show');
}

// ===== REVIEW MISTAKES =====
function updateReviewButton() {
  const mistakes = getIncorrectAnswers();
  const btn = document.getElementById('reviewMistakesBtn');
  if (mistakes.length > 0) {
    btn.classList.add('show');
    btn.textContent = `üìù Review ${mistakes.length} Mistake${mistakes.length > 1 ? 's' : ''}`;
  } else {
    btn.classList.remove('show');
  }
}

function getIncorrectAnswers() {
  const mistakes = [];
  MODULES.forEach((mod, mi) => {
    mod.slides.forEach((slide, si) => {
      if (slide.type === 'decision') {
        const did = `dec_${mi}_${si}`;
        const answer = gameState.answeredQuestions[did];
        if (answer) {
          const correct = slide.content.options.find(o => o.correct);
          const chosen = slide.content.options.find(o => o.letter === answer);
          if (chosen && !chosen.correct) {
            mistakes.push({
              module: mod.title,
              question: slide.content.question,
              scenario: slide.content.scenario,
              yourAnswer: chosen.text,
              correctAnswer: correct.text,
              explanation: slide.content.feedback.correct
            });
          }
        }
      }
      if (slide.type === 'quiz') {
        const qid = `quiz_${mi}_${si}`;
        const answer = gameState.answeredQuestions[qid];
        if (answer !== undefined) {
          const chosen = slide.content.options[answer];
          if (chosen && !chosen.correct) {
            const correct = slide.content.options.find(o => o.correct);
            mistakes.push({
              module: mod.title,
              question: slide.content.question,
              scenario: null,
              yourAnswer: chosen.text,
              correctAnswer: correct.text,
              explanation: slide.content.feedback.correct
            });
          }
        }
      }
    });
  });
  return mistakes;
}

function showReviewPanel() {
  const mistakes = getIncorrectAnswers();
  const content = document.getElementById('reviewContent');

  if (mistakes.length === 0) {
    content.innerHTML = '<p style="text-align:center;opacity:0.7;padding:2rem">No mistakes to review. Great job!</p>';
  } else {
    content.innerHTML = mistakes.map(m => `
      <div class="review-item">
        <div class="review-module">${m.module}</div>
        ${m.scenario ? `<div class="review-question" style="font-size:0.85rem;opacity:0.8;margin-bottom:0.5rem">${m.scenario}</div>` : ''}
        <div class="review-question">${m.question}</div>
        <div class="review-your-answer">‚ùå Your answer: ${m.yourAnswer}</div>
        <div class="review-correct-answer">‚úì Correct: ${m.correctAnswer}</div>
        <div class="review-explanation">${m.explanation}</div>
      </div>
    `).join('');
  }

  document.getElementById('reviewPanel').classList.add('show');
}

function closeReviewPanel() {
  document.getElementById('reviewPanel').classList.remove('show');
}

// ===== INIT =====
renderAll();
checkStreakWarning();
updateReviewButton();
</script>
</body>
</html>
